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Resumo 
A Fibrose Quística (FQ) é a doença genética autossómica recessiva mais comum na 
população Caucasiana. Esta doença é causada por mutações no gene que codifica a 
proteína CFTR (do inglês: Cystic Fibrosis Transmembrane Conductance Regulator) 
que conduzem à sua perda de função e expressão correctas. A FQ é caracterizada por 
uma obstrucção pulmonar crónica devido a infecções bacterianas recorrentes, sendo 
esta a principal causa de mortalidade. Outros sintomas típicos da doença incluêm 
insuficiência pancreática, aumento da concentração de sódio e cloreto no suor e 
infertilidade masculina. No pulmão dos doentes com FQ, a composição iónica alterada 
do líquido que reveste as vias respiratórias dificulta o transporte mucociliar e leva à 
acumulação de um muco espesso, propício à colonização por bactérias, em particular 
Pseudomonas aeruginosa. Estas infecções bacterianas e o processo inflamatório que 
daí resulta, geram um ciclo vicioso que conduz à perda progressiva da função 
pulmonar e à morte precoce do doente. Até à identificação da causa molecular da 
doença, a determinação da concentração salina no suor (elevada na FQ) era 
praticamente a única ferramenta de diagnóstico, continuando ainda a ser o método 
mais usado para diagnosticar a doença. 
O CFTR funciona como um canal de iões cloreto (Cl-) na membrana apical das células 
epiteliais, activado pelo cAMP e por fosforilação pela proteína cinase A (PKA). A 
proteína CFTR, composta por uma única cadeia polipeptídica com 1.480 resíduos de 
aminoácidos, pertence à vasta família de transportadores celulares que são 
responsáveis por facilitar a passagem de diversas substânicas através de membranas 
das células. Este processo requer energia pelo que é acoplado à hidrólise de ATP, 
sendo os membros desta família designados por transportadores ABC (do inglês: ATP-
binding cassette). Porém, o CFTR é o único transportador ABC que funciona como um 
canal iónico. 
O CFTR regula também outros canais iónicos presentes na membrana plasmática, 
sendo bastante relevante na FQ o efeito inibitório que as correntes de Cl- através do 
CFTR têm na activade do canal epitelial de sódio (do inglês: Epithelial Sodium 
Channel ou ENaC). Deste modo, a doença pulmonar na FQ deve-se, não só à 
existência de uma secreção de Cl- ineficiente mas, também, a uma absorção excessiva 
de sódio (Na+) devido à hiperactividade do ENaC nos tecidos dos pacientes. Como já 
foi referido, o ENaC é um canal de sódio, constituído por três subunidades diferentes, 
-, - e -ENaC, que oligomerizam e formam um canal funcional. Para além da 
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relevância desta proteína no contexto da FQ, mutações nas suas cadeias 
polipeptídicas estão também relacionadas com diferentes formas de hipertensão. 
Várias abordagens terapêuticas para o tratamento da FQ têm sido desenvolvidas e 
testadas nos pacientes. Porém, a elevada complexidade desta doença requer, muitas 
vezes, a combinação de diferentes estratégias, não existindo ainda cura para a 
doença. As duas abordagens mais relevantes para esta tese de doutoramento 
basearam~se na tentativa de mimetizar e ultrapassar os problemas causados pela 
falta do CFTR na membrana apical do epitélio pulmonar. Particularmente, tem-se 
depositado grande esperança em compostos que levem à inibição do ENaC ou à 
activação de outros canais de Cl- (como os canais de Cl- activados pelo Ca2+ ou 
CaCCs). Porém, a utilidade destas estratégias terapêuticas requer o conhecimento e 
melhor compreensão das características e mecanismos de regulação dos canais 
iónicos em questão, para que seja possível criar uma superfície pulmonar hidratada e 
aliviar os sintomas pulmonares observados na FQ. 
Os mecanismos que levam à inibição do ENaC pelo CFTR não estão ainda 
completamente esclarecidos, embora muitas proteínas já tenham sido propostas como 
possíveis mediadoras da interacção entre o CFTR e o ENaC. Estas teriam um efeito 
diferente na actividade do ENaC consoante estivessem na presença de um canal 
CFTR funcional ou de uma proteína mutada. Uma destas proteínas é o cinase de 
caseína 2, também conhecido por CK2 (do inglês: casein kinase 2), cuja ligação ao 
ENaC e utilização do mesmo como substrato do cinase tinham sido previamente 
demonstradas. A localização da CK2 na membrana plasmática das células só é 
detectada quando a proteína CFTR wild-type está presente. O efeito da fosforilação 
pela CK2 na actividade e expressão do ENaC foram analisados em detalhe e 
constituem o tópico principal do Capítulo 1 da tese. Descobrimos que a fosforilação 
basal pela CK2 de dois resíduos nas extremidades COOH das subunidades - e - do 
ENaC mantêm o canal activo e impossibilita a ligação, e consequente ubiquitinação, 
de um ligase de ubiquitina E3 conhecido como Nedd4-2, inibindo deste modo a 
endocitose do ENaC. 
Um outro enzima que afecta, simultaneamente, tanto a actividade do CFTR como a do 
ENaC é o cinase dependente do AMP (do inglês: AMP-dependent protein kinase 
AMPK). Este cinase é activado quando as células estão privadas de ATP, catalisando 
a fosforilação e inibição de uma série de vias metabólicas que consomem ATP, 
nomeadamente, das que levam ao transporte iónico através do CFTR e do ENaC. O 
mecanismo pelo qual a AMPK controla a actividade do ENaC, assim como a 
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relevânica fisiológica deste processo foram analisados em oócitos, em linhas celulares 
epiteliais e em ratinhos cujo gene responsável pela codificação da subunidade 
catalítica da AMPK não se encontrava funcional. Os resultados destas experiências, 
apresentados no Capítulo 2, sugerem que activação da AMPK estimula a endocitose 
do ENaC de uma maneira dependente da actividade da Nedd4-2, levando a uma 
inibição do transporte de Na+. Os tecidos dos ratinhos que não possuem AMPK 
funcional expressam mais ENaC na membrana apical, e exibem um transporte mais 
significativo de Na+. Deste modo, podemos concluir que a regulação do ENaC pela 
AMPK é distinta daquela efectuada pela CK2 no sentido em que, enquanto esta última 
ocorre em condições basais, a primeira é apenas relevante numa situação de stress 
como a falta de energia nas células. 
Contudo, tanto a CK2 como a AMPK têm uma expressão ubíqua e fosforilam muitas 
outras proteínas nas células, tornando difícil o uso das mesmas como alvos 
terapêuticos na FQ e evidenciando a necessidade da identificação de outros 
reguladores do ENaC. De modo a cumprir este objectivo, realizámos um screen e 
analisámos por microscopia o efeito de cerca de 20,000 siRNAs na função do ENaC. 
Deste screen resultaram 174 genes que activam o ENaC e cuja inibição pode ser 
eficaz para reduzir o transporte excessivo de Na+ que tanto prejudica as vias 
respiratórias dos pacientes com FQ.  
Na ausência de CFTR, o movimento de iões no epitélio de superfície decorre através 
dos canais de Cl- activados pelo Ca2+ (do inglês: Ca2+-activated Cl- channels ou 
CaCCs) os quais, sob tais condições, se tornam de crucial importância para a 
manutenção do equilíbrio iónico normal. Esta observação é demonstrada pela 
inexistência de sintomas de doença pulmonar em ratinhos cujo gene CFTR foi 
reprimido, contrariamente ao que se observa em humanos, pois os CaCCs são a via 
mais significativa de saída de Cl- nas vias respiratórias dos ratos. Apesar das 
propriedades biofísicas que caracterizam os CaCCs serem bem conhecidas e 
determinadas, só recentemente se descobriu que a entidade na membrana plasmática 
das células epiteliais responsável por este tipo de correntes pertence à família 
TMEM16 (ou anoctaminas). 
Assim sendo, a função de candidatos propostos previamente como CaCCs não era 
clara, sendo importante esclarecer o papel de uma outra família de CaCCs, as 
bestrofinas, na secreção epitelial. Estudos anteriores tinham demonstrado a existência 
de uma correlação entre a expressão de bestrofinas, nomeadamente da isoforma 1 
(Best1) e a existência de correntes de Cl- activadas pelo Ca2+. Os resultados que 
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obtivemos sugerem que Best1 está localizada na membrana do retículo 
endoplasmático, onde funciona como um canal de Cl- sensível ao Ca2+ que 
contrabalança as cargas negativas deixadas quando da entrada ou saída de Ca2+ 
deste organelo. Deste modo, Best1 possibilita a sinalização intracelular que usa o Ca2+ 
como segundo mensageiro e facilita o transporte iónico dependente do Ca2+, tal como 
é apresentado no Capítulo 4. 
Para finalizar, o último capítulo (Capítulo 5) aborda a importância das proteínas 
TMEM16 em diferentes processos celulares, tal como a regulação do volume das 
células após um choque hipotónico e o aumento do mesmo. Os nossos resultados 
demonstram que a capacidade que as células têm de recuperar o seu volume inicial 
após um choque hipotónico depende da actividade de várias membros desta família 
de proteínas, num processo que requer a libertação de ATP e a ligação do mesmo a 
receptores de membrana. 
Em conclusão, os resultados obtidos permitem aprofundar o conhecimento existente 
sobre a expressão e regulação de dois tipos de canais com elevada importância no 
campo da FQ, ENaC e CaCCs, sendo este essencial para o desenvolvimento de 
terapias alternativas para a doença. 
 
Palavras-Chave: Fibrose Quística, CFTR, ENaC, CaCCs, cinases, regulação, canais 
iónicos, epitélio. 
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Summary 
Cystic Fibrosis (CF) is a genetic disease leading to a progressive major pulmonary 
dysfunction and caused by mutations in the gene encoding the Cystic Fibrosis 
Transmembrane Conductance Regulator (CFTR) protein, which, in CF, has impaired 
function and/or expression. CFTR is an ABC-transporter expressed at the apical 
membrane of epithelial cells where it functions as a cAMP-dependent, PKA-regulated 
Cl- channel. In turn, CFTR also regulates other ion conductances such as the epithelial 
Na+ channel (ENaC) which is inhibited by CFTR. This leads to a major characteristic of 
CF epithelia, i.e., defective CFTR-mediated Cl- secretion and enhanced Na+ 
absorption. Traditional CF therapies treat the symptoms. However, several different 
therapeutic approaches for the treatment of the basic defect in CF are being pursued. 
In addition to “CFTR-assist” strategies aiming at correct the intrinsic defect of multiple 
CFTR mutations, others such as inhibition of ENaC and/or activation of alternative Cl- 
channels, e.g. Ca2+-activated Cl- channels (CaCCs) may be able to partially by-pass 
and overcome the defects caused by the loss of CFTR. The feasibility of these non-
CFTR based approaches requires a better knowledge of the characteristics and 
regulation of the ion channels in question, so that a normally hydrated epithelial surface 
can be maintained and soften CF lung disease severity. 
The mechanism(s) through which CFTR controls ENaC activity remain elusive. Several 
proteins have been suggested to mediate CFTR-ENaC functional interaction and to 
have a differential effect on ENaC activity depending on the presence or absence of 
wild type CFTR protein. One of the proposed mediators is the casein kinase 2 (CK2), 
previously shown to phosphorylate - and -ENaC subunits, and whose localization at 
the apical membrane of epithelial cells is abolished when the most common CFTR 
mutation in CF is present. In Chapter 1 on the Results section, the effects of CK2 
phosphorylation on ENaC activity and expression were addressed in detail. We found 
that basal CK2 phosphorylation of ENaC C termini keeps the channel active and 
impairs the binding of the ubiquitin ligase Nedd4-2, inhibiting channel endocytosis. 
In Chapter 2 of the Results section, another kinase affecting CFTR and ENaC activity, 
the AMP-dependent protein kinase (AMPK), was investigated. AMPK is activated upon 
ATP depletion in the cells, switching off ATP-consuming pathways, such as those that 
lead to ion transport through ENaC and CFTR. Here, the mechanism by which AMPK 
controls ENaC activity and its physiological relevance in a knockout mouse model for 
the catalytic subunit of AMPK. We observed that AMPK activation stimulates Nedd4-2-
dependent ENaC endocytosis and consequent inhibition of Na+ transport that is 
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coupled to ATP consumption through the activity of Na+/K+-ATPase. Knockout animals 
have increased expression of ENaC at the apical membrane of different epithelia as 
well as enhanced Na+ transport in these tissues. Regulation of ENaC by AMPK differs 
from that mediated by CK2 in the way that while the last occurs constitutively, the 
former is most relevant under stress conditions and energy depletion. 
The fact that both CK2 and AMPK are ubiquitously expressed and have many cellular 
targets questioned their use as therapeutic targets in CF and evidenced the urge for 
the identification of novel ENaC regulators. This was performed using high-content 
screening microscopy and human siRNA libraries and these data are presented in 
Chapter 3 of the Results. The screen resulted in the identification of 174 different 
genes whose products activate ENaC that constitute potential targets for ENaC 
inhibition and treatment of CF lung disease.  
In the absence of CFTR, movement of Cl- ions across epithelial surfaces procedes 
through Ca2+-activated Cl- channels (CaCC) which, under such conditions become 
crucially important for the maintenance of a normal ionic balance. This is evidenced in 
CF mouse models that fail to exhibit the lung disease observed in humans, most 
probably due to the high CaCC activity which, in murine airways, serves as the main 
pathway for Cl- transport. Although the biophysical properties that characterize CaCC 
are well established for long, the molecular identity of these CaCCs was only recently 
identified as being the TMEM16 (anoctamin) protein family. As bestrophins, whose 
expression correlate well with Ca2+-activated Cl- currents, could also play a role in 
CaCC conductance, we investigated them in Chapter 4 of the Results. We observed 
that Bestrophin 1 (Best1) is localized in the endoplasmic reticulum (ER) membrane and 
we propose that its function is to conduct Cl- as the counteracting ion for the movement 
of Ca2+ into and out of the ER. Best1 thus allows proper signaling by Ca2+ and 
facilitates Ca2+-dependent ion conductance in epithelial cells. 
Finally, in Chapter 5 of the Results section, data are included on the role of TMEM16 
proteins on different important cellular properties, such as the regulation of the cell 
volume after a hypotonic shock and cell swelling. We showed that the ability of the cells 
to recover their initial volume after swelling depends on the activity of TMEM16A and 
other members of this family, in a process that requires ATP release and binding to 
purinergic receptors. 
Altogether, these data bring new insights into the expression and regulation of two 
types of channels of very high relevance to the Cystic Fibrosis field, ENaC and CaCCs, 
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which may be crucial for the development of “by-pass therapies”, i.e. those aiming at 
overcoming the ionic defects caused in epithelia by the loss of CFTR. 
 
Key-words: Cystic Fibrosis, CFTR, ENaC, CaCCs, regulation, kinases, ion channels, 
epithelial cells. 
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I Introduction 
 
1.1 Overview of Cystic Fibrosis 
Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease 
among Caucasians (incidence of 1:2,500-6,000 newborns), characterized in initial 
studies by abnormally high electrical potential differences and decreased chloride (Cl-) 
ion conductance across the apical membrane of epithelial cells from CF patients2,3. 
Later it was shown that it is caused by failure of a adenosine-3’,5’-monophosphate 
(cAMP)-regulated Cl- ion channel4,5 that is encoded by a gene on chromosome 7 and 
termed cystic fibrosis transmembrane conductance regulator (CFTR)6,7. CFTR is in 
charge of proper secretion and absorption of electrolytes in epithelial tissues such as 
those that line the airways, the intestinal tract and ducts in the pancreas, testes and 
sweat glands8. In addition to its function as a Cl- channel, CFTR is also known to 
regulate other ion conductances, being particularly critical its inhibitory effect on sodium 
(Na+) absorption through the epithelial Na+ channel (ENaC)9. Thus, the CF disease is 
characterized by defective epithelial Cl- secretion and enhanced Na+ absorption, being 
the major CF symptom a progressive pulmonary dysfunction. The lack of Cl- flow 
together with Na+ hyperabsorption lead to dehydration of the airway surface liquid layer 
(ASL) and thickening of the mucus layer that accumulates in ducts and lung, where 
lethal Pseudomonas aeruginosa infections start to colonize10. Other CF symptoms 
include pancreatic dysfunction, elevated sweat electrolytes and male infertility1.  
Although approximately 1,800 variants of the CFTR gene have been identified and 
uploaded (http://www.genet.sickkids.on.ca/cftr/), deletion of Phe508 in the first 
nucleotide binding domain (NBD1) of CFTR (F508del-CFTR) is the most frequent 
mutation (~70% of CF chromosomes worldwide) and is associated with a very severe 
clinical phenotype11. Most F508del-CFTR protein fails to mature properly and is 
recognized by the endoplasmic reticulum (ER) quality control and targeted for 
proteasomal degradation. Low temperature incubation (~26ºC) leads to maturation, 
trafficking and insertion of F508del-CFTR into the plasma membrane, where it displays 
~20% activity of the wild type (wt) CFTR protein12.   
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1.2 Pathophysiology of Cystic Fibrosis 
CF is a pleiotropic disease affecting all exocrine epithelia and characterized by a 
multitude of symptoms, since all types of epithelial tissues are affected by loss of CFTR 
function. The reason for this is that, in addition to its ion channel function, CFTR 
directly or indirectly impact different cellular proteins and processes13. It is still unclear, 
however, if all the alterations observed in CF are due to the loss of the CFTR protein 
itself or instead to the absence of the Cl- conductance that it mediates. 
The most devastating phenotype in 
CF is the impairment of lung function 
and airways disease. Briefly, CF 
causing mutations lead to deficient 
CFTR protein expression or activity. 
Altered ionic transport leads to 
increased water absorption and 
dehydration of the airway surface 
liquid (ASL) layer that alters mucus 
composition, important to protect 
against infections. Thickening of the 
mucus layer leads to obstruction of 
the small airways and constitutes an 
ideal environment for survival of 
Pseudomonas aeruginosa colonies. 
Inflammatory response is initiated to 
fight bacterial infections but their 
recurrence culminates with 
bronchiectasis and ultimately with 
severe respiratory failure14 (Fig. I.1). 
 
Epithelial salt and fluid transport is a complex phenomenon involving a large number of 
hormones, transmembrane receptors, agonists and intracellular signaling molecules 
involved in downstream regulation of transport proteins and ion channels. Normal 
airway epithelia have the capacity to absorb excess liquid in the ASL, mediated by Na+ 
absorption through ENaC, that exit the cell via the basolateral Na+-K+-ATPase with Cl− 
following passively through the tight junctions. Cl- is secreted from the cell by the apical 
Fig. I.1 CF pathogenesis cascade in the lung, from
the primary CFTR gene defect to lung deficiency.
Adapted from Amaral (2007)1 
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membrane Cl− channels like CFTR or Ca2+-activated Cl- channels (CaCC), with Cl− 
entering the cell principally via the basolateral Na+-K+-2Cl- cotransporter (Fig. I.2). 
Indeed, besides the role of ENaC, the control of ASL volume is regulated by an 
interplay between CFTR and CaCCs, where CFTR controls the basal level of the 
mucus layer and CaCC works as an acute regulator. Apart from mediating a Cl- 
conductance, CFTR also inhibits Na+ conductance through ENaC9,15, which constitutes 
a major regulatory mechanism for electrolyte and water movement in leaky secretory 
epithelium which are unable to maintain large osmotic gradients. In CF lung disease, 
the influence of the lack of the inhibitory effect of CFTR on ENaC channels is specially 
relevant16 and continued or enhanced Na+ absorption observed in CF3 is primarily 
responsible for the dehydration of the airway surface, which impairs mucociliary 
clearance17. 
 
 
Fig. I.2 Regulation of the volume of ASL by active ion transport. Adapted from Boucher (2004)18. 
Scheme describing routes of Na+, Cl- and H2O transport in airway epithelia cells. At the apical membrane 
of these cells, ENaC is expressed as well as the two Cl- channels, CFTR and CaCC. CFTR is depicted as 
both a regulator of channels and as a Cl- channel itself. On the basolateral surface are the Na+/K+ pump, 
K+ channels, and the loop diuretic sensitive Na+-K+-2Cl- cotransporter (left panel). Interconversion of 
normal human airway epithelia between absorptive and secretory ion transport modes. When excess ASL 
is present, ENaC-dependent Na+ absorption is dominant (middle panel). Cl- absorbed passively via the 
paracellular path since there is no electrochemical driving force (DFaCl-) favoring Cl- exit from the cell. Both 
negative apical membrane potential (Va) and low intracellular Na+ concentration (~20 mM) favour Na+ 
entry.. When ASL volume is low (right panel), ENaC is inhibited, which makes the apical membrane 
potential more negative and generates a driving force for Cl- secretion. 
  
 
 
CF patients suffer in addition from pancreatic insufficiency due to the important role 
that CFTR also plays in HCO3- secretion19. CFTR is expressed at the apical membrane 
of pancreatic duct epithelial cells where it facilitates hydration and alkalinization of 
pancreatic secretions since it is permeant to the anion (with a permeability for HCO3- of 
25% of that of Cl-) and also regulates Cl-/HCO3- exchange proteins20. Many CF patients 
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require supplementation with pancreatic enzymes for proper fat absorption and develop 
diabetes, with a prevalence of about 40% in CF patients older than 30 years. Apart 
from the failure in pancreatic HCO3- secretion, which leads to impairment of intestinal 
digestion and absorption, CF airways also suffer from the lack of cAMP-stimulated Na+-
dependent HCO3- secretion. In this way, CF airways have a different pH of the ASL 
which prevents the normal processing of mucins and contributes to their hyperviscosity 
and to the pathophysiology of the disease19.  
Additionally, the lack of a CFTR chloride channel in the sweat duct blocks NaCl 
reabsorption, which are coupled in this tight epithelium differing from what is observed 
in the airways. Thus, NaCl concentration in the sweat is assessed during the diagnostic 
of CF disease and, if it is higher than 60 mM, patients are diagnosed with classic or 
typical CF. 
Although CFTR is mostly expressed in salt-transporting epithelia, it has also been 
detected in cells of the immune system, like macrophages, neutrophils and other 
hematopoietic cells21, which might account for the apparent hyperinflammatory status 
of CF patients’ tissues prior to infection22. In alveolar macrophages, CFTR has been 
proposed to participate in phagosomal pH control and therefore suggested to have 
bacterial killing capacity23. Other authors have proposed that CFTR serves as a 
receptor for Pseudomonas aeruginosa, and binding of the microorganism to CFTR 
would instigate its internalization and stimulate cytokine secretion necessary to 
counteract infection24. These diverse effects of CFTR reflect the multitude of symptoms 
observed in CF. Nevertheless, it is definitely hard to conceive only one biological entity 
having so many distinct roles. 
 
1.3 CFTR protein: structure, function and trafficking  
CFTR plays a fundamental role in fluid and electrolyte transport across epithelial 
tissues. The amino-acid sequence of CFTR and its “modular architecture” and 
regulation indentified it as a member of the superfamily of ATP-binding cassette (ABC) 
transporter ATPases. However, CFTR is the only member of this superfamily that 
functions as an ion channel, although the sulphonylurea receptor (SUR) associates 
with inward rectifier potassium-ion channels to form nucleotide-sensitive potassium 
conductance25. The CFTR protein, which is expressed at the apical membrane of 
different epithelial tissues, comprises several domains, namely (i) two membrane-
spanning domains (MSD1/2), (ii) two nucleotide-binding domains (NBD1/2), each 
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containing conserved aminoacid sequences that interact with ATP, (iii) a unique 
regulatory (R) domain not found in other ABC transporters, distinguished by multiple 
consensus phosphorylation sites and many charged aminoacids6 and (iv) cytosolic N- 
and C-termini which mediate CFTR participation in macromolecular complexes26. 
CFTR channel gating is a tightly regulated process and conformational movements 
within the two NBDs are coupled to rearrangements among the MSDs, which shift the 
equilibrium between the open and the closed state27. Protein kinase A (PKA)-
dependent phosphorylation of the R domain is needed for transmission of the events 
occurring at the NBDs to the channel gate and to restrain channel opening/closing28. In 
particular, the open probability of the channel depends on the degree of 
phosphorylation of the R domain at multiple sites, reflecting the balance between 
protein kinases and phosphatases activity10. Although being primarly phosphorylated 
by PKA, CFTR is also a substrate of other kinases that (i) activate the channel, e.g. 
cGMP-dependent protein kinase, (ii) inhibit CFTR, e.g. AMP-dependent protein kinase 
(AMPK), or (iii) have dual effects on channel activity depending on the consensus site 
phosphorylated, like protein kinase C (PKC) and PKA26,28. Differential kinase activity 
and basal phosphorylation status of CFTR partly account for the functional difference 
observed in epithelial tissues. For example, while CFTR is continually phosphorylated 
by PKA to become active, in the reabsorptive duct of the sweat gland, the channel is 
unphosphorylated and inactive in secretory epithelia, until cyclic AMP (cAMP) levels 
increase and activate PKA27. 
CFTR goes through four broad trafficking pathways (i) biosynthesis, conformational 
maturation and trafficking from the ER to the plasma membrane, (ii) endocytic retrieval 
from the plasma membrane to early or sorting endosomes, (iii) recycling of 
endocytosed CFTR back to the cell surface and (iv) targeting of endocytosed CFTR for 
degradation29. 
Regarding CFTR biosynthesis, it is co-translationally inserted into the ER membrane 
where N-linked glycosylation and several cycles of interaction with the ER chaperone 
calnexin facilitate folding through an iterative process until the fully folded native 
conformation is achieved30. Although maturation of wild type (wt)-CFTR is already an 
inefficient process (less that 30% of synthesized protein trafficks to the plasma 
membrane in heterologous expression systems) deletion of Phe508 (F508del) causes 
a even greater maturation and trafficking defect31,32. F508del-CFTR does not achieve 
the native folded conformation and remains in the ER as an early folding intermediate 
of wt-CFTR33. Formation of a stable complex between F508del-CFTR and the cytosolic 
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chaperones Hsc/Hsp70 leads to its degradation by the proteasome34. The cellular 
levels of Hsc70 co-chaperones seem to influence directly the folding efficiency of CFTR 
and to shift the equilibrium between either CFTR folding or degradation, according to 
the cellular needs30,35. Rigorous ER quality control mechanisms exist to assure that 
only correctly folded CFTR progresses through the Golgi complex until the plasma 
membrane36. 
CFTR carboxyl termini contain several internalization motifs such as YXX where  is 
bulky hydrophobic aminoacid, and D/EXXXLL/I and DXXLL as di-leucine-based motifs. 
In particular, CFTR has a phenylalanine- (1413FLVI), a tyrosine- (1424YDSI) and di-
leucine-based motifs (1430LL)29. CFTR is removed from the cell surface mainly by 
clathrin-mediated pathways, although it has also been proposed that CFTR enters 
caveolae and its localization to lipid rafts triggers its function as a cellular receptor for 
Pseudomonas aeruginosa lypopolysaccharide (LPS)-core oligosaccharide24,37. 
Bacterial binding leads to CFTR-dependent Pseudomonas internalization and triggers 
signalling mechanisms critical for innate immune resistance to infection with this 
pathogen37. 
Internalized CFTR is recycled back to the cell surface, as it is suggested from the lack 
of effect of biosynthetic inhibitors on cAMP-activated Cl- currents29. Pools of endosomal 
CFTR in sub apical compartments can be detected and these are the sites of acute 
regulation of CFTR by cAMP-dependent protein kinase A (PKA) in intestinal cells, 
although there is no direct evidence for such regulation in airways epithelial cells29. 
Vesicular trafficking through endosomal and recycling compartments is regulated by 
several different molecules, including Rab GTPases, RmeI and myosins38. 
 
1.4 Epithelial Na+ Channel (ENaC) 
1.4.1 ENaC structure and function 
The epithelial Na+ channel (ENaC) belongs to the ENaC/Degenerin family of ion 
channels that show a high degree of functional heterogeneity and tissue expression, in 
either transporting epithelia or in neuronal excitable tissues39. Depending on their 
function in the cell, these channels are either constitutively active, like ENaC, or 
activated by mechanical stimuli, like degenerins, or by ligands such as peptides or 
protons in the case of FMRF-amide-gated (FaNaC) and acid-sensing ion channel 
(ASIC)39.  
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ENaC is the rate-limiting step for Na+ reabsorption, favoured by the its electrochemical 
gradient, in several absorptive epithelia, including the colon, sweat gland, salivary duct, 
airways and kidney cortical collecting duct, where it localizes at the apical membrane. 
After being absorbed, Na+ is then pumped out of the cells into the blood through the 
Na+-K+ ATPase, making ENaC a critical regulator of extracellular fluid volume and thus 
blood pressure. In this regard, alterations in ENaC structure and function have been 
associated with several human diseases which can be linked to an increase in ENaC 
activity, like Liddle’s syndrome, hypertension and cystic fibrosis, or to a reduced Na+ 
absorption like in pseudohypoaldosteronism and pulmonary edema. 
Native epithelial Na+ channels show diverse biophysical properties, namely the single 
channel conductance, permeability to Na+ over K+ and amiloride affinity differ between 
tissues and species40. Accordingly, native epithelial Na+ channels can be classified in 
highly selective (type I), moderate (type II) or nonselective Na+ channels (type III). The 
highly selective ENaC channel is formed by three homologous subunits termed alpha-, 
beta- and gamma-ENaC (-, - and -ENaC)41. Two additional subunits, - and -
ENaC, have also been cloned and they are closer in aminoacid sequence to -ENaC40. 
The fact that -ENaC can replace -ENaC and oligomerize with - and -subunits, 
giving rise to Na+ channels with different biophysical properties, can account for the 
heterogeneity observed in native epithelial Na+ channels39. In particular, in Xenopus 
oocytes, expression of -ENaC results in an approximately tenfold increase in 
amiloride-sensitive current compared to -ENaC42. Differential expression of the  
and  subunits may provide an additional mode of regulating ENaC activity. 
Each subunit has two transmembrane domains (M1 and M2) between which there is a 
large hydrophilic loop (approximately 50 kDa) that remains in the lumen of the 
organelle and short cytoplasmic N- and proline-rich C-termini (with 9 and 10 kDa)43 
(Fig. I.3). All three subunits are glycosylated at several N-linked glycosylation sites in 
the extracellular loop. ENaC is specifically inhibited by submicromolar concentrations of 
the potassium-sparing diuretic amiloride and this compound is always used to assess 
the contribution of ENaC to Na+ transport. 
Based on the recent crystal structure of ASIC, the issue of ENaC subunit stoichiometry 
appears to be settled with ENaC presumably consisting of a 1:1:1 complex44. 
However, ASIC is a homotrimer, and previous functional studies with ENaC subunits 
have suggested a heterotetrameric or even variable stoichiometry. 
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Fig. I.3 Representation of the structural model of the rat -ENaC subunit. 
Adapted from Gaillard et al (2010)45. Each ENaC subunit has two transmembrane 
domains, a large extracellular loop. For all the subunits, the C- and N-termini are 
intracellular. The structural model was generated based on the crystal structure of 
cASIC. 
 
 
1.4.2 ENaC biogenesis and traffic 
1.4.2.1 ER-coupled protein translation and export 
In spite of the progress made in understanding ENaC regulation at the molecular level, 
many questions remain to be answered, in particular those regarding biosynthesis and 
traffic of channels46. As a plasma membrane protein, ENaC is co-translationally 
inserted in the ER membrane and its export requires assembly of the -, - and - 
subunits into a complex with correct folding47. In Xenopus oocytes, ENaC subunits are 
readily synthesized in the ER but most of them remain as immature proteins in pre-
Golgi compartments, where they are degraded by the proteasomal pathway without 
apparent ubiquitination48. In this study, even when the three subunits were expressed, 
only a very small fraction (~1%) of the total channel population reached the cell 
surface48. Although the majority of endogenous newly-synthesized ENaC subunits 
present in A6 cells, a polarized and hormonally responsive Xenopus kidney cell line, is 
rapidly degraded after synthesis (half-life (t1/2)=2h), still a significant amount can be 
found at the plasma membrane (~20%)49. Indeed, the half-life of ENaC that reaches the 
plasma membrane is considerably longer (- and -ENaC, t1/2~24h, -ENaC: t1/2~6h), 
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with -xENaC having the shortest half-life, suggesting specific insertion and retrieval of 
-xENaC in response to alterations in Na+ influx49. 
Non-coordinate transcription of ENaC subunits is tissue-specific. In the kidney, when 
the rate of Na+ transport is low, -ENaC is transcribed to a lesser extent than - or -
ENaC and aldosterone increases -ENaC transcription. However, in rat colon, 
aldosterone increases - and -ENaC transcription to a much greater extent than -
ENaC and in M1 cells expression of -ENaC might limit formation of functional 
channels47. Although the synthesis and degradation of excess ENaC subunits appears 
wasteful, its advantage is in the ability to control channel activity and delivery by 
transcriptional regulation of a single ENaC subunit47. Traffic of ENaC is an inefficient 
process and most cells express only few channel molecules at the plasma membrane. 
 
1.4.2.2 ENaC endocytosis 
ENaC trafficking plays an important role in regulating the abundance of active vs. 
inactive channels and endocytosis is stimulated once a channel is active as a way to 
protect the cells from a large Na+ load. The brief residency of ENaC at the plasma 
membrane is related to its ability to be modified and negatively regulated by the 
addition of ubiquitin. ENaC subunits have a PPPXYXXL sequence conserved in the C 
terminus. This sequence fits a Pro-Tyr (PY) motif (PPPXY) which is required for the 
binding of the E3 ubiquitin ligase Nedd4-250. Nedd4-2 stands for neural precursor cell-
expressed developmentally downregulated (gene 4) protein isoform 2 which, apart from 
its HECT (homologous to the E6-AP carboxyl terminus) ubiquitin ligase domain, has a 
series of WW domains (Trp based motifs of 38 amino acid residues) through which it 
binds to ENaC51. Nedd4-2 mediates ubiquitination of Lys residues on the N-terminus of 
- and -ENaC that serves as signals for protein retrieval to endosomes or lysosomes 
and either sorted for recycling or degraded, respectively52. While -ENaC channels 
are degraded in the lysosomes, it has been shown that unassembled ER localized 
subunits are degraded in the proteasome52. 
The mendelian disorder called Liddle's syndrome (pseudoaldosteronism, OMIM 
177200) that shows dietary salt sensitive hypertension and hypokalemia, was initially 
shown to arise from constitutive activation of ENaC due to mutations in - and - 
subunits53. It is now well-established that these gain-of-function mutations impair 
Nedd4-2 binding to ENaC and inhibit ENaC endocytosis52. The interaction between 
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Nedd4-2 and ENaC has been identified as an important site for physiological 
regulation.  
After being ubiquitinated by Nedd4-2, it is still possible that ENaC is not targeted for 
degradation if deubiquitinating (DUBs) enzymes remove the ubiquitin molecules. One 
DUB known to act on ENaC is the ubiquitin COOH-terminal hydrolase (UCHL3), which 
is not induced by aldosterone and is ubiquitiously expressed. Knockdown of UCHL3 
inhibited ENaC basal and cAMP-stimulated activity54. Since there was little decrease in 
whole cell levels of ENaC upon UCHL3 inhibition, it is likely that this enzyme is not 
involved in degradation at the level of the ER but near the apical surface. Like UCHL3, 
Usp2-45, an early aldosterone-induced gene product, also deubiquitinates ENaC and 
overexpression of this DUB increases Na+ transport55. However, the cellular level at 
which this mechanism occurs is still unclear. In summary, direct deubiquitination of 
ENaC is an important mechanism to control channel targeting for degradation, but 
there are also a number of accessory and trafficking proteins which are likely regulated 
by DUBs and may alter ENaC abundance. In addition, it is possible that ubiquitinating 
and deubiquitinating enzymes are themselves regulated by ubiquitination offering 
another level of regulation46.  
Apart from the PY motifs present in the conserved region PPPXYXXL in the C terminus 
of -, - and - ENaC, this sequence is similar to two endocytic motifs, NPXY and 
YXX, where  is a hydrophobic amino acid, suggesting that it might mediate ENaC 
endocytosis. Mutation of the conserved Tyr (Y) in this region of -ENaC leads to an 
increase in ENaC activity, either by downregulating interaction with Nedd4-2 or by 
disrupting the AP-2-mediated internalization motif, necessary to recruit clathrin to 
deform the plasma membrane. The overlapping PY and YXX motifs in ENaC are 
capable of independent function and phosphorylation of Ser/Thr residues just 
preceding and within these domains impacts their recognition56.  
Membrane proteins modified by attachment of one or more ubiquitin molecules appear 
to require binding to accessory proteins which link them to clathrin adaptors57. 
Members of the evolutionary conserved epsin family have been shown to interact with 
membranes and with specific components of the endocytic machinery through 
individual domains: at the N-terminus the ENTH (for epsin amino terminal homology) 
domain that stably associates with phosphatidylinositol-4,5-biphosphate (PI(4,5)P2) at 
the plasma membrane; two or three copies of UBI (for ubiquitin-interacting) motifs and 
at the C-terminus numerous linear peptide sequences that bind clathrin, accessory 
components and adaptor proteins of the endocytic machinery, such as AP257. 
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Indeed, coexpression of epsin as well as Nedd4-2 inhibits ENaC activity, in contrast 
with what is observed for dynamin 1 dominant negative mutant, in a heterologous 
expression system56. Concerning epsin-dependent clathrin-coated vesicles formation, 
PI(4,5)P2 plays an important role since it not only mediates the association of epsin 
with the ubiquitinated cargo proteins and the plasma membrane which triggers clathrin 
lattice formation, but also enables the recruitment of dynamin-1 and vesicle fission. It 
has been demonstrated that stimulation of PI(4,5)P2 levels by phosphatidylinositol 4-
phosphate 5-kinase  (PIP5-K) results in an enhanced rate of clathrin-mediated 
endocytosis and overexpression of this kinase in both mouse cortical collecting duct 
(CCD) cells and in oocytes results in increase in PI(4,5)P2 levels and decrease in 
ENaC surface expression consistent with increased retrieval58. However, PIP5-K 
isoform appears to stimulate exocytosis in overexpression systems, suggesting that the 
effects of PI(4,5)P2 on ENaC are very complex and depend on several other factors 
and physiologic stimuli.  
 
1.4.3 ENaC regulation 
Although many aspects of ENaC trafficking and regulation are still unresolved, it is now 
clear that this channel is under tight regulatory mechanisms since it is the rate-limiting 
step for Na+ transport. Indeed, abnormalities in ENaC activity lead to hypertension or 
other disease states. These mechanisms mainly control the number of channels at the 
plasma membrane (N) and the channel open probability (Po)50. ENaC single channel 
conductance (i) is not affected by significant regulatory and genetic alterations. 
Expression of ENaC at the apical membrane in polarized epithelial cells can be 
regulated by the action of hormones, such as aldosterone and insulin, which, either by 
translocating additional channels from subapical locations or by increasing the 
residence at the cell surface (increased synthesis and delivery and/or impaired 
retrieval), lead to an enhancement of sodium transport. This homeostatic control 
ensures the finetuning of sodium homeostasis and, along with chloride movement, 
provides the osmotic driving force for water transport. 
ENaC has a relatively short half-life at the apical membrane and, although different 
estimates (form 15 min to over 3h) have been reported, some consensus has emerged 
on that ENaC surface half-life is of 20-30 min in several polarized cell systems or for 
endogenously expressed ENaC (A6, MDCK, FRT)46.  
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1.4.3.1 Regulation by hormones 
Aldosterone and glucocorticoids 
Upon volume depletion, decreased renal perfusion results in release of renin from the 
juxtaglomerular apparatus, activating the renin-angiotensin-aldosterone pathway. 
Aldosterone increases within 1h renal Na+ absorption and K+ secretion by a mechanism 
that is triggered at the level of gene transcription. Abundance of -, - and -ENaC 
mRNA is significantly higher already after 24h of stimulation with aldosterone59. 
Aldosterone also rapidly up-regulates serum- and glucocorticoid-dependent kinase 
isoform 1 (SGK1), by binding to its intracellular mineralocorticoid receptor (Fig. 4). 
Corticosteroids, via glucocorticoid receptors, increase Na+ transport through similar 
mechanisms and an increase in abundance of -, -, -ENaC and SGK1 mRNA is 
readily observed after 1h treatment in lung epithelial cell lines60. 
Some heterogeneity in the increase of ENaC transcripiton is observed upon different 
stimuli, such as low NaCl diet, acute glucocorticoids or mineralocorticoids exposure, in 
the kidney, lung and colon. In particular, ENaC in the airways is distinguished from 
ENaC expressed in other tissues by its insensitivity to aldosterone, being mainly 
regulated by glucocorticoids making its expression linked to changes in inflammation 
rather than in blood pressure/volume61. 
ENaC is regulated not only by hormones, but also by intracellular signalling, including 
ubiquitination and/or phosphorylation. The molecular mechanisms involving 
phosphorylation in the regulation of ENaC were firstly revealed by expression studies in 
Xenopus oocytes and then in mammalian cells (FRT cells) that showed that the 
aldosterone-induced SGK1 interacts with Nedd4-2 in a PY motif-dependent 
manner62,63.  
SGK1 phosphorylates xNedd4-2 at two conserved consensus sites (on Ser444 and, to 
a lesser extent, on Ser338), reducing the interaction between ENaC and Nedd4-2 and 
leading to an increased channel cell surface expression63 (Fig. I.4). SGK1 does not 
phosphorylate the Nedd4-2 paralog, Nedd4-1, which contains no consensus 
sequences for SGK1-dependent phosphorylation and does not seem to be primarily 
involved in ENaC regulation 63,64. A stimulatory effect of SGK1 on ENaC activity has 
also been reported, mediated by a SGK1 consensus motif in -ENaC and independent 
of Nedd4-265. SGK1-dependent phosphorylation of Nedd4-2 induces the interaction 
between the ubiquitin ligase and specific aldosterone-induced 14-3-3 protein 
isoforms51,66. The phosphorylation of Nedd4-2 and its interaction with 14-3-3 proteins 
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result in a decreased affinity of Nedd4-2 for ENaC and, by disrupting channel 
ubiquitination, leads to increased retention of channels at the apical membrane of 
aldosterone-responsive cells67. SGK1 consensus sequences on Nedd4-2 
(RXRXX(S/T)) overlap with cAMP-dependent protein kinase (PKA) consensus motif 
(RXX(S/T)) and Nedd4-2 is also phosphorylated by PKA, justifying the inhibitory effect 
of cAMP on Nedd4-2 and the stimulatory effect of vasopressin on ENaC activity68. 
A similar modulatory effect is the phosphorylation of -ENaC by the G protein receptor-
coupled kinase Grk2, rendering the channel insensitive to inhibition by Nedd4-269. Grk2 
also phosphorylates Nedd4-2 and, like SGK1, decreases channel association with the 
ubiquitin ligase70. Additional evidence for the relevance of Grk2-mediated 
ENaC/Nedd4-2 interaction is the association observed of overactivity of this kinase with 
hypertension71. 
In contrast, the opposite effect has been ascribed to the extracellular regulated kinase 
ERK which phosphorylates T613 in -ENaC and T623 in -ENaC (rat) and apparently 
leads to an increase in affinity for Nedd4-2 binding72,73. This may be particularly 
relevant for cAMP-induced stimulation of ENaC in vivo since intracellular cAMP favors 
the dephosphorylation of these two ERK sites, reducing channel retrieval and 
increasing Po by modulating ENaC/Nedd4 interaction73. The ERK cascade may be 
constitutively active in native ENaC expressing tissues or may be activated through the 
epidermal growth factor (EGF) signaling pathway or by progesterone46,74. The 
aldosterone-induced protein GILZ appears to disrupt the activation of ERK, blocking 
this phosphorylation mechanism and leading to a decrease in affinity of the channel for 
Nedd4-275, in line with the physiological role of aldosterone which is to increase Na+ 
absorption and hence blood pressure.  
SGK1, Grk2 and ERK-mediated phosphorylation mechanisms provide major pathways 
that control the ability of Nedd4-2 to bind and ubiquitinate ENaC and thereby regulate 
ENaC cell surface density by manipulating its endocytic rate. Ubiquitination appears to 
be the predominant signal for ENaC internalization and channel endocytosis is a critical 
point of physiological control by the hormones that regulate Na+ balance46. 
 
Insulin 
The cytoplasmic domains of - and -ENaC subunits contain several positively charged 
lysine- or arginine-rich motifs among all species including human, rat, mouse, and 
Xenopus76. In contrast to C-termini truncation, deletion of the N-terminus of - and -
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ENaC inhibits channel activity, due to the disruption of channel interaction with 
negatively charged PI(4,5)P2 present in the cytoplasmic leaflet of the plasma 
membrane. 
It has been shown that reduction of PI(4,5)P2 levels at the cell surface mediates 
purinoceptor-induced (namely, P2Y2 receptor) inhibition of ENaC, through binding of 
ATP/UTP to the receptor and activation of phospholipase C (PLC)76. A similar 
mechanism is on the basis of EGF inhibition of ENaC which, by binding to its receptor, 
also leads to a reduction of membrane PI(4,5)P2. Similar to PI(4,5)P2, also PI(3,4,5)P3 
upregulates ENaC, and aldosterone and insulin enhance Na+ transport by activating 
phosphatidylinositol-3-kinase (PI3K) in A6 cells and increasing ENaC Po.  
It might seem contradictory that PI(3,4,5)P3 also upregulates ENaC since its production 
involves phosphorylation of PI(4,5)P2 by PI3K. Interestingly, it has been shown that, 
upon insulin binding to its basolateral receptor, PI3K is activated and phosphorylates 
PI(4,5)P2 in the basolateral membrane and PI(3,4,5)P3 is rapidly transported to the 
apical membrane because the inner leaflet of the plasma membrane is not constrained 
by tight junctions77. These two lipid second messengers, PI(4,5)P2 and PI(3,4,5)P3, 
jointly regulate plasma membrane targeting of proteins with clusters of positively 
charged aminoacids in the cytosolic domains78. The role of PI(3,4,5)P3 in endosomal 
sorting has also been examined and, while PI3K inhibition impairs trafficking through 
endosomes by collapsing discreet sorting compartments, PI4P phosphatase rescues 
it46. In addition, PI3K-dependent formation of PI(3,4,5)P3 leads to the activation of 
phosphatidylinositol-dependent kinases (PDKs). PDK1 phosphorylates and activates 
SGK, further increasing Na+ transport (Fig. 4). 
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Fig. I.4 Regulation of ENaC by aldosterone, insulin and PPAR-. Adapted from Kiryluk et al (2007)79. 
Aldosterone interacts with its mineralocorticoid receptor (MR) and directly upregulates the mRNA levels of 
ROMK, -ENaC- and SGK1 (Sgk-1). SGK1 inactivates Nedd4-2, stimulates basolateral Na+K+ATPase and 
activates ROMK (left panel). The right panel illustrates a possible convergence point of the insulin and 
TZD-mediated pathways at Sgk-1 level. Thiazolidinediones (TZDs) activate PPAR-, which in turn 
increases the expression of -ENaC and of an inactive form of Sgk-1. Insulin acts via phosphatidylinositol 
3-kinase (PI3K) and phosphoinositide-dependent kinase (PDK) pathway which converts inactive SGK1 to 
its active form by phosphorylation. * shows the PY motif-mediated interaction between ENaC subunits and 
ubiquitin ligase Nedd4-2. 
 
 
 
Vasopressin (and cAMP) 
In addition to aldosterone and insulin, the hormone vasopressin (antidiuretic hormone, 
ADH) also increases ENaC activity (as well as water absorption) in the distal nephron 
by binding to V2 receptors and stimulating activation of adenylate cyclase and the 
release of cAMP80. As already mentioned, PKA-dependent phosphorylation of Nedd4-2 
(which is activated by cAMP) provides inhibitory function much like SGK1, leading to 
increased cell surface abundance of the channel68. cAMP increases the density of 
ENaC channels at the plasma membrane by inhibiting the ERK-dependent Nedd4-
2/ENaC73 and by mobilizing ENaC channels from intracellular pools81. Vasopressin 
(and cAMP) also regulates aquaporin-2 exocytosis, stimulating at the same time Na+ 
absorption through ENaC and water transport, two processes that are tightly 
correlated47. 
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1.4.3.2 Regulation by proteases 
Another mode of ENaC regulation, distinct from changes in channel number, is the 
ability to modulate Po that channel activating proteases (CAP) have, converting near-
silent channels into active ones. A seminal observation suggesting that ENaC is 
regulated by endogenous serine proteases was that aprotinin, a broad-spectrum 
inhibitor of Ser peptidases, inhibited ENaC in A6 cells and trypsin abolished this 
effect82. In the airways, regulation of ENaC by proteases seems to be the predominant 
mode of regulation since knockdown of either endogenous serine proteases such as 
prostasin, or inhibitors of ENaC proteolysis such as SPLUNC1, have large effects on 
ENaC activity45.  
From the crystal structure of ASIC1, another member of the ENaC/Degenerin ion 
channel family, important insights can be retrieved regarding the structural organization 
of these proteins. The extracellular domain of ASIC1 has a highly ordered structure 
with defined subdomains which, through changes in their conformation, communicate 
with the transmembrane domains to modulate ASIC1 proton-dependent gating44. 
Interestingly, sites where functional relevant ENaC proteolysis occurs are located 
within some of these subdomains at peripheral sites which would be accessible to 
proteases83.  
Three different types of proteases have been shown to cleave ENaC: (1) intracellular 
convertase-type proteases, such as furin, (2) extracellular, cell-attached proteases, 
which can either be membrane spanning (with either C- or N- terminus intracellular) or 
glycosylphosphatidylinositol (GPI)-anchored and (3) soluble proteases including trypsin 
and neutrophil elastase45. 
Right after initial translation-coupled embedding in the ER membrane, ENaC subunits 
mature prior to insertion into the plasma membrane by addition and processing of N-
linked sugar residues and by proteolysis at two sites in -ENaC and in -ENaC at one 
site by furin, a membrane-anchored Ca2+-dependent serine endoprotease that localizes 
principally to the lumen of the trans-Golgi network84. Cleavage of the -ENaC activates 
channel Na+-transporting activity by relieving ENaC from Na+ self inhibiton85 and by 
dissociating an inhibitory domain in the extracellular loop86.  
At the cell surface, ENaC function appears to be further upregulated by one or more 
extracellular or plasma membrane-associated CAPs. The first CAP (CAP1) to be 
identified was cloned from Xenopus laevis and found to be expressed in kidney, gut, 
lung, skin and ovary and to be a GPI-anchored protein87. CAP1 was later identified as 
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prostasin (TMPRSS8) and shown to further enhance ENaC activity, by processing -
ENaC at a site distal to the furin cleavage site88. Other proteases have been shown to 
both activate ENaC and cleave the  subunit similarly to prostasin, including elastase, 
CAP2 (TMPRSS4) and plasmin83. Matriptase (or CAP3) also activates the channel, 
although it has not been shown that this protease directly cleaves ENaC87. Trypsin can 
also activate ENaC and since exposure to this protease following elastase does not 
further enhance ENaC activity, suggests that the two proteases share a common mode 
of action to stimulate Na+ transport45. Clearly, a number of proteases can cleave and 
activate ENaC and they are likely to activate the channel indirectly by cleaving and 
activating other proteases that subsequently work on the channel.  
 
1.4.3.3 Regulation by CFTR 
As mentioned earlier, CFTR is in charge of proper secretion and absorption of 
electrolytes, since an inhibitory effect of CFTR on ENaC has been detected under very 
different experimental conditions. Accordingly, enhanced Na+ absorption can be 
observed in CF tissues, including human airways3 and intestine, which, together with 
defective Cl- secretion cause ASL volume depletion, mucus adhesion that favours 
bacterial infection.  
Regulation of ENaC by CFTR has been studied in detail in Xenopus oocytes but also in 
epithelial tissues from intestine and trachea as well as in renal cells. Although a direct 
interaction between CFTR and ENaC has been proposed89, it is still not clear how 
CFTR might control ENaC activity and a number of hypotheses have been presented. 
It was shown that CFTR NBD1 is a requirement for the inhibitory effect that CFTR 
exerts on ENaC90. Additionally, it has been demonstrated that other ABC transporters, 
such as MDR1, SUR1 or the cadmium permease (YCF1), cannot mimic the inhibitory 
effect of CFTR on ENaC90. This finding was then supported by evidences that the local 
intracellular concentration of Cl- plays an important role on the CFTR-dependent 
inhibiton of ENaC. In this regard, it was shown that Cl- ions, as well as other anions, 
have an inhibitory effect on ENaC, when accumulated on the cytosolic side and the 
carboxyl termini of ENaC subunits are crucial for this process91. It was shown, in a 
different study also using Xenopus oocytes, that ENaC is not regulated appropriately 
by a non-Cl--conducting CFTR mutant (F508del-CFTR) upon activation with cAMP-
elevating agents, but after genistein treatment the regulatory interactions between 
ENaC and F508del-CFTR are restored92. In contrast, CFTR Cl- conductance is 
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increased in the presence of ENaC due to an increase in both CFTR open probability 
and in the number of channels expressed, suggesting that in addition to acting as a 
regulator of ENaC, CFTR activity is regulated by ENaC93. 
Recently, it has been proposed that the association between ENaC and CFTR protects 
ENaC from proteolytic cleavage by selective endoproteases that act on the 
extracellular domains of - and -subunits and stimulate channel open probability94. In 
contrast, F508del-CFTR fails to protect ENaC from proteolytic cleavage and 
stimulation94. 
Striking evidence that Na+ hyperabsorption and ASL volume depletion are key 
mechanisms in the pathogenesis of CF lung disease came from a transgenic mouse 
model overexpressing in the airways one of ENaC subunits (-ENaC)95. In this animal 
model, airway-specific overexpression of -ENaC mimics the dehydration and mucus 
clogging, even in the absence of goblet cell metaplasia, which characterizes CF lung 
disease. In the airways from neonatal mice, there were epithelial cells that underwent 
swelling and necrosis95. Since CFTR and ENaC are linked to the cytoskeleton, there 
may also be indirect interactions between these two ion channels.  
Noticeably, the inhibition of ENaC by CFTR is not present in the sweat duct epithelium. 
The sweat duct is a tight epithelium, where all the transport occurs transcellularly, and 
devoted exclusively to absorption of electrolytes and even requires CFTR for activation 
of ENaC96. In this regard, the absence of CFTR necessarily reduces absorption of Na+ 
because of coupled movement of both Cl- and Na+. The situation is quite different for 
the colon and airways, which are leaky epithelia, unable to maintain larger osmotic 
gradients91. This essential difference between both types of epithelia may reflect 
differential expression of accessory proteins necessary for the CFTR/ENaC 
interaction13.  
 
1.5 Ca2+-activated Cl- channels (CaCCs) 
Cl- is the most abundant anion in living organisms and consequently the predominant 
permeating halide under physiological conditions. Besides CFTR, there are other 
categories of Cl- channels which differ in their gating mechanism, namely voltage-gated 
Cl- channels, summarized in the large CLC family of genes, ligand-gated Cl- channels, 
which are activated upon extracellular binding of glycine or -aminobutyric acid 
(GABA), volume-regulated anion channels (VRACs) or “swelling-activated” Cl- 
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channels and Ca2+-activated Cl- channels (CaCCs)97. To date, little is known about the 
putative intracellular Cl- channel (CLICs) family. 
Cl- channels have several important physiological implications, such as regulation of 
electrical excitability in nerve and muscle, regulation of cell volume during which, upon 
a hypotonic stress, swelling-activated Cl- channels (as well as K+ channels) open to 
allow recovery of the initial volume, maintenance of ionic homeostasis and pH, in which 
Cl- transport is coupled to that of other ions to preserve electroneutrality and, finally, in 
transepithelial transport, allowing the vectorial movement of salt and fluid across 
epithelia. 
From the energetic point of view, transport of Cl- is “cheap” because the equilibrium 
potential of Cl- is close to the resting potential of most cells and its transport against the 
electrochemical gradient depends on the energy provided by the electrochemical 
gradients of K+ and Na+ which are built up by the activity of the Na+-K+-ATPase97. 
Regarding Cl- secretion in the airways epithelium, Cl- channels localized at the apical 
membrane, such as CFTR and CaCC, actively secrete Cl-, which is recycled back into 
the cell due to the presence of Na+-K+-2Cl- cotransporters that, together with K+ 
channels, are expressed at the basolateral membrane. 
CaCCs are anion-selective channels activated by cytosolic Ca2+ concentrations in the 
range of 0.2-5 M, which is released from ER Ca2+ stores. Upon store depletion, STIM1 
proteins present in the ER membrane oligomerize, translocate to junctions adjacent to 
the plasma membrane and open Orai or TRPC (transient receptor potential cation) 
channels to allow Ca2+ influx into the cell98. Depending on the cell type, Ca2+ activates 
CaCCs either directly by binding to the channel, indirectly through Ca2+-binding 
proteins or via phosphorylation through Ca2+/calmodulin-dependent protein kinase II 
(CaMKII)99,100. Another feature that characterizes CaCCs is their poor anion selectivity, 
discriminating hardly between anions with a selectivity sequence similar to that of 
Eisenman type I (SCN- > I- > Br- > Cl- > F-)99,101. The kinetics of activation by Ca2+ is 
another biophysical fingerprint of CaCCs and Ca2+-activated Cl- currents are 
characterized by their voltage- and time-dependence at subsaturating Ca2+ 
concentrations (<1 M). At these low physiological Ca2+ levels, the current activates 
slowly at positive membrane potentials (Vm) and deactivates fast at negative Vm and 
the resulting steady-state current/voltage (i/v) relationship is outwardly rectifying but 
becomes progressively linear at high Ca2+ levels (>1 M). Although there are 
uniforming biophysical properties, CaCCs widely differ in their single channel 
conductance properties (1-310 pS) and in their sensitivity to inhibitors. 
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CaCCs were initially described in Xenopus oocytes and then later in many other cell 
types, such as for example in vascular endothelial cells, neurons, olfactory and photo-
receptors, smooth and cardiac muscle cells and in various epithelial cells102. Their 
ubiquitous expression has caused serious difficulties in the cloning of the responsible 
gene, since the background activity present in most of the expression systems used 
was hard to subtract103. An additional problem was the lack of specificity of inhibitors 
used that did not allow the differentiation between CaCC and other Cl- channels104. For 
these reasons, although the biophysical properties that characterize CaCC are well 
described, much effort was made to find the molecular counterpart of CaCC but 
previous candidates, such as CLC-3 or CLCA, revealed controversial results105. Only 
recently, two novel protein families could be clearly correlated to Ca2+-dependent Cl- 
conductance: the bestrophin proteins family and TMEM16 (anoctamins) family. 
 
1.5.1 CFTR-dependent regulation of CaCCs 
As already mentioned, the height of the ASL and the efficiency of mucus clearance in 
the airway epithelia depend largely on the movement of ions through ENaC, CFTR and 
on Ca2+-activated Cl- channels (CaCC)106. The importance of these last type of 
channels is supported by the fact that the airways of CF mouse models (several have 
been generated)107 fail to exhibit the severe pathology seen in humans, since CaCC 
serves as the main pathway for Cl- exit in murine airways108 (Fig. 4). 
 
 
 
Fig. I.5 Contribution of Ca2+-dependent Cl- secretion by the recently identified CaCC channel 
TMEM16A (ANO1) in mouse and human airways. Adapted from Kunzelmann et al (2009)103. Cell 
models for electrolyte transport in human (left) and mouse (right) airways. CFTR is the dominant pathway 
for luminal Cl− exit in human airways, while TMEM16A (ANO1) is probably the major secretory pathway in 
mouse airways. (ADE: adenosine). 
 
 
 
Ca2+-activated Cl- conductance is also present in the pancreatic ductal epithelium but 
not detected in intestinal epithelia108. In this way, all CF mouse models have the 
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gastrointestinal pathophysiology of CF, characterized by intestinal obstruction and 
known as meconium ileus (MI)107. An upregulation of CaCC in CF epithelia has been a 
controversial matter reflecting mainly the lack of consensus regarding the molecular 
identity of the CaCC gene family. An increased CaCC activity in response to mucosal 
nucleotides is observed in CF nasal epithelia but not in isolated ciliated nasal cells106. 
In this regard, the rate and severity of organ disease in CF depends on the type of 
CFTR mutation but also on extrinsic factors, such as the presence of alternative Cl- 
channels that protect the organ from the drastic effect of CFTR disruption. 
 
1.5.2 Bestrophins 
The human genome has four bestrophin paralogs, while in mouse there are only three 
and one pseudogene109,110. Bestrophin family members are activated by physiological 
Ca2+ concentrations and mutations of certain amino acids alter the permeability and 
conductance properties, suggesting that bestrophins comprise the molecular 
counterpart of a new family of CaCCs. Although the finding that bestrophin siRNAs 
suppress endogenous Cl- currents from different cell types strengthenes this 
conclusion, the first evidences appeared when mutations in bestrophin 1 (Best1) were 
found to cause an autosomal dominant macular dystrophy (Best disease, OMIM 
607854)105. Best1 is expressed at the basolateral membrane of retinal pigment 
epithelial (RPE) cells and impairment of Best1 function was associated with reduction 
of the light peak in the electrooculogram of the eyes, which requires the activity of 
CaCC in RPE cells. However, the role of Best1 in RPE cells and its function as CaCC 
are not well determined mainly because Best1 knockout (KO) mice do not present an 
ocular pathology and Ca2+ activated Cl- currents are still present in different tissues of 
this knockout animal, respectively103. 
Regarding the structure of bestrophin proteins, two different topology models have 
been proposed for Best1. Although contradictory, these models share common 
features, namely that membrane insertion of Best1 depends on 4 out of its 6 
hydrophobic domains that transverse the lipid bilayer (TMD3 faces the cytosol) and N- 
and C-termini are intracellularly localized109,111. The highly conserved 350 amino acids 
at the N-terminus include all the predicted TMDs among bestrophins, suggesting 
similar topology for all vertebrate bestrophins112. 
Similarly to many ion channels, bestrophin proteins also oligomerise, although 
discrepant results regarding channel stoichiometry have been published. In particular, it 
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was shown in an over-expression study that Best1 could exist as a homomeric tetramer 
or pentamer and also associate with human bestrophin 2 (hBest2), raising the 
possibility of heteromeric structures113. However, native Best1 isolated from RPE cells 
was only found in dimers, accounting for the possibility of aggregation upon over-
expression114. Since bestrophin paralogs induce Cl- conductances of different 
amplitudes when expressed in HEK293 cells and respond differently to purinergic 
activation, it was suggested that they could heterooligomerize giving rise to channels 
with different biophysical and regulatory properties115. In particular, bestrophins 1 and 3 
could be acutely activated, while bestrophins 2 and 4 produced large baseline Cl− 
currents under control conditions that were not further activated by agonists115, 
probably due to the lack of an inhibitory domain present in the other paralogs103. A 
fraction of hBest2 and hBest4 is expressed at the plasma membrane, while most of 
hBest1 is localized in the ER115. 
Expression of Best1 was detected initially only in the retinal pigment epithelium and 
later on a wide range of epithelial and non-epithelial cells112. In the airways, expression 
levels for Best2 were found to be much higher when compared to Best1 and Best2 was 
also detected in the cilia of olfactory sensory neurons116 and of both mouse and human 
airways103. Since several studies confirmed a role of bestrophins in Ca2+-activated Cl- 
secretion117-120, it was surprising to find that bestrophin 2 KO mice do not show any 
obvious phenotype, apart from a reduced intraocular pressure121, as well as the 
apparent lack of a phenotype in bestrophin 1 KO mice. These animals show normal 
fertility and thriving and have no obvious defects but an attenuated Cl− secretion upon 
stimulation with low ATP concentrations (higher ATP concentrations produced the 
same response in wt and KO animals)119. This suggests that in epithelial cells Best1 
modulates Cl− secretion rather than being a plasma membrane Cl− channel. 
Along a different line, it was also shown that Best1 affects the properties of voltage-
gated Ca2+ channels (CaV) in RPE122 and HEK293 cells. In particular, transient 
overexpression of hBest1 in RPE-J cell line influence the kinetics of endogenous L-type 
Ca2+ channels along with a shift to the left for the voltage-dependence of Ca2+ 
activation closer to the resting potential122. The finding that Cav channels play a role in 
generating the light peak, as the Cav channel blocker nimodipine diminished its 
amplitude, and the greater ATP-induced Ca2+ response in RPE cells from best1 KO 
mice, supported the notion that Best1 is involved in Ca2+ channel regulation122,123. 
An upregulation of Best1 and Ca2+-activated Cl- currents during dedifferentiation and 
proliferation has been observed in epithelial cells and fast growing cancer cell 
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lines124,125. In contrast to proliferating cells, native epithelial tissues show very little 
Ca2+-dependent Cl- conductance. Thus, Best1 could affect proliferation through its 
property as a Cl− channel126 or by controlling intracellular Ca2+ signaling. Interestingly, 
Best1 and 2 have been proposed to play a role in cell volume regulation, facilitating the 
large volume changes to which RPE cells are exposed during phagocytosis of shed 
photoreceptor discs127. 
Similarly to CFTR, bestrophins are highly permeable not only to Cl- but also to HCO3-, 
which gives further understanding of the molecular basis of human Best disease due to 
the importance of HCO3- in regulating the intracellular pH and maintenance of fluid and 
ion transport across RPE128. In conclusion, again like CFTR, Best1 seems not to be just 
a Cl- channel but also a regulator of other ion channels and hence involved in several 
different cellular processes112. 
 
 
1.5.3 TMEM16 proteins 
Although a number of proteins have been proposed to be responsible for CaCC 
currents, the anoctamin family (ANO, also known as TMEM16) exhibits characteristics 
most similar to those expected for the classical CaCC. The discovery and 
characterization of ANO1 (or TMEM16A) as CaCC happened only recently in three 
independent studies using different approaches such as searching using bioinformatic 
tools for channel- or transporter-like genes with multiple transmembrane domains and 
isoforms129, microarray analysis of genes that are upregulated upon long-term 
stimulation with IL-4 in airway epithelial cells, a treatment which had been shown to 
markedly increase CaCC currents130, and expression cloning in a cellular system where 
endogenous CaCC are absent such as axolotl oocytes, by expressing a cDNA library 
prepared from RNA isolated from Xenopus oocytes131.  
TMEM16A belongs to a family of ten TMEM16 proteins (TMEM16A-K, ANO1-10) and 
has eight putative transmembrane (TM) domains, a p-loop between TM5 and TM6 and 
cytosolic amino- and carboxy-termini, where a number of consensus sites for 
phosphorylation by different kinases are present (Fig. I.6). It has however been 
suggested that, unlike cytosolic ATP that is essential for channel full activation, 
phosphorylation by protein kinases does not seem to be required132. In addition, 
TMEM16A is activated by intracellular Ca2+ and, although no specific consensus sites 
for Ca2+ binding exist129, calmodulin appears to be indispensable and to interact 
physically with the channel132. Unlike TMEM16A, Best1 carries a C-terminal cluster of a 
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acidic amino acids, an EF hand and a regulatory domain essential for Ca2+ sensing and 
channel activation133. The existence of a putative pore forming region between TM5 
and TM6 has been proposed due to the fact that mutation of conserved positively 
charged amino acids in this region change the ion selectivity of the channel103. This 
putative pore forming region contains in addition three cysteine residues that bind the 
cysteine-reagent MTSET. Inhibition of the channel by MTSET was largely attenuated 
after changing these cysteines into alanines103. TMEM16A has no apparent similarity to 
other ion channels. Moreover, multiple alternative splice variants exist in different cell 
types130, suggesting that TMEM16A proteins are the product of complex regulatory 
mechanisms still unknown. 
TMEM16 proteins are well conserved among eukaryotes, including yeast, and the ten 
genes present in mammals share considerable homology particularly around the pore 
forming region (Fig. I.6). Notably, TMEM16K and TMEM16H are quite different to the 
other TMEM16 members, with the putative p-loop of TMEM16K being remarkably 
shorter, while TMEM16H has a largely extended p-loop, and no short transmembrane 
region between TM5 and TM6 as for the other TMEM16 proteins103. Although the roles 
of most of the TMEM16 proteins are still unknown, it has been shown that TMEM16B 
expression also evokes the appearance of CaCCs, but with biophysical characteristics 
(voltage dependence, unitary conductance) different from those associated to 
TMEM16A in the olfactory epithelium134. 
 
 
 
Fig. I.6 Phylogenetic tree depicting the anoctamin family in human and predicted topology of 
mouse TMEM16A. Adapted from Yang et al. (2008)129. Scale bar corresponds to 0.1 nucleotide 
substitutions per site. 
 
 
TMEM16A is broadly expressed in almost every tissue but predominantly in those of 
epithelial nature103,129 and in both mammary and salivary glands131. In particular, 
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TMEM16A contributes to Ca2+-activated Cl- secretion in a broad spectrum of epithelial 
tissues, such as the airways, colonic epithelium, pancreatic acinar cells, salivary gland 
cells and hepatocytes, since these currents were reduced in epithelial tissues from 
TMEM16A knockout (TMEM16A-KO) mice135. Interestingly, a recent study, aimed at 
identifying new TMEM16A specific inhibitors, suggests that TMEM16A carries most or 
all CaCC current in human salivary gland cells, but only a small fraction of total CaCC 
current in human airway and intestinal cells136. These results suggest that TMEM16A 
may only comprise part of the CaCC channel in human airway and intestinal epithelia 
and other TMEM16 isoforms (or other unidentified proteins) may have also a role in 
allowing endogenous CaCC currents in these tissues. 
The major phenotype of TMEM16A-KO mouse is a pronounced tracheomalacia, i.e. 
pathological collapsibility of the upper airways. Knockout animals die early during 
postnatal phase and exhibit severe tracheomalacia with gaps in the tracheal cartilage 
rings along the entire length of the trachea137. In addition, the development of the 
trachealis muscle that spans the dorsal aspect of the trachea is also abnormal in 
TMEM16A-KO animals, supporting the role of TMEM16A as a novel regulator of 
epithelial and smooth muscle cell organization in murine development137. Moreover, 
there is also accumulation of mucus in the lumen of tracheas of TMEM16-KO mice, 
which points out to an important function of TMEM16A in mucociliary clearance in 
mouse airways138.  
TMEM16A and other members of this protein family are upregulated during cell 
proliferation and cancer139, which may be related to an increased expression in Best1 
and CaCC current observed upon dedifferentiation and proliferation. TMEM16A is 
located in the 11q13 human chromosome where many tumour-related genes such as 
cyclin D1 are clustered. This protein is markedly upregulated in squamous cell 
carcinoma of the head and neck and in gastrointestinal stromal tumours140. 
Nevertheless, the reason for this propensity of TMEM16A in tumours is unknown, but it 
is conceivable that a secretory environment might be necessary for tumour cell 
proliferation. Interestingly, it was found that different cell lines show the same “basic” 
equipment of TMEM16-proteins, which may suggest that these channels are necessary 
for proliferation and cell survival103. The abundance of ANO1 in tumours may provide 
clues relating to the treatment or prediction of cancer in these tissues. 
In conclusion, CaCCs are involved in Cl- secretion by the airways and other secretory 
epithelia and in CF mice they appear to compensate the loss of CFTR function. Even 
though such functional compensation is not evident in human CF, activation of latent 
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CaCCs could compensate for CFTR loss of function in CF patients, as it was observed 
upon treatment of human CF airway epithelial cells with UTP, a purinergic receptor 
agonist, and stimulation of a Cl- conductance. Thus, TMEM16A and other members of 
this protein family may present an alternative target in CF but further characterization of 
their regulation and contribution to electrolyte transport in human epithelial tissues is 
still missing. 
 
 
1.6 Therapeutic approaches 
The development of rational therapeutic approaches to the treatment of CF bases itself 
on the vast knowledge that exits on the different causes and manifestations of the 
disease. There are currently in progress different approaches on how to treat CF, 
which include CFTR gene replacement, suppression of nonsense mutations, 
restoration of folding and function of mutant CFTR channels, activation of alternative 
Cl- channels and inhibition of sodium absorption27. Much effort is being directed to 
identifying proteins and small molecules that might chaperone F508del-CFTR to the 
cell surface in CF patients, since gene therapy approaches, which focus on introducing 
wild type CFTR DNA into airway epithelial cells, face many difficulties with gene 
delivery and expression. The highlighted (in bold) strategies presented, classified as 
“salt modulators” in CF therapy drug design, are the main stimuli of this PhD work and 
were considered in a first place on the basis that normalizing electrolyte secretion and 
absorption and hence fluid on epithelial surfaces might compensate for the loss of 
CFTR and overcome some of the pathophysiological characteristics of CF lung 
disease. 
On one hand, the therapeutic potential of ENaC inhibitors in CF lung disease has been 
tested. However, the classical ENaC inhibitor, amiloride, had little therapeutic benefit in 
CF patients with established lung disease, due not only to the later stage when it was 
administered, but also to its low potency and rapid absorption14. It proved to be much 
more effective when administered repeatedly before the onset of CF lung disease in a 
in vivo mouse model14. More potent and longer-lived ENaC inhibitors, i.e. less 
reversible and slower in crossing the epithelium, have been developed and are also in 
clinical trials141. 
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On the other hand, although CFTR is a crucial element in epithelial anion permeability, 
activation of other Cl- channels present in most epithelial tissues can provide potential 
alternative pathways in CF. The recent identification of TMEM16A as a component of 
CaC channels increased their potential, although TMEM16A relative contribution for 
CaCC currents in airway and intestinal epithelia is still questionable136. In the airways, 
CaCCs can be activated by purinergic receptors and nucleotide analogue agonists of 
the coupled P2Y(2) receptors are already in clinical trials (e.g. Denufosol)142. These 
compounds inhibit Na+ absorption, restore Cl- conductance and hence rehydrate the 
CF airway surface, together with an enhancement of the ciliary beat frequency that 
helps mucociliary clearance143. Another Cl- channel activator, a polycyclic peptide 
(Moli1901), is already in Phase II in CF drug development programs. In the same line, 
hyperosmolar agents, such as hypertonic saline and mannitol, create a luminal osmotic 
gradient that leads to rehydration of the airway mucosa and improves mucociliary 
clearance144. 
In summary, activation of alternative anion channels and/or inhibition of ENaC may be 
able to partially mimic and overcome the defects caused by the loss of CFTR. 
Nevertheless, the feasibility of these non-CFTR based, termed “by-pass approaches” 
requires a better knowledge of the characteristics and regulation of the ion channels in 
question, so that a normally hydrated epithelial surface can be maintained and soften 
CF lung disease, and this was one of the main aims of this doctoral work. 
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II Objectives of the present work 
 
The present doctoral work aimed at giving further insight into the complex network that 
allows a proper function of ion channels with a crucial role in CF, namely ENaC and 
two families of CaCCs, bestrophins and TMEM16 proteins (Fig. II.1). The mechanism 
through which CFTR controls ENaC remains elusive and we decided to study the effect 
of known CFTR regulators on ENaC activity, as well as to identify novel proteins that 
affect ENaC function. CaC channels are essential in epithelial ion transport. Several 
candidates had been suggested to constitute the molecular entities of these channels 
but only two protein families reached consensus regarding their function as CaCCs. 
We thus decided to study in more detail the role of these channels in epithelial ion 
transport and how they affect cell response to physiological stimuli such as hypotonic 
stress (Fig. II.1). 
 
Towards these overall goals, this work was focused on the five following specific 
objectives. 
 To understand how phosphorylation of ENaC C-termini by CK2 affects ENaC 
function and elucidation of the underlying molecular mechanism, both in 
Xenopus oocytes and in mammalian epithelial cells; 
 To investigate how phosphorylation of the E3 ubiquitin ligase Nedd4-2 by AMP-
dependent protein kinase AMPK affects ENaC function, both in Xenopus 
oocytes and in mammalian epithelial cells, and to study the physiological 
relevance of this regulation in an AMPK catalytic subunit knockout mouse 
model; 
 To identify novel regulators of ENaC activity by high-content siRNA 
miscroscopy screens using a live-cell assay that reports endogenous ENaC 
activity and to evaluate their potential use as therapeutic targets in CF; 
 To characterize the role of bestrophins as ER-localized CaCC that facilitate 
Ca2+-dependent ion (Cl- and K+) conductance, both in Xenopus oocytes and in 
different cell types.  
 To analyse the role and participation of TMEM16 proteins on the regulation of 
cell volume in response to a hypotonic shock in mammalian epithelial cells, 
Xenopus oocytes and in mouse epithelial tissues. 
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Fig. II.1 Thesis outline 
 
 
Research partners 
The work presented in this PhD thesis was developed in three different institutions, in 
collaboration with the following research groups: group of Margarida Amaral at the 
Faculty of Sciences of the University of Lisbon, group of Karl Kunzelmann at the 
Institute of Physiology of the University of Regensburg and in the group of Rainer 
Pepperkok at the European Molecular Biology Laboratory in Heidelberg. 
In this regard, some experiments shown in this thesis were not performed by the author 
but instead by other members from the institutions mentioned above. When such 
figures are shown, the name of the corresponding author is referred in the figure 
legend. 
 
  
  Cystic Fibrosis
as central problematic
Defective CFTR function
caused by
cAMP-regulated Cl- channel
regulator of ion channels
Epithelial Na+ channel
CaCCs
Ca2+-activated Cl- channels
Potential therapeutic
targets in CF
several canditates
had been proposed
unknown protein(s)
Bestrophins
TMEM16A
"real" CaCC 
was identified
known CFTR
regulators
CK2
AMPK
Large-scale
siRNA screen
increasing need of 
novel "players"
"putative" ENaC regulators
ENaC
III Materials and Methods 
30 
 
III Materials and Methods 
 
3.1 Materials 
3.1.1 Cell lines 
During this PhD work, three different mammalian cell lines were used to study ENaC 
since they endogenously express this channel, namely: 1) mouse kidney cortical 
collecting duct M1 cells (kindly provided by C. Korbmacher, Physiologisches Institut, 
Universitaet Erlangen, Germany), 2) human alveolar type II A549 cells (ATCC, Cat no 
CCL-185) parental and CFTR-transduced (see below) and 3) human bronchial 
epithelial H441 cells. These cells were maintained in culture in DMEM 4.5 g/L D-
glucose supplemented with 10% foetal calf serum (FCS), 2 mM glutamine, a mixture of 
insulin/transferrin/selenium (Gibco) and 100 nM dexamethasone (Sigma). 
The transduced A549 cell lines used here to study ENaC activity and the effect of 
putative regulators were generated to express fluorescently labeled wt- or F508del-
CFTR after induction with doxycycline (DOX) (produced by ADV Bioscience, 
Firmingham, Alabama, USA), using wt- and delF508-mCherry-FLAG-CFTR constructs 
(generated by Filipa Mendes, Simão Luz and Shehrazade Dahiméne). 
For this, wt- or F508del-CFTR were fused in the N-terminus to mCherry, a fluorescent 
protein obtained from DsRed by changing the chromophore environment145, and with a 
FLAG tag (octapeptide: DYKDDDDK) inserted in the fourth extracellular loop of CFTR. 
The expression of these constructs was controlled by TetON DOX-sensitive promoter 
on lentivirally transduced A549 cells. 
CaCC function and regulation were studied in four different mammalian cell lines, 
namely: 1) human embryonic kidney HEK293 cells, 2) human colon carcinoma HT29 
cells, 3) human bronchial epithelium 16HBE14o− (kindly provided by Prof. D. Gruenert, 
CPMRI, San Francisco, USA) and 4) human cystic fibrosis pancreatic epithelial 
(CFPAC) cells were cultured as described previously118.  
Cells were transfected using standard methods (Lipofectamine, Invitrogen, Karsruhe, 
Germany). All experiments were performed 48 h after the transfection with cDNAs or 
siRNAs. 
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3.1.2 cDNA constructs 
The Usp2-45 cDNA was a generous gift of Prof. Dr. F. Verrey (Department of 
Physiology, University of Zürich, Switzerland). Complementary DNA (cDNA) for human 
bestrophin 1 (kindly provided by Dr. J. Nathans, Johns Hopkins University, Baltimore, 
USA), hSTIM1 (OriGene Technologies, Rockville, USA), hIP3R-3 (kindly provided by 
Dr. H. De Smedt, Leuven, Belgium), hTRPC1 (kindly provided by Dr. L. Birnbaumer, 
Research Triangle Park, USA), hPak2 (kindly provided by Dr. K. Saksela, Tampere, 
Finland), SK4 (kindly provided by Dr. W. J. Joiner, New Haven, USA) and the highly 
Ca2+-sensitive GFP protein, G-CaMP2 (kindly provided by Dr. J. Nakai, Wako City, 
Saitama, Japan) were cloned into mammalian expression vectors. 
cDNA for human TMEM16A was cloned into pcDNA3.1 V5-His (Invitrogen, Karlsruhe, 
Germany) from total RNA of 16HBE-14o by RT-PCR using the primers on Table 2 (in 
Appendix 2). 16HBE-14o cells express a TMEM16A isoform containing the exons a, b 
and c130. cDNA for mouse TMEM16B was purchased from ImaGenes GmbH (Berlin, 
Germany, Clone name: IRAVp968H1167D). hBest1 and P2Y2 receptors were His6-
tagged at the C terminus. Site-specific mutations (hBest1-R218C, hBest1-S358A) were 
introduced using QuickChange™ (Stratagene, Heidelberg, Germany). G-CaMP2 fusion 
protein was generated by PCR. All cDNAs were verified by sequencing. 
 
3.1.3. Animals 
Generation of a null allele of Tmem16a and TMEM16A knockout animals has been 
described previously137. Pups (1-4 days) were sacrificed with Isofluran (Baxter, 
Germany). The pancreas and submandibular glands were removed and epithelial cells 
were dispersed in a PBS buffer composed of Collagenase VIII (Sigma, Taufkirchen, 
Germany). Tracheas were dissected, opened longitudinally on the opposite side of the 
cartilage free zone and were transferred immediately into an ice cold buffer solution. 
Stripped colon was put into ice cold Ringer bath solution containing in addition 
amiloride (10 M) and indomethacin (10 M). 
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3.1.4. Chemicals 
All compounds (ionomycin, carbachol, ATP, tamoxifen, 4,4'-diisothio-cyanostilbene-
2,2'-disulfonic acid (DIDS), suramin, BAPTA-AM, U0126, staurosporine, CFTRinh-172, 
apyrase, MTSET, cyclopiazonic acid, okadaic acid and Pak2 enzyme) were of highest 
available grade of purity and were from Sigma (Taufkirchen, Germany), Merck 
(Darmstadt, Germany) or Calbiochem (Germany). All cell culture reagents were from 
GIBCO/Invitrogen (Karlsruhe, Germany). 
 
3.1.5. Antibodies 
The antihTMEM16A was a generous gift from Prof. van de Rijn (Dept. of Pathology, 
Stanford University, USA). The Nedd4-2 antibody was a generous gift from Prof. Dr. J. 
Loffing (University of Zürich, Switzerland). The following antibodies were used: mouse 
anti-hSTIM1 (Abcam 53551), goat antihSK4 (Santa Cruz sc-27081), rabbit anti-IP3R-
I/II/III (Santa Cruz sc-28613), goat anti-hTRPC1 (Santa Cruz sc-15055), rabbit anti-
hNa+/K+ ATPase (Upstate Biotechnology 21217), goat anti-hSERCA3 (Santa Cruz sc-
8097). Goat antirabbit IgG-HRP (Acris R1364 HRP), donkey antigoat IgG-HRP (Santa 
Cruz sc-2020), and a mouse anti-His–Tag antibody (Qiagen) were used as secondary 
antibodies. 
 
3.2 Functional characterization of ENaC 
3.2.1 Ussing Chamber experiments 
Ussing chamber experiments were performed on trachea and distal colon tissues 
removed from mice euthanized by ethically approved institutional procedures 
(C57BL/6, Charles Rivers, Germany) and placed immediately into ice-cold buffer 
solution. After stripping the colonic mucosa and opening tracheas by a longitudinal cut, 
tissues were mounted into a micro Ussing chamber with a circular aperture of 0.95 
mm2 and measured under open circuit conditions. In addition, mouse kidney collecting 
duct M1 cells were grown to confluence on permeable supports and mounted into the 
Ussing chamber91.  
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Luminal and basolateral sides of the different epithelia were perfused continuously with 
Ringer solution at a rate of 5 mL/min that was heated to 37ºC and the pH adjusted to 
7.4 on the day of the experiment. 
Experiments were carried out mainly under open circuit conditions since these are in 
general more protective and less exhausting for the epithelia and closer to the in vivo 
situation. However, short circuit measurements were also done in polarized M1 cells, 
after permeabilization of the basolateral membrane with 75 μg/mL nystatin to eliminate 
the electrical resistance of this side of the monolayer. 
Values for transepithelial voltages (Vte) were referred to the serosal side of the 
epithelium. Transepithelial resistances (Rte) were determined by applying short (1 s) 
current pulses (l = 0.5 A) and after subtracting the resistance of the empty chamber, 
using Ohm’s law (Rte = Vte/I). The equivalent short-circuit current (Isc) was calculated 
(Isc=Vte/Rte) and the amiloride-sensitive Isc (Isc-Amil) used to express the amount of 
equivalent short-circuit current that depends on ENaC activity and is inhibited by 10 μM 
amiloride. Tissue preparations and monolayers were accepted only if the transepithelial 
resistance exceeded that obtained for the empty chambers at least by a factor of 3. 
Transepithelial resistances obtained for mouse trachea preparations were 65.5 ± 3.8 
Ωcm2 (n = 12), for mouse colon 32 ± 3.8 Ωcm2 (n = 13) and for M1 cells grown on filters 
669 ± 45 Ωcm2 (n = 38). 
 
3.2.2 cRNA and double electrode voltage clamp  
Xenopus laevis oocytes were isolated from adult female frogs (Xenopus express, 
South Africa), dispersed and defolliculated by a 45 min-treatment with collagenase 
(type A, Boehringer, Germany). Subsequently, oocytes were rinsed and kept at 18°C 
either in ND96-buffer or in NMDG buffer, when overexpressing ENaC. Oocytes were 
injected with cRNA (10 ng, 47 nL double-distilled water) encoding wild-type (wt) and 
mutant ENaC and Usp2-45 or Nedd4-2 small-interfering RNA (siRNA). 
For cRNA production, complementary DNAs (cDNAs)-encoding rat ENaC 
constructs were linearized with Notl or HpaI and in vitro transcribed using T7 or SP6 
promotor and polymerase (Promega). For some experiments, cDNAs of ENaC 
subunits used were tagged with a FLAG reporter epitope (DYKDDDDK) (kindly 
provided by Prof. Dr. B. Rossier, Pharmacological Institute of Lausanne, Switzerland), 
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inserted in the extracellular loops of ENaC subunits and not affecting ENaC biophysical 
and pharmacological properties146. 
The ENaC truncated mutants H648X, R561X, and S608X and point mutations in - and -
ENaC S631A, T599A, Y618A and S633A were generated by polymerase chain reaction and 
confirmed by sequencing. cDNAs encoding wt and mutant ubiquitinase Usp2-45 (kindly 
provided by Prof. Dr. F. Verrey, University of Zurich, Switzerland) were linearized in 
pSDeasy with BamHI and in vitro transcribed using T7 promotor and polymerase 
(Promega). A siRNA targeting Xenopus Nedd4-2 (for sequence see Table 1, Appendix 
2) was injected in oocytes (500 pg/oocyte), and the measurements were performed 72 
h after injection. The scrambled RNAi used was a mixture of double-stranded RNA 
sequences that had no match to any of the known Xenopus messenger RNA 
sequences (Invitrogen). 
Two to four days after injection, oocytes were impaled with two electrodes (Clark 
Instruments Ltd, Salisbury, UK), which had resistances of <1 MΩ when filled with 2.7 M 
KCI. Using two bath electrodes and a virtual ground head stage, the voltage drop 
across Rserial was effectively zero. Membrane currents were measured by voltage 
clamping (oocyte clamp amplifier, Warner Instruments LLC, Hamden CT) in intervals 
from -60 to +40 mV, in steps of 10 mV, each 1 s. The bath was continuously perfused 
at a rate of 5 mL/min with ND96 buffer. All experiments were conducted at room 
temperature (22 °C). Conductances (G) were calculated according to Ohm’s law and 
amiloride-sensitive conductance (Gamil) was used to express the amount of ENaC 
current which is specifically inhibited by 10 M amiloride. 
 
3.2.3 Rectal potential difference (RPD) measurements  
For RPD measurements, mice were anesthetized by intraperitoneal injection of 20 L 
(75 mg/mL) ketamine and 5 mg/mL xylazine. A catheter made of polythene tube with 
OD 1 mm and perfused at 3 mL/min with standard Ringer solution, whose composition 
was already mentioned, attached to an AgCl electrode and inserted 2 cm into the 
mouse rectum. The reference electrode was a subcutaneous needle that was placed 
under the abdominal skin, also perfused with Ringer solution and connected to an agar 
bridge. 
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3.3 Subcellular localization and expression of ENaC 
3.3.1 Chemiluminescence Measurements 
To quantify the amount of FLAG-tagged ENaC channels present at the plasma 
membrane in oocytes, the latter were fixed for 60 min at room temperature with 3% 
paraformaldehyde (in Tris-buffered saline (TBS), pH 8.0) and washed at room 
temperature with TBS. Then the oocytes were incubated for 60 min in TBS with 1% 
(w/v) bovine serum albumin (BSA), another 60 min with 1 g/mL mouse monoclonal 
anti-FLAG M2 antibody in 1% BSA/TBS at 4 °C (Sigma-Aldrich), washed at 4°C with 
1% BSA/TBS and incubated with sheep anti-mouse IgG peroxidase-linked whole 
antibody (Amersham Biosciences) diluted 1:20,000 in 1% BSA/TBS for 40 min at 4°C. 
Afterwards, oocytes were washed for 60 min at 4 °C in 1% BSA/TBS and finally in TBS 
(60 min, 4°C). Oocytes were placed separately in 50 L of ECL Plus Western blotting 
detection reagents (Amersham Biosciences). After incubation for 5 min at room 
temperature, chemiluminescence was measured in a BioOrbit 1250 Luminometer 
(Turku, Finland), and an integration period of 1 s was allowed. 
 
3.3.2 Oocyte Staining 
Oocyte staining was performed by incubating the oocytes for 60 min in ND96 solution, 
fixing them for 60 min with 3% paraformaldehyde (in TBS, pH 8.0) and washed in TBS. 
After embedding in optimum cutting temperature compound (Sakura Finetek Europe, 
Zoeterwoude, NL), oocytes were cut to 20 m slices with a cryostat (Leica CM3050 S, 
Wetzlar, Germany). Sections were put in either TBS or phosphate-buffered saline 
(PBS), incubated for 5 min in 0.1% (w/v) SDS in PBS and washed two times with either 
TBS or PBS. Sections were incubated for 60 min in TBS or PBS (5% BSA) and for 60 
min at 37 °C with the anti-FLAG M2 antibody diluted 1:50 in 2% BSA/TBS or a goat 
polyclonal casein kinase II antibody (Santa Cruz Biotechnology, Heidelberg, 
Germany) diluted 1:25 in 2% BSA/PBS. Afterwards, sections were washed twice in 
PBS and incubated for 1 h with secondary antibodies (donkey anti-mouse IgG-Alexa 
Fluor 488 conjugated and donkey anti-goat IgG-Alexa Fluor 546 conjugated; Molecular 
Probes, Eugene, OR) at a dilution of 1:1000 in 2% BSA/PBS. Sections were washed 
two times with PBS for 5 min and covered with DakoCytomation fluorescent mounting 
medium (DakoCytomation, Inc., Carpinteria, CA). Images were obtained using a Zeiss 
Axiovert 200M microscope with a 63X objective (Carl Zeiss, Jena, Germany). 
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3.3.3 Immunohistochemistry  
Tissues isolated from AMPK1+/+ and AMPK1-/- were fixed with 4% 
paraformaldehyde and 15% picric acid in PBS (pH 7.4) and embedded in paraffin. 
Paraffin-embedded tissues were cut with a rotary microtome (Leica Mikrotom RM 2165, 
Wetzlar, Germany) and mounted on Super Frost Plus object slides. Sections were 
dewaxed and rehydrated in xylene–isopropanol series. Sections obtained from 
tracheas were subjected to heat-induced epitope retrieval in sodium-citrate buffer for 
20 min. Blocking endogenous biotin activity was performed before the incubation with 
rabbit anti-mouse -subunit of ENaC (Alomone labs, Israel) overnight at 4°C. Tissues 
were incubated in donkey anti-rabbit biotinylated antibody (Santa Cruz Biotechnology, 
USA) diluted 1:400 for 1 h following incubation in avidin biotinylated peroxidase 
complex kit (Vector Elite, Vector, USA) for 1.5 h. The peroxidase was then developed 
by 3,3-diaminobenzidine and counter-stained with hematoxylin. 
 
3.3.4 Western blotting 
Lysates of isolated distal colonic crypt cells and total kidney lysates from AMPK1+/+ 
and AMPK1−/− mice were resolved by 10% sodium dodecyl sulfate polyacrylamide 
gel electrophoresis, transferred at 200 mA for 1.5h to Hybond-P membrane 
(Amersham, RPN303F), blocked for 1 h with 5% skimmed milk in PBS-Tween 0.1% 
(v/v), and incubated with a rabbit polyclonal anti-ENaC antibody (diluted 1/1,000, 
overnight, at 4°C; Babco, Berkeley, CA, USA). Bands were visualized with a goat anti-
rabbit IgG antibody conjugated to horseradish peroxidase (1/30,000, 1 h, at RT; Acris, 
R1364HRP) and the signal detected using a Fluor-STM MultiImager (Bio-Rad, 
Hercules, USA). Expression levels were compared to those of -actin labeled with a 
specific antibody at 1/1,000 for 1 h at room temperature (Sigma, A2066).  
 
3.4 Indirect measurements of ENaC activity 
3.4.1 Plasma and urine analyses  
Animals were kept under standard conditions without metabolic cages, with free access 
to water and chow. Blood was collected from mice submandibular glands after small 
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incision. Samples were centrifuged and the plasma was frozen and kept at -80°C. 
Plasma aldosterone levels were determined using a 125I RIA kit (Immunotech, IM1664). 
Renin activity was measured by incubating mouse plasma (1.5 h, 37°C) with the 
plasma of bilaterally nephrectomized male rats as renin substrate to generate 
angiotensin I (ng ml−1 h−1). Angiotensin I levels (ng ml−1 h−1) were determined by 125I 
RIA (Byk and DiaSorin Diagnostics, Germany) to assess plasma renin activity. Na+, K+, 
and Cl- contents in the urine were measured using an AVL 9180 Electrolyte analyzer 
(Roche,Switzerland). Urinary creatinine was determined using an autoanalyzer 
(Sunrise, Tecan, Germany). 
 
3.4.2 Blood pressure measurements  
Blood pressure measurements (mean arterial pressure) were carried out by tail cuff 
manometry (TSE, Blood Pressure 209000-series, Germany). Mice were conditioned to 
the measurement procedure during four consecutive days. Before each measurement, 
the animals were allowed to stay up for at least 10 min in the holding device, which was 
warmed to 37°C. In the three subsequent days, blood pressure values were 
determined and averaged. 
 
3.4.3 Measurement of mucociliary clearance  
Measurement of mucociliary clearance was performed as previously described147. 
Tracheas were mounted with insect needles onto an extra thick blot paper (Bio-Rad, 
Germany) and transferred into a chamber with water saturated atmosphere at 37°C. 
The filter paper was perfused with buffer solution at a rate of 1 mL/min and at 37°C. 
Polystyrene black dyed microspheres (diameter, 6.51±0.58 m, Polyscience, 
Warrington, PA, USA) were washed with buffer solution (±ATP, 10 M). Particle 
solution (10 L with approximately 0.5% Latex) was added onto the surface of the 
trachea twice, without and subsequent with ATP (10 M). Particle transport was 
visualized by taking pictures every 30s for 10-15 min, using a Zeiss stereo microscope 
Discovery V12 with PlanS objective (1.0x, FWD 81 mm), Zeiss digital camera AxioCam 
ICc1 and the software AxioVision (Release 4.6.3, Zeiss, Göttingen, Germany). Five to 
15 moving particles of different regions of the trachea were selected, and the transport 
was calculated by measuring the distance per time (m/min) using the AxioVision 
Software (Release 4.6.3, Zeiss, Göttingen, Germany). 
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3.5 Automatic FMP/Amiloride assay and siRNA screening 
The live-cell assay used to identify novel regulators of ENaC activity consisted on 
transfecting A549 cells with different siRNAs by solid-phase reverse transfection148 for 
48h. Afterwards, we performed live-cell imaging of cells loaded with a warm (37ºC) 
membrane-potential sensitive fluorescent dye (FMP) before and after incubation with 
ENaC specific inhibitor amiloride (30 M). We used as positive controls for the assay 
siRNAs targeting -ENaC subunit or COPB1 coatomer. 
 
3.5.1 siRNA spotting on chambered slides 
Lyophilised siRNA oligonucleotides were resuspended in water at a concentration of 30 
M, and were stored in aliquots at - 20 ºC. Preparation of siRNA mixtures for spotting 
into single well chambered glass coverslips (NalgeNunc) was as previously 
described148,149. In total, 384 spots were arrayed per slide in a 12x32 format, with a spot 
diameter of 400 m and a spot-to-spot distance of 1125 m. Sixty-three different 
spotted chambered slides were screened. Every chambered slide contained at least 7 
identical scrambled siRNA spots and at least 1 validated siRNA spot targeting COPB1. 
 
3.5.2 Automated Microscopy and Highthroughput Screening 
A549 cells (~ 150,000 cells) were plated in 1.5 mL of culture medium in each siRNA 
pre-spotted chambered slide and allowed to adhere and take up the oligonucleotides 
for 48 h prior to the beginning of the assay. After 2 days, the cells were incubated for 
10 min with FMP in the pre-warmed microscope chamber of an automated 
epifluorescence ScanR screening microscope (Olympus), comprising a cooled CCD 
camera (Hamamatsu), Marzhauser SCAN IM IX2 scanning stage, MT20 stabilised light 
source, standard filter sets and objectives and an automated liquid dispenser. After 
recognition of the initial spot (labeled with a blue marker), the siRNA arrays were 
imaged on every spot with a 10x objective (Olympus, UPSAPO) in the Cy3 channel 
with an exposure time of 25 ms and a gradient-based auto-focus. After spot 384th has 
been imaged, the FMP staining solution was automatically replaced by 30 M amiloride 
diluted in FMP and, after three minutes, image acquisition of each spot restarted 
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without auto-focus. Raw images from the microscope were in the form of non-
compressed 16-bit TIFF files. 
 
3.5.3 Image analysis 
The images acquired were processed and the mean intensity of FMP fluorescence 
before and after amiloride was quantified using a Labview-based software. In 
particular, based on the FMP signal, a mask for each cell in a spot was generated and 
applied to the second image of this spot (after amiloride). Gating parameters in the 
software were defined such that cells with irregular shape and size and containing 
saturated pixels were disregarded. Background subtraction was then performed to 
reduce the background grey levels to zero in the Cy3 channel. Using this mask, the 
fluorescence signal was quantified for each cell in the spot before and after amiloride 
and an amiloride-sensitive fluorescence ratio (amil-sensitive ratio) reflecting ENaC 
activity was calculated (see Results). Since, after seeding on siRNA microarrays, there 
are on average 200 (±60) cells on each image field, the overall behavior of a cell 
population is documented, increasing the significance of the observed phenotype. 
Therefore, the median amil-sensitive ratio is calculated for each image field containing 
a siRNA spot and used as the “score” for each spot.  
 
3.5.4 Statistical analysis of data from high-content screens 
To account for contamination between spots and spatial effects in individual plates, a 
background correction was performed by using Bioconductor150 software that is based 
on R statistical programming language. Background correction was performed by 
applying the locfit method which consists of subtracting from each spot score the mean 
of scores of 25 surrounding spots. This routine was then applied to all spots from the 
same chambered slide.  
Because most siRNAs did not have any effect on ENaC activity, the median ratio for a 
given chambered slide was very close to that of negative control spots. Therefore, for 
each spot, the corrected score was then normalized to the whole plate data, by 
subtracting the median plate corrected score and dividing it by the median associated 
deviation (MAD)151 and termed robust Z-score (similar normalization procedure already 
used in previous screens152). Each plate was screened 2-3 times and the mean of the 
Z-scores for each spot in the different replicates was calculated. siRNA spots that had 
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as an averaged Z-score a value at least 2 MAD away from the plate median (i.e lower 
than -2) were considered as putative ENaC inhibitors, while Z-scores higher than 2 
were obtained for putative ENaC activators. Individual spots with less than 100 
”quantifiable” cells (according to the gating described above) or where apoptosis had 
been induced were not considered valid for the final calculation of z-scores and were 
excluded. 
 
3.5.5 Secondary (validation) screen and hit classification 
To validate the hits from the primary screen, we ordered one or two additional 
independent siRNAs targeting the top ~60% hit genes and performed the 
FMP/amiloride assay. Image quantification and data analysis was performed as 
described for the primary screen, except for normalization of the data because, in 
contrast to the primary screen, most siRNAs did have an effect on ENaC activity. 
Therefore, normalization consisted on applying the locfit method and subtracting from 
each spot score the mean of scores of the surrounding negative controls. 
In order to classify the hits in known pathways that affect ENaC function, A549 cells 
were treated with aprotinin (20 g/mL) for 16 before the FMP/amiloride assay or pre-
transfected with a siRNA targeting Nedd4-2 (or scrambled) for 24h and only then plated 
on pre-spotted chambered slides 48h before the assay. 
 
3.6 Functional characterization of CaCCs 
3.6.1. Measurements of volume-dependent Cl- currents in mouse tracheas 
For activation of volume dependent Cl- currents in mouse tracheas, isotonic Ringer 
bath solution was changed to isotonic control solution in which 50 mmol/L NaCl was 
replaced by 100 mmol/L mannitol. Subsequently, mannitol was removed to produce 
extracellular hypotonicity of 100 mosmol/L, which corresponds to approximately 33% 
hypotonicity. Tissues were mounted into a micro-perfused Ussing chamber with a 
circular aperture of 0.785 mm2. Luminal and basolateral sides of the epithelium were 
perfused continuously at a rate of 5 mL/min. Bath solutions were heated to 37 °C, using 
a water jacket and the experiments were carried out under open circuit conditions. Data 
were collected continuously using PowerLab (AD-Instruments, Australia). Values for 
transepithelial voltages (Vte) were referred to the serosal side of the epithelium and 
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transepithelial resistance (Rte) was determined by applying short (1s) current pulses (I 
= 0.5 A). Rte and equivalent short circuit currents (ISC) were calculated according to 
Ohm’s law (Rte = Vte/I, ISC = Vte/Rte). 
 
3.6.2 CaCCs measurements by patch clamp  
Cells and acini isolated from mouse glands were allowed to settle onto poly-L-lysine 
coated cover slips and mounted on the stage of an inverted microscope (IM35, Zeiss) 
and kept at 37°C. The bath was perfused continuously with Ringer solution at about 10 
mL/min. For activation of volume dependent Cl- currents, isotonic Ringer bath solution 
was changed to isotonic control solution in which 50 mM NaCl was replaced by 100 
mM mannitol. Subsequently, mannitol (50, 75 and 100 mM) was removed to produce 
extracellular hypotonicity of -50, -75, and -100 mosmol/L, i.e. 17%, 25% and 33% 
hypotonicity. 
Patch-clamp experiments were performed in the fast whole-cell configuration. Patch 
pipettes had an input resistance of 2–4 MΩ, when filled with in an intracellular-like 
physiological solution. The access conductance was measured continuously and was 
between 60 and 140 nS. Currents (measured when in the voltage clamp mode) and 
voltages (measured in the current clamp mode) were recorded using a patch-clamp 
amplifier (EPC 7, List Medical Electronics, Darmstadt, Germany), the LH1600 interface 
and PULSE software (HEKA, Lambrecht, Germany) as well as Chart software (AD-
Instruments, Spechbach, Germany). Data were stored continuously on a computer 
hard disk and were analyzed using PULSE software. In regular intervals, membrane 
voltages (Vm) were clamped in steps of 10 mV from −50 to +50 mV relative to resting 
potential. Membrane conductance (Gm) was calculated from the measured current (I) 
and Vm values according to Ohm’s law. 
 
3.6.3 In vitro transcription and double-electrode voltage clamp 
cDNAs encoding SK4, hBest1-R218C, hBest1-S358A, hBest1-S358E, TMEM16A, 
TMEM16AK610A and P2Y2 receptors were linearized and in vitro transcribed using the 
T7, T3, or SP6 promoter and polymerase (Promega, USA). Isolation and microinjection 
of oocytes, as well as as the two-electrode voltage clamp technique, were performed 
as described in the previous section. Oocytes were injected with cRNA (10 ng, 47 nL 
double-distilled water) encoding these channels and receptors and kept at 18ºC for 
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48h-72h. Two milligrams of Pak2 enzyme were injected into Xenopus oocytes 30 min 
before measurements. Water-injected oocytes served as controls. Membrane currents 
were measured by voltage clamping the oocytes in intervals from −60 to +40 mV (−90 
to +30 mV for SK4-expressing oocytes), in steps of 10 mV, each 1 s. 
 
3.7 Subcellular localization and expression of CaCCs 
3.7.1 Subcellular localization by immunocytochemistry  
HEK293 cells and 16HBE cells were grown on glass cover slips and washed three 
times in phosphate-buffered saline (PBS). Cells were fixed with methanol at -20°C for 5 
min or with 4% paraformaldehyde and 0.2 M picric acid in PBS for 10 min and 
incubated with primary antibodies at 4°C overnight. Polyclonal hBest1 antibodies were 
raised against mouse Best1 (sequence AESYPYRDEAGTKPVLYE) or the human 
Best1 (sequence KDHMDPYWALENRDEAHS; Davids Biotechnologie, Regensburg, 
Germany). Mouse monoclonal anti- human calreticulin and mouse monoclonal anti-
hSTIM1antibodies were from BD Transduction Laboratories (Heidelberg, Germany). 
Mouse monoclonal anti- human calnexin was raised against amino acid residues from 
116 to 301. For immunofluorescence, cells were incubated with secondary AlexaFluro 
488 goat anti-rabbit IgG and tetramethylrhodamine goat antimouse IgG (Molecular 
Probes) for 1 h at room temperature and counterstained with Hoe33342 (Sigma-
Aldrich, Taufkirchen, Germany). Immunofluorescence was detected using an Axiovert 
200 microscope equipped with an ApoTome and Carl Zeiss AxioVision software 
(Axiovert 200M, Zeiss, Jena, Germany). 
 
3.7.2 Knock-down by siRNA and expression by RT-PCR and real time PCR 
Expression of mRNAs encoding all 10 human TMEM16-proteins were examined in 
HEK293, HT29 and CFPAC cells by standard RT-PCR using real time and additional 
primers (primers sequence on Table 1, Appendix 2). Expression of TMEM16A, 
TMEM16F, TMEM16H, and TMEM16J were suppressed by two independent sets of 
siRNA. Duplexes of 25-nucleotide of siRNA were designed and synthesized by 
Invitrogen (Paisley, UK) and Santa Cruz (Heidelberg, Germany). siRNA was 
transfected using Lipofectamin (1 g/L) and cells were examined 48 h or 72 h after 
transfection. Suppression of expression of TMEM16A, TMEM16F, TMEM16H, and 
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TMEM16J was verified by real time PCR. Total RNA was isolated from HEK293 or 
HT29 cells using NucleoSpin RNA II columns (Macherey-Nagel, Düren, Germany). 
Total RNA (2 g) was reverse transcribed using random primer and reverse 
transcriptase (M-MLV Reverse Transcriptase, Promega, Mannheim, Germany). The 
oligonucleotide primers used are presented in Table 2, Appendix 2. 
Real-time PCR was performed in a Light Cycler (Roche), using the Quanti Tect SYBR 
Green PCR Kit (Qiagen, Hilden, Germany). Each reaction contained 2 L Master Mix 
(including Taq polymerase, DNTPs, SYBR green buffer), 1 pM of each primer sense 
and anti-sense, 2.5 mM MgCl2, and 2 L cDNA. After activation of the Taq polymerase 
for 10 min at 94° cDNA was amplified by 15 s at 94°C, 10 s at 55°C, and 20 s at 72°C, 
for 50 cycles. The amplification was followed by a melting curve analysis to control of 
the PCR products. Analysis of the data was performed using Light Cycler software 
3.5.3. Standard curves for TMEMs mRNA and -actin mRNA were produced by using 
cDNA of transfected HEK cells at different dilutions. The ratio of the amount of TMEM 
to -actin mRNA was calculated for each sample and analysis was performed in 
triplicates. 
 
3.7.3 2D electrophoresis and MALDI-TOF analysis (technique performed by Dr. 
Fadi Aldehni) 
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) was performed with 
immobilized pH gradient (IPG) strip gels (Amersham, Germany) after overnight 
rehydration at room temperature. Isoelectric focusing was carried out with an IPGphor 
(Amersham Biosciences) for a total of 16 kV h at 20°C. The IPG gel was equilibrated in 
3 M urea, 50 mM Tris-HCl pH 8.8, 30% glycerol, 1.0% sodium lauryl sulfate (SDS), and 
16 mM dithiothreitol (DTT) for 15 min. Equilibrated IPG gels were placed on the top of 
the second-dimension 10% SDS gel with embedding agarose, and second-dimension 
electrophoresis was performed at room temperature for 5 h. Proteins were silver 
stained, and spots were excised, trypsin-digested, and analyzed by matrix-assisted 
laser desorption/ionization–time of flight (MALDI-TOF) and mass spectrometry 
database comparison (SEQLAB, Goettingen, Germany).  
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3.7.4 Immunoprecipitation and Western blotting  
HEK293 cells transfected with different cDNAs were lysed with lysis buffer and the 
cellular lysates precleared with protein A/G agarose beads (Pierce, Rockford, USA). 
Incubation of the precleared protein lysates with primary antibodies (1–5 g) was 
performed overnight at 4°C, and the protein–antibody complex was immobilized with 
the addition of 25 L of 50% slurry of protein A/G– or Ni NTA–agarose beads for 1 h at 
4°C. The beads were washed three times in lysis buffer, and after the last washing 
step, beads were boiled in 1x Laemmli sample buffer for Western blot analysis or the 
proteins were dissolved in 8 M urea, 4% CHAPS, 60 mM DTT, 2% Pharmalyte™3–10, 
0.002% bromophenol blue for 2D-PAGE analysis. For Western blot analysis, the 7% or 
10% SDS polyacrylamide gel was transferred to a polyvinylidene difluoride membrane 
(GE Healthcare EuropeGmbH, Munich, Germany) using semidry transfer (BioRad, 
Munich, Germany). Membranes were incubated with primary antibodies (dilution from 
1:2,000 to 1:5,000) overnight at 4°C. Proteins were visualized using a horseradish 
peroxidase (HRP)-conjugated secondary antibody (dilution 1:30,000) and ECL 
Detection Kit (GE Healthcare, Munich, Germany); the protein bands were detected by 
FujiFilm LAS-3000. 
 
3.7.5 In vitro phosphorylation (technique performed by Dr. Fadi Aldehni) 
Human bestrophin C-terminal domains (wild-type and mutant) were expressed in BL21 
(DE3) Escherichia coli strain from a plasmid encoding 295 fragments from position 291 
to 585 with an N-terminal polyhistidine (6x His) tag and SUMO in the pETSUMO™ 
vector (Invitrogen, Carlsbad, USA). Cells were grown to A600 = 0.8-1 at 37°C and 
induced with 0.5 mM IPTG for 12-16 h at 16°C. After production in bacteria, the 
hBest1C regions were purified through a Talon Metal Affinity Resin (Clontech 
Laboratories, Mountain View, USA), and samples were further concentrated and 
exchanged into the buffer of interest. Purity of the samples was analyzed by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. 
The C-terminal of hBest1 was phosphorylated by Pak2 (300 ng) in 20 L 
phosphorylation buffer containing 125 M [-32P] ATP 20 Ci at 30°C for 40 min. The 
reactions were stopped by 1x Laemmli SDS sample buffer and used for analysis by 
10% SDS-PAGE. The radioactive SDS gels were dried and analyzed by X-ray film. 
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3.7.6. Immunohistochemistry by convencional and electron microscopy 
(technique performed by René Barro-Soria in collaboration with Prof. Witzgall) 
For conventional electron microscopy, adult mice were perfusion-fixed for 3 min 
through the distal abdominal aorta with 1x PBS/2% glutaraldehyde. Tracheas were 
removed, incubated overnight in fixative, and treated with 1% OsO4 before being 
embedded in Epon. After ultrathin sections were stained with uranyl acetate and lead 
citrate, they were analyzed with a Zeiss EM 902 transmission electron microscope 
equipped with a cooled CCD camera (TRS, Moorenweis, Germany). To visualize 
increased Ca2+ concentrations in intracellular organelles, adult mice were perfusion-
fixed for 3 min through the distal abdominal aorta with 100 mM sodium cacodylate/3% 
paraformaldehyde/2.5% glutaraldehyde/ 50 mM potassium oxalate. Tracheas were 
removed, incubated overnight in the perfusion buffer and then 3 days in 100 mM 
sodium cacodylate/1% OsO4/100 mM potassium ferricyanide before being embedded 
in Epon. Electron spectroscopic imaging of ultrathin sections was performed in the 
Zeiss EM 902 transmission electron microscope without further staining. To 
demonstrate precipitated Ca2+ salts, the L2.3 edge at ΔE = 346 eV was used. 
 
3.8 Indirect measurements of CaCCs activity 
3.8.1 Measurement of the intracellular Ca2+ concentration (technique performed 
by René Barro-Soria) 
HEK293 cells were loaded either with 5 μM Fura2-AM (to measure global cytosolic 
Ca2+ changes using standard ratiometric techniques) or membrane-bound 
Furapiperazine-C12H25 (FFP-18, TEFLabs, Austin, USA) in Ringer solution at 37°C for 
2 h (to measure Ca2+ signals close to intracellular membranous compartments such as 
the ER). Fluorescence was detected at 37°C, using an inverted microscope IMT-2 
(Olympus, Nürnberg, Germany) and a high speed polychromator system (Visi-Chrome, 
Puchheim, Germany). FFP-18 was excited at 340/380 nm, and emission was recorded 
between 470 and 550 nm using a CCD camera (CoolSnap HQ, Visitron). The results 
were obtained at 340/380 nm fluorescence ratio (after background subtraction). We 
further measured cytosolic Ca2+ in close proximity to the ER store and bestrophin 1. 
To that end, we fused the Ca2+-sensitive protein G-CaMP2 to hBest1 and to mutant 
hBest1-R218C, respectively. When using hBest1-G-CaMP2 or hBest1-R218C-G-
CaMP2, fluorescence was excited at 485 nm and was detected at 520 to 550 nm.  
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3.8.2 Analysis of cell volume and FACS  
For cell volume measurements, HEK293 cells were loaded with 2 μg calcein-AM 
(Molecular Probes) and 0.025% Pluronic in standard bath solution (Ringer) for 30–60 
min at 37ºC. Analysis was done at excitation wavelength of 500 nm and emission 
wavelength of 520-550 nm. Cell swelling and RVD were observed for 10-15 min after 
applying hypotonic bath solution. To produce extracellular hypotonicity, isotonic Ringer 
bath solution (mM: NaCl 145, KH2PO4 0.4, K2HPO4 1.6, D-glucose 6, MgCl2 1, Ca-
gluconate 1.3, pH 7.4) was changed to isotonic control solution in which 50 mmol/l 
NaCl was replaced by 100 mmol/l mannitol. Subsequently, mannitol was removed to 
reduce extracellular hypotonicity by 100 mosmol/L (33% hypotonicity). Experiments 
were performed 48h after transfection of HEK293 cells with cDNAs encoding P2Y2 and 
hTMEM16A and 72h after transfection with siRNA targeting TMEM16 family members 
or scrambled. All the compounds were dissolved in the bath solutions and their effect 
on cell swelling was analyzed after 5-10 min incubation. Cell volume of HEK293 cells 
was also assessed by flow cytometry (Prof. Mathias Mack, University Hospital 
Regensburg) before (t = 0), 30 sec (t = 0.5 min) and 5 min (t = 5 min) after swelling 
which was induced by reduction of the solution osmolarity to 1/3. In flow cytometry 
experiments, HEK293 cells were resuspended in PBS and the average volume of 
30000 cells per condition was determined. 
 
3.9 Statistical analysis  
Student’s t-test (for paired or unpaired samples as appropriate) and analysis of 
variance (ANOVA) was used for statistical analysis. P<0.05 was accepted as 
significant. 
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IV Results and Discussion 
 
Chapter 1 - Regulation of the Epithelial Na+ Channel by the Protein Kinase 
CK2 
Bachhuber, T. (2008) J Biol Chem 283 (19): 13225-13232 
 
Abstract 
CK2 is a ubiquitous, pleiotropic, and constitutively active Ser/Thr protein kinase that 
controls protein expression, cell signaling, and ion channel activity. Phosphorylation 
sites for CK2 are located in the C terminus of both - and -subunits of the epithelial 
Na+ channel (ENaC). We examined the role of CK2 on the regulation of both 
endogenous ENaC in native murine epithelia and in Xenopus oocytes expressing 
rENaC. In Ussing chamber experiments with mouse airways, colon, and cultured M1-
collecting duct cells, amiloride-sensitive Na+ transport was inhibited dose-dependently 
by the selective CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB). In oocytes, ENaC 
currents were also inhibited by TBB and by the structurally unrelated inhibitors heparin 
and poly(E:Y). Expression of a trimeric channel lacking both CK2 sites (S631AT599A) 
produced a largely attenuated amiloride-sensitive whole cell conductance and rendered 
the mutant channel insensitive to CK2. In Xenopus oocytes, CK2 was translocated to 
the cell membrane upon expression of wt-ENaC but not of S631AT599A-ENaC. 
Phosphorylation by CK2 is essential for ENaC activation, and to a lesser degree, it also 
controls membrane expression of -ENaC. Channels lacking the Nedd4-2 binding 
motif in -ENaC (R561X, Y618A) no longer required the CK2 site for channel activity 
and siRNA-knockdown of Nedd4-2 eliminated the effects of TBB. This implies a role for 
CK2 in inhibiting the Nedd4-2 pathway. We propose that theCterminus of -ENaC is 
targeted by this essential, conserved pleiotropic kinase that directs its constitutive 
activity toward many cellular protein complexes. 
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4.1.1 Introduction 
Electrogenic Na+ absorption across the apical membrane of epithelia utilizes an 
amiloride-sensitive channel (ENaC) composed of three () subunits produced from 
different genes41. In kidney-collecting duct, distal colon, airway, secretory ducts from a 
variety of organs, and the absorptive sweat duct, ENaC is regulated by an interaction 
between the - and -subunits (at their C terminus) and the E3-ubiquitin ligase Nedd4-
2. The WW domains of Nedd4-2 bind proline-rich PY (PXXY) motifs in each ENaC 
subunit leading to channel ubiquitination, internalization, and degradation and hence 
channel inactivation63,74. Nedd4-2 interaction with ENaC is positively and negatively 
controlled by phosphorylation of either Nedd4-2, or the C termini of both - and -
ENaC. Accordingly, the aldosterone-induced serum and glucocorticoid-dependent 
kinase, Sgk-1, phosphorylates xNedd4-2 on serines (Ser) 444 and 338, thereby 
reducing its interaction with the channel and causing enhanced ENaC activity62,63. 
Apart from this, Sgk-1 also phosphorylates -ENaC (rat) directly at Ser-621, causing a 
stimulatory effect on the channel, which appears to be Nedd4-2-independent65.  
Protein kinase A (PKA), which is known to activate ENaC in alveolar epithelial cells, 
sweat duct, and kidney, was also shown to phosphorylate hNedd4-2 (at serine residues 
221 and 327 and threonine 246) and to reduce binding to ENaC68. Moreover, PKA 
prevents inhibition of ENaC by preventing -ENaC (rat) phosphorylation at threonine 
(Thr) 613 by the extracellular-regulated kinase (Erk)73. Indeed, phosphorylation of Thr-
613 in -ENaC and Thr-623 in -ENaC was previously shown to increase channel 
affinity toward Nedd4-2, thereby down-regulating channel activity72. Thus, differential 
phosphorylation of both - and -ENaC subunits can either enhance or reduce its 
affinity for Nedd4-2, thereby controlling its degradation and hence the channel activity.  
Along this line, the G protein-coupled receptor kinase 2 (Grk2) was found recently to 
upregulate the activity of ENaC in salivary duct cells69. Grk2 acts at the C terminus of 
-ENaC phosphorylating Ser-633, i.e. twenty amino acids downstream of Erk. Grk2 
increases the activity of ENaC by rendering the channel insensitive to Nedd4-269. 
Notably, an increased Grk2 activity has been reported to be associated with 
hypertension in humans and in animal models71. Therefore, imbalance in ENaC 
channel regulation by activatory or inhibitory pathways may lead to inappropriate Na+ 
absorption, hypertension, or cystic fibrosis153.  
Additional phosphorylation sites at the C terminus of the -and -subunits of ENaC 
include those for the pleiotropic but essential protein casein kinase 2 (CK2)154. It has 
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been demonstrated that CK2 specifically binds to and phosphorylates the C termini of 
both these ENaC subunits. As found for the Grk2 site (Ser-633) in -ENaC, a pair of 
CK2 phosphorylation sites (Ser-631 and Thr-599) is located in close proximity to their 
respective PY motifs. CK2 is not easy to study, as siRNA approaches invariably impact 
on a number of targets in multiple pathways, some of which coupled to its essential 
function for cell survival. In a previous study, no contribution of CK2 to regulation of 
ENaC was observed following the mutation of single putative CK2 sites154. 
Notwithstanding, we investigated a role for CK2 on ENaC function in native epithelia 
from airway and colon as well as in Xenopus oocytes expressing rat ENaC. We found 
that constitutive CK2 phosphorylation not only maintains ENaC active, but it also 
controls the membrane expression of its subunits. 
 
4.1.2 Results 
CK2 blocker inhibits ENaC activity 
We examined the contribution of CK2 to the regulation of epithelial Na+ channels in 
native epithelia from mouse trachea and colon. In Ussing chamber experiments, we 
explored CK2-selective concentrations of the specific inhibitor TBB, which was shown 
to have no effect on over 30 other kinases. TBB selectivity depends on its ability to bind 
an unusual hydrophobic ATP binding site that differs from the equivalent in 
conventional kinases. Electrogenic Na+ transport in mouse trachea was assessed by 
inhibition of ENaC with amiloride (10 M) (Fig. IV.1.1A). TBB (10 M) reduced the 
transepithelial voltage Vte and attenuated amiloride-sensitive short-circuit currents (Isc-
amil) in a dose-dependent manner (Fig. IV.1.1, A and B). Similarly, TBB significantly 
blocked amiloride-sensitive Na+ transport in mouse distal colon (Fig. IV.1.1, C and D). 
This effect could be reproduced in cultured mouse M1-collecting duct cells, grown on 
permeable supports (Fig. IV.1.1, E and F). These combined results suggest that 
endogenous epithelial Na+ channels expressed in epithelial tissues are maintained in 
an active state by constitutively active CK2. 
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Fig. IV.1.1 CK2 activates ENaC in native epithelia and in epithelial cells. Original Ussing chamber 
recordings of the transepithelial voltages Vte detected in mouse trachea (A), mouse colon (C), and M1 
cells (E). Effects of amiloride (A, 10 M) and the CK2 inhibitor TBB (10 M). Concentration-dependence of 
the effects of TBB on amiloride-sensitive transport in trachea (B), colon (D), and M1 cells (F). The asterisk 
(*) indicates significant effects of TBB (paired t-tests, number of experiments: 9–13 for each series). 
 
To further confirm regulation of epithelial Na+ channels by CK2, the three ()-ENaC 
subunits were expressed in Xenopus oocytes and examined in double electrode 
voltage clamp experiments. As shown in the original recording in Fig. IV.1.2A, the 
simultaneous expression of the three ENaC subunits produced a large current, which 
was inhibited by amiloride (A, 10 M). The CK2 structure is virtually identical in 
Xenopus compared with mammals. Thus, TBB (10 M) also significantly reduced 
amiloride-sensitive whole cell currents and conductance (Gamil), respectively (Fig. 
IV.1.2, A and B) in oocytes. Another compound, DMAT, has recently been shown to 
inhibit CK2 with higher inhibitory potency, but it has limited efficacy in vivo due to its 
rapid turnover (L.A. Pinna personnal communication). At 2 M, we did not observe 
inhibition of ENaC currents by DMAT in Xenopus oocytes; however, 5 M reduced 
amiloride-sensitive ENaC conductance significantly from 31.9±6.8 to 25.7±4.1 S 
(n=5). Regulation of ENaC by CK2 was further validated using the structurally 
unrelated peptide inhibitor of CK2, poly(E:Y) and conversely, by activating CK2 with 
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polylysine (poly(K))155. The peptides were injected into oocytes at final concentrations 
between 10 and 100 M, and amiloride-sensitive Na+ conductances were compared 
before and 1–5 h after injection. During these few hours, ENaC conductance 
increased, almost doubling initial values in water-injected controls (Fig. IV.1.2). This 
time-enhanced Na+ conductance was nevertheless inhibited by poly(E:Y) and was 
further activated through stimulation of CK2 by poly(K) (Fig. IV.1.2C). CK2 is known to 
associate with protein phosphatase 2A (PP2A). To confirm phosphorylation-dependent 
activation of ENaC, ooctyes were exposed to okadaic acid at a PP2A-specific 
concentration (100 nM), which further increased amiloride-sensitive Na+ transport (Fig. 
IV.1.2, D and E). Thus ENaC appears to be stimulated by constitutively active CK2 with 
counter-regulation by PP2A-like inhibition. To further confirm this activation by CK2, 
injection of the nonspecific CK2 inhibitor heparin (10 M) also reduced Na+ 
conductance in Xenopus oocytes (Fig. IV.1.4C). 
 
 
 
 
Fig. IV.1.2 CK2 activates ENaC in Xenopus oocytes. A, current recording from a Xenopus oocyte 
expressing -ENaC and effects of amiloride (10 M) and TBB (10 M). Oocytes were voltage-clamped 
from -60 mV to +40 mV in steps of 10 mV, and the resulting currents were recorded. B, summary of the 
effects of amiloride and TBB on whole cell conductance in ENaC-expressing oocytes. C, summary of the 
change of amiloride-sensitive conductance (Gamil) after injection of water, the CK2 inhibitor poly(E:Y) (50 
M) and CK2 activator poly(K) (50 M), respectively. D, current recording of an ENaC expressing oocyte 
and the effects of amiloride (A, 10 M) and okadaic acid (100 nM). E, summary of the effect of okadaic 
acid on the amiloride-sensitive whole cell conductance measured in oocytes. The asterisk (*) indicates 
significant effects (paired t-test). The number sign (#) indicates a significant difference for the effects of 
amiloride before and after incubation with TBB (paired t-test, 6 –25 experiments for each series). 
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Removal of CK2 sites from - and -ENaC inhibits amiloride-sensitive Na+ conductance 
and renders it insensitive to TBB 
Similar to endogenous Na+ currents present in epithelial tissues (Fig. IV.1.1), ENaC 
expressed exogenously in Xenopus oocytes was inhibited by TBB in a dose-dependent 
manner (Fig. IV.1.3, A and C). ENaC contains two phosphorylation sites for CK2, in -
ENaC (serine 631) and -ENaC (threonine 599). Changing both CK2 sites to alanines 
(S631AT599A) virtually eliminated Na+ conductance and rendered residual conductance 
of the double mutant channel insensitive to TBB (Fig. IV.1.3, B and D). Trimeric Na+ 
channels carrying only one mutation in either -ENaC (S631A) or -ENaC (T599A), 
produced more measurable but still significantly attenuated Na+ conductances when 
compared with wt-ENaC (Fig. IV.1.3E). Moreover, the remaining amiloride-sensitive 
Na+ conductances formed by dimeric -ENaC and -ENaC channels were further 
reduced by S631A and T599A, respectively (Fig. IV.1.3F). Finally, coexpression of hCK2 
together with wt-ENaC increased Gamil (65.9±9.0 S; n=7), when compared with 
injection of wt-ENaC alone (47.2±8.1 S; n=7). Co-expression of hCK2 did not 
augment Gamil of S631AT599A-ENaC (3.3±0.7 S; n=11 versus 3.4±0.5 S; n=11). 
Taken together, these results demonstrate that phosphorylation of S631 and T599 is 
essential for ENaC. 
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Fig. IV.1.3 Elimination of CK2 phosphorylation sites on ENaC inhibits channel activity. A, current 
recording from a Xenopus oocyte expressing -ENaC and effects of amiloride (10 M) and TBB (10 
M). Oocytes were voltage-clamped from -60 mV to +40mV in steps of 10 mV, and the resulting currents 
were recorded. B, current recording from a Xenopus oocyte expressing S631AT559A-ENaC and effects of 
amiloride and TBB. C and D, summaries of the effects of amiloride and TBB on Gamil generated by -
ENaC and S631AT559A-ENaC. E, comparison of Gamil produced by wt-()-, single mutants (S631A, 
T559A)- and a double mutant (S631AT559A)-ENaC. F, summaries of Gamil produced by dimeric wt-
(,)- and mutant (S631A, T559)-ENaC channels. The asterisk (*) and number sign (#) indicate a 
significant difference (paired t-test, 13–25 experiments for each series). 
 
CK2 controls ENaC activity and membrane expression of -ENaC 
To examine whether CK2 phosphorylation controls membrane expression of ENaC, 
FLAG-tagged -ENaC was coexpressed with non-flagged -ENaC in Xenopus 
oocytes. The appearance of Flag-ENaC in the cell membrane was monitored by 
chemiluminescence, during an observation period of 40-48 h (Fig. IV.1.4, B, D, and F 
and Fig. IV.1.5A, see “Materials and Methods”). Control injection with non-flagged 
ENaC did not produce a chemiluminescence different from background (data not 
shown). In parallel, amiloride-sensitive Na+ conductance was assessed at 
corresponding intervals (Fig. IV.1.4, A, C, and E). When Flag-ENaC was expressed 
in control oocytes, both Gamil and membrane expression continuously increased (Fig. 
IV.1.4, A and B). In contrast, when oocytes were kept in 10 M TBB-containing buffer, 
amiloride-sensitive Na+ conductance was completely abolished, and membrane 
expression was significantly reduced, albeit not completely. Moreover, co-injection of 
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-ENaCcRNAs together with the CK2 inhibitors heparin (final concentration 10 M) 
or the peptide inhibitor poly(E:Y) (final concentration 50 M) also inhibited Na+ 
conductance along with membrane expression of -ENaC (Fig. IV.1.4, C–F). Finally, 
M1 cells were grown on permeable supports, in the absence or presence of 10 M 
TBB. As observed in oocytes, TBB reduced amiloride sensitive transport from 
2.05±0.35 A/cm2 (n=19) to 1.52±0.25 A/cm2 (n=16). Thus, CK2 phosphorylation 
differentially controls membrane expression of -ENaC and ENaC activity. Of note, the 
inhibitory effect on conductance (3–5-fold) was significantly greater than on membrane 
expression (typically 2-fold). 
 
 
 
Fig. IV.1.4 CK2 controls membrane expression of ENaC in Xenopus oocytes. Time course for Gamil 
(A, C, E) and membrane expression of Flag- ENaC (B, D, F). Ooctyes were kept in ND97 or in ND97 
containing TBB (10 M), or were injected with heparin (10 M), poly(E:Y) (50 M), or equal amounts (30 
nL) of water. The asterisk (*) indicates significant differences when compared with ND96 or water 
(unpaired t-tests, 6–13 experiments for each series). Chemiluminescence measurements were performed 
by Tanja Bachhuber (Regensburg) and are reproduced here with permission. 
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CK2 is essential for ENaC activity, but has a small effect on membrane expression of 
-ENaC 
The contribution of both CK2 phosphorylation sites in -ENaC and -ENaC, to 
membrane expression of -ENaC was further examined by expressing single mutants 
(FlagS631A-ENaC or FlagT599A-ENaC) or the double mutant (FlagS631AT599A-ENaC) in 
oocytes. For the sake of simplicity, we only show a summary of the data obtained for 
membrane expression and ENaC conductance after 40 h of expression of those ENaC 
variants (relative to wild type). Importantly, single mutations in -ENaC or -ENaC 
largely reduced the Na+ conductance but had only a small effect on membrane 
expression. Elimination of both CK2 sites in -ENaC and -ENaC also strongly reduced 
Gamil, with a minor effect on membrane expression (Fig. IV.1.5A). Of note, TBB reduced 
-ENaC expression only when one CK2 site was intact. 
The nearby located Grk2 phosphorylation site Ser-633 was reported to control Nedd4-2 
binding to ENaC69. We explored whether the same might hold true for CK2 
phosphorylation sites. To this end, we compared whole cell conductances of several 
ENaC mutants to that of wt-ENaC. A mutation in the Nedd4-2 binding site (Y618A) 
increased ENaC whole cell conductance relative to the wild type and eliminated the 
inhibitory effect of S631A on ENaC conductance (Fig. IV.1.5B). This strongly suggests 
that CK2 phosphorylation at Ser-631 antagonizes the inhibitory action of Nedd4-2 in 
ENaC72 (Fig. IV.1.8). Similarly, when we expressed the truncated R561X-ENaC 
channel, we found that amiloride-sensitive whole cell conductance was largely 
increased (64.5±5.9 S; n=14) when compared with -ENaC, and was now 
unaffected by 10 M TBB (64.1±6.1 S). Interestingly, mutating the Grk2 site also 
reduced ENaC conductance; however, eliminating both CK2 and Grk2 sites in -ENaC 
produced a channel with similar activity to that of wt-ENaC (Fig. IV.1.5B). This 
suggests that the closely located phosphorylation sites of CK2 and Grk2 (Ser-631, Ser-
633) influence each other. 
The role of Nedd4-2 on CK2 regulation of ENaC was further examined by siRNA-
knockdown of xNedd4-2, similar to a recent study (Fig. IV.1.5C)156. Two remarkable 
results were obtained, namely: (i) wt-ENaC was no longer inhibited by TBB, (ii) 
S631A-rENaC, which normally produced only small amiloride-sensitive Na+ 
conductance, generated a whole cell conductance that was indistinguishable to that 
obtained for wt -rENaC (Fig. IV.1.5C). These effects were not observed when 
scrambled RNAi was injected. The contribution of Nedd4-2 to CK2 regulation of ENaC 
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was further examined in mammalian cells. M1 cells were grown on permeable supports 
after treatment with RNAi for mCK2, mNedd4-2, or scrambled RNAi, or as 
nontransfected control cells (Fig. IV.1.5D). Knockdown of CK2 and Nedd4-2 was 
verified by Western blotting (supplemental Fig. IV.1.S1). Isc-amil was enhanced in M1 
cells following Nedd4-2 knockdown, and inhibition by TBB was largely reduced (Fig. 
IV.1.5D). In contrast, CK2 knockdown reduced Isc-amil and also abolished the effect of 
TBB on Isc-amil (Fig. IV.1.5D). Taken together, these results suggest that CK2 
phosphorylation of ENaC antagonizes the inhibitory effects of Nedd4-2. 
 
 
 
 
Fig. IV.1.5 CK2 is essential for ENaC activity and antagonizes the inhibitory effect of Nedd4-2 on 
ENaC. A, summary of -ENaC membrane expression and Gamil after 40 h. TBB inhibited membrane 
expression of -ENaC via single mutants (S631A, T559A) but not that of the double mutant 
(S631AT559A). Gamil was largely reduced for all mutants, and Gamil produced by the double mutant was no 
longer inhibited by TBB. Dashed lines indicate membrane expression and Gamil of wt-ENaC. B, whole cell 
conductances relative to wt-ENaC. A mutation in the PY motif (Y618A) of -ENaC increased Na+ 
conductance, and S631A no longer inhibited ENaC conductance. The Grk2 mutant S633A inhibited ENaC, 
but not as a double mutant S631A/S633A. C, inhibition of xNedd4-2 expression by siRNA-xNedd4-2 but 
not scrambled siRNA. The abundant poly(A)-binding protein indicates equal loading. Summary of ENaC 
whole cell conductances measured in the absence or presence of siRNA-xNedd4-2 or scrambled siRNA 
(see “Materials and Methods”). D, summary of the amiloride-sensitive short-circuit current and effects of 
TBB (10 M) in control M1 cells and M1 cell treated with scrambled RNAi, mNedd4-2-RNAi, and mCK2-
RNAi (see “Materials and Methods”). The asterisk (*) indicates significant effects of TBB (paired t-tests). 
The number sign (#) indicates a significant difference compared with control (unpaired t-test, 6–24 
experiments for each series). Chemiluminescence measurements were performed by Tanja Bachhuber 
(Regensburg) and are reproduced here with permission. 
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CK2 controls membrane expression of_-ENaC and _-ENaC 
The activity of epithelial Na+ channels largely depends on coexpression of both - and 
-subunits. Membrane expression of -ENaC and -ENaC was monitored by injecting 
Flag-ENaC or Flag-ENaC, respectively, and Na+ conductances were measured in 
parallel. Na+ conductances generated by either Flag-ENaC or Flag-ENaC, 
respectively, were almost completely abolished when oocytes were exposed to 10 M 
TBB, while membrane expression of Flag and Flag were reduced by about 50% (Fig. 
IV.1.6A). We further examined whether Flag and Flag behave in a similar fashion in the 
absence of -ENaC. Dimeric channels formed by Flag-ENaC or Flag-ENaC produced 
small but detectable amiloride-sensitive whole cell conductances (0.74±0.2 S; n=8 
and 0.2±0.1 S; n=7, respectively). Interestingly expression of Flag-ENaC and Flag-
ENaC in dimeric and trimeric channels was similar, but expression of both subunits in 
the dimeric channel was not affected by TBB (data not shown). This suggests a 
complex role of -ENaC for expression of -ENaC. To further assess the impact of 
CK2 phosphorylation on membrane expression of -ENaC and -ENaC in trimeric 
(Flag-ENaC and Flag-ENaC) channels, we expressed single mutants (S631A-Flag-
ENaC or T599A-Flag-ENaC) and double mutants (S631A-FlagT599A-ENaC or 
S631AT599A-Flag-ENaC) in the absence or presence of 10 M TBB. For all mutant 
combinations, Na+ conductances were largely reduced in comparison to that of wt-
ENaC, and residual conductances generated by the double mutants were insensitive to 
TBB (Fig. IV.1.6, B and C). In contrast, the membrane expression of -ENaC and -
ENaC was not affected by any of the mutations individually, and membrane expression 
of the double mutants (S631A-FlagT599A-ENaC and S631AT599A-Flag-ENaC) was no 
longer inhibited by TBB (Fig. IV.1.6, B and C). These data suggest that when CK2 sites 
are present in -ENaC and -ENaC, they need to be phosphorylated to allow proper 
membrane expression of all three subunits. 
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Fig. IV.1.6 CK2 is not essential for membrane expression of -ENaC and -ENaC. A, inhibition of 
membrane expression of Flag-ENaC and Flag-ENaC and Gamil by 10 M TBB. B and C, TBB inhibited 
membrane expression of Flag-ENaC and Flag-ENaC in single mutants (S631A, T559A), but not in 
double mutants (S631AT559A). Gamil was largely reduced for all mutants, and Gamil produced by the double 
mutants was no longer inhibited by TBB. Dashed lines indicate membrane expression and Gamil of wt-
ENaC. The asterisk (*) indicates a significant effect of TBB (paired t-tests, 6–12 experiments for each 
series). Chemiluminescence measurements were performed by Tanja Bachhuber (Regensburg) and are 
reproduced here with permission. 
 
ENaC translocates CK2 to the cell membrane 
It has been reported that CK2 binds directly to ENaC154. This suggests that CK2 may 
be translocated by ENaC to the cell membrane as found for CFTR157. Oocytes 
expressing ENaC and non-injected control oocytes were immunolabeled, after 
embedding and cutting into 20-m sections. Using an anti-FLAG antibody, -ENaC 
could be visualized in membranes of Xenopus oocytes expressing Flag-ENaC (Fig. 
IV.1.7A). Moreover, upon expression of Flag-ENaC or Flag-ENaC, - and -
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subunits could be immunolabeled in the oocyte membrane (Fig. IV.1.7B, left panels). 
Expression of the three subunits was similar in S631AT559A-ENaC-injected oocytes 
(Fig. IV.1.7B, right panels). However, while CK2 was detected in membranes of 
oocytes expressing wt-ENaC, no membrane staining of CK2 was detectable in 
S631AT559A-ENaC-injected oocytes (Fig. IV.1.7B, lower panels). These results suggest 
that CK2 may be translocated to oocyte membranes by binding to ENaC - and -
subunits. 
 
 
 
Fig. IV.1.7 wt-ENaC translocates CK2 to the cell membrane. A, DIC image of the oocyte membrane 
(left panels) and immunostaining of Flag-ENaC in an ENaC-expressing (right upper panel) and a non-
injected (right lower panel) oocyte. B, immunostaining of the three ENaC subunits (green) and CK2 (red) in 
wt-ENaC (left panel) and S631AT559A-ENaC (right panel)-expressing oocytes. Bars indicate 10 m. 
Experiments were performed in at least triplicates. Experiments in this figure were performed by Tanja 
Bachhuber (Regensburg) and are reproduced here with permission. 
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4.1.3 Discussion  
CK2 regulates ion channels 
CK2 is an essential, constitutively regulated multifunctional protein kinase whose 
functions are not fully understood154. CK2 is believed to insert into protein complexes 
bringing its constitutive activity to many signaling complexes (p53, ion channels, actin 
capping at membranes, lipid flippases, etc). Notably, CK2 controls trafficking and 
sorting of trans-Golgi proteins. CK2 affects a number of membrane channels and 
pumps, among them is polycystin-2 (PC2), a divalent cation-selective channel. CK2 
was shown to maintain the Ca2+ sensitivity of PC2. Elimination of a CK2 site in PC2 
reduced its Ca2+ sensitivity, without changing membrane expression158. Others reported 
the importance of phosphorylation of PC2 by CK2, for proper ciliary localization of the 
channel159. CK2 also phosphorylates three critical serine residues within nephrocystin, 
another ciliary protein. CK2 phosphorylation is essential for co-localization of 
nephrocystin with the sorting protein PACS-1 at the base of cilia. Inhibition of CK2 was 
shown to eliminate interaction of PACS-1 and nephrocystin and to induce defective 
nephrocystin targeting160. CK2 may thus be relevant to the common autosomal form of 
polycystic kidney disease. 
We found here that ENaC is regulated by CK2 in a related manner, i.e. CK2 regulates 
ENaC activity as well as membrane expression. Lack of CK2 phosphorylation appears 
to reduce Nedd4-2 binding to ENaC, thereby enhancing channel activity and 
membrane expression. Notably, phosphorylation of ENaC by ERK inhibits both channel 
activity and membrane expression, and both effects are mediated by Nedd4-2 binding 
to ENaC72. 
CK2 has also been described to influence other ion channels, namely by regulating the 
current amplitude of voltage-dependent Ca2+ channels161, as well as the Ca2+-
dependent gating of small conductance Ca2+-activated K+ channels162. SK channels are 
organized in multiprotein complexes together with CK2 and PP2A, located in the 
postsynaptic pole of cochlear outer hair cells162. Furthermore, CK2 has recently been 
found to regulate CFTR, the chloride channel that is defective in cystic fibrosis and, as 
in this study, CK2 becomes membrane-associated with CFTR157. Once again both CK2 
and PP2A co-localize with different domains of CFTR157. Importantly, CK2 binding may 
be disease relevant because phenylalanine 508 (F508), the common missing residue 
in most patients with CF (F508del), is critical in promoting the interaction with CFTR. In 
both CFTR-expressing Xenopus oocytes and cell-attached mammalian cells, inhibition 
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of CK2 induced prompt closure of CFTR in less than 80 s157. However, direct 
phosphorylation of CFTR by CK2 at Ser-511 close to F508 has not been confirmed by 
radiolabeling cells and direct phosphopeptide mapping, and the exact mechanism 
remains unknown. Moreover, CFTR expression determines the cellular localization of 
CK2, which in turn could affect other membrane conductances such as 
amiloridesensitive Na+ absorption. It is interesting to note that the effect of CK2 is not 
stimulatory of the function of all proteins studied to date. Indeed, CK2 is inhibitory of 
another ABC family member, ABCA1; thus, constitutively suppressing the lipid flippase 
activity of this CFTR-related protein. 
 
C terminus of -ENaC, a target for kinase regulation of ENaC 
Phosphorylation-dependent regulation of ENaC by CK2 is demonstrated in the present 
study by several agents, namely, heparin, a nonspecific inhibitor of CK2 directed 
against acidic motifs; the peptide inhibitor of CK2, poly(E:Y); and the specific CK2 
inhibitors TBB and DMAT. Inhibition of protein phosphatases with okadaic acid further 
increased Na+ conductance, indicating the importance of basal CK2-dependent 
phosphorylation for ENaC regulation163. Furthermore, elimination of CK2 
phosphorylation sites (Ser-6331) abrogated Na+ conductance in Xenopus oocytes. 
Thus, together with results obtained in native epithelia and in epithelial cells, these data 
show that ENaC is compellingly regulated by CK2 (Fig. IV.1.8). 
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Fig. IV.1.8 Model for CK2 action on ENaC. Binding of the ubiquitin ligase Nedd4-2 leads to ubiquitination 
of ENaC and subsequent degradation of the channel and/or channel inactivation. Phosphorylation of 
ENaC at Ser-631 reduces affinity of ENaC for Nedd4-2, thereby maintaining membrane localization and 
ENaC activity. 
 
Notably, CK1 was shown recently to control intracellular trafficking of ENaC164. Yet, in a 
previous report such regulation could not be detected in salivary duct cells69. Instead, 
activation of ENaC by the G protein-coupled receptor kinase 2 Grk2 was found. 
Because of phosphorylation of Ser-633 by Grk2 in the C terminus of -ENaC, the 
affinity of Nedd4-2 binding to ENaC is apparently reduced, thus enhancing ENaC 
currents. According to the present data (Fig. IV.1.5B), a similar scenario may hold true 
for CK2-dependent regulation of ENaC, because both phosphorylation sites for Grk2 
and CK2 are located in close proximity to one other. Because CK2 classically engages 
in hierarchical phosphorylation with other kinases, phosphorylation through either Grk2 
or CK2 could control ENaC activity and membrane expression depending on the cell 
type and expression levels of the kinases involved. Moreover, phosphorylation by CK2 
is likely to affect regulation by Grk2 and vice versa (Fig. IV.1.5B). Further experiments 
will be needed to unravel this complex regulatory network and should focus on the 
inhibitory phosphorylation by Erk and its counteraction by activation through PKA, 
Grk2, and CK2, with Nedd4-2 as the central control switch69,72,73,165. As suggested in a 
previous report and supported by the present data, acute and chronic regulation may 
be different, inasmuch as acute regulation is changing the open probability of the 
channel, while chronic regulation by Nedd4-2 controls membrane expression166. 
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4.1.4 Supplement material 
Inhibition of mCK2 and mNedd4-2 by RNAi 
 
 
Supp. IV.1.1 Mouse collecting duct (M1) cells were transfected with siRNAs for CK2 or Nedd4-2 or with a 
scrambled RNAi (each 1 μg) for 7 hours. Cells were harvested 72 h after siRNA treatment and subjected 
to western blot analysis. Equal amounts of lysates (40 μg) were loaded on a gel and after transfer to a PE 
membrane probed with CK2 and Nedd4-2 antibodies, respectively. Experiments in this figure were 
performed by Fadi Aldehni (Regensburg) and are reproduced here with permission.
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Chapter 2 - AMPK controls epithelial Na+ channels through Nedd4-2 and 
causes an epithelial phenotype when mutated 
Almaça, J. et al (2009) Pflügers Arch 458 (4): 713-721 
 
Abstract 
The metabolic sensor adenosine-monophosphate-activated kinase (AMPK) detects the 
cellular energy status and adjusts metabolic activity according to the cytosolic AMP to 
ATP ratio. Na+ absorption by epithelial Na+ channels (ENaC) is a highly energy-
consuming process that is inhibited by AMPK. We show that the catalytic subunit 1 of 
AMPK inhibits ENaC in epithelial tissues from airways, kidney, and colon and that 
AMPK regulation of ENaC is absent in AMPK1−/− mice. These mice demonstrate 
enhanced electrogenic Na+ absorption that leads to subtle changes in intestinal and 
renal function and may also affect Na+ absorption and mucociliary clearance in the 
airways. We demonstrate that AMPK uses the ubiquitin ligase Nedd4-2 to inhibit ENaC 
by increasing ubiquitination and endocytosis of ENaC. Thus, enhanced expression of 
epithelial Na+ channels was detected in colon, airways and kidney of AMPK1−/− mice. 
Therefore, AMPK1 is a physiologically important regulator of electrogenic Na+ 
absorption and may provide a novel pharmacological target for controlling epithelial 
Na+ transport. 
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4.2.1 Introduction 
The metabolic sensor adenosine-monophosphate-activated kinase (AMPK) senses 
cellular “low-fuel” situations through detection of the adenosine triphosphate 
(ATP)/adenosine diphosphate (ADP) ratio by binding to the C terminus of its γ-subunit. 
It protects the cell by switching off ATP consuming pathways and switching on 
alternative pathways for ATP generation167.  
Electrogenic Na+ absorption by the epithelial Na+ channel ENaC takes place in kidney, 
airways, and large intestine. It is a highly ATP-consuming process that uses the 
electrochemical driving force for luminal uptake of Na+ into the cell. Sodium ions that 
enter the cell through apical ENaC are pumped out on the basolateral side by the 
action of the Na+/K+-ATPase41. It has been demonstrated in vitro that stimulation of 
AMPK by compounds like phenformin, metformin, and 5-aminoimidazole-4-
carboxamide-1-beta-D-ribofuranoside (AICAR), inhibits ENaC conductance in Xenopus 
oocytes, HEK293 cells, and polarized renal epithelial cells168-170.  
While it is clear that Na+ absorption is inhibited by AMPK in vitro, it is not obvious that a 
similar regulation takes place in vivo and whether AMPK1 or AMPK2 or both 
enzymes regulate ENaC. In this study, we demonstrate that AMPK1 is the isoform 
crucial for ENaC regulation in various Na+ absorbing epithelia in vivo. AMPK controls 
ENaC by facilitating ubiquitination and retrieval of ENaC from the cell membrane. Lack 
of expression of AMPK1 in AMPK1-knockout (KO) animals causes an epithelial 
phenotype with enhanced Na+ absorption in addition to other changes. 
 
4.2.2 Results 
AMPK inhibits ENaC through activation of endocytosis 
Activation of AMPK by phenformin (5mM) inhibited ENaC whole-cell currents in 
Xenopus oocytes in a time-dependent fashion (Fig. IV.2.1A, B). In parallel, membrane 
expression of Flag-tagged -ENaC was inhibited, as detected by chemiluminescence 
(Fig. IV.2.1C). This suggests that Na+ transport is inhibited by reduced membrane 
expression of ENaC. 
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Fig. IV.2.1 Inhibition of ENaC by AMPK A Amiloride (A, 10 M) sensitive whole-cell ENaC conductances 
(Gamil) measured in Xenopus oocytes in the absence and presence of phenformin (Phen, 5 mM) at two 
different incubation times. Phenformin leads to a progressive decrease in Gamil (B) and ENaC membrane 
expression as detected by chemiluminescence (C). Asterisk (*) indicates significant difference when 
compared to control (unpaired t test). Number of experiments, 7–17 for each series. 
 
 
A major regulator for membrane expression of ENaC is the ubiquitin ligase Nedd4-2, 
which binds to the C termini of ENaC subunits and controls endocytosis of ENaC by 
ubiquitination of the channel protein52. We therefore expressed trimeric (-ENaC) 
channels, in which -ENaC, -ENaC, or -ENaC were truncated individually. Channels 
containing truncated subunits were only slightly but not significantly inhibited by 
phenformin (Fig. IV.2.2A). Moreover, triple truncated H648XR561XS608X-ENaC channels 
were completely unaffected by phenformin (data not shown), supporting the concept 
that AMPK acts through enhancing Nedd4-2 binding to the ENaC subunits. When 
endogenous xNedd4-2 was suppressed with xNedd4-2-siRNA, ENaC conductance 
was enhanced, and inhibition of ENaC by phenformin (5 mM) was no longer observed 
(Fig. IV.2.2B). Endocytosis of ENaC occurs in a dynamin-dependent fashion, which can 
be inhibited by the dynamin inhibitor dynasore171. In fact, dynasore (40 M) abolished 
the inhibitory effect of phenformin on ENaC conductance, while treatment with the 
cytoskeletal disrupter cytochalasin D (10 M) reduced ENaC currents but did not 
suppress the inhibitory effect of AMPK on ENaC (Fig. IV.2.2C). Finally coexpression of 
the ubiquitin-specific ubiquitinase Usp2-4555 also abolished phenformin inhibition of 
ENaC, while the catalytic dead mutant Usp2-45 was without any effects (Fig. IV.2.2D). 
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Taken together, these data show that ENaC is inhibited by AMPK in Xenopus oocytes 
by activation of Nedd4-2-dependent endocytosis. 
                           A 
 
 
Fig. IV.2.2 AMPK inhibits ENaC by Nedd4-2-binding, ubiquitination, and endocytosis. A) Summary of 
the effects of phenformin on trimeric (-ENaC) channels, in which -ENaC, -ENaC, or -ENaC were 
truncated individually. Channels containing truncated subunits were not inhibited by phenformin. B) siRNA 
knockout of Xenopus Nedd4-2 enhanced Gamil and abolished the effects of phenformin. PolyA-binding 
protein (PolyA BP) was used to assure an equal loading for different samples. C) The inhibitor of dynamin-
dependent endocytosis, dynasore (40 M), abolished the effects of phenformin, which were still detectable 
after disruption of the actin cytoskeleton by cytochalasin D (10 M, 2 h). D) The inhibitory effects of 
phenformin on Gamil were abolished by the wt ubiquitinase Usp2-45 but not by the kinase dead mutant 
Usp2-45. Asterisk indicates significant difference when compared to control (paired t test). Number symbol 
indicates significant difference when compared without treatment (unpaired t-test). Number of experiments, 
8–24 for each series. 
 
We further analyzed whether similar mechanisms take place in mammalian cells. To 
that end, M1 cortical collecting duct cells were examined in open circuit Ussing 
chamber recordings. We found that phenformin (5 mM) significantly inhibited amiloride 
(10 M) sensitive Na+ transport from 5.1±0.8 to 1.8±0.2 A/cm2 (n=8). More 
importantly, phenformin inhibited amiloride-sensitive Na+ currents in the short circuited 
epithelial monolayer and after permeabilization of the basolateral membrane with 
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nystatin (75 g/mL) (Fig. IV.2.3A, B). Again, when endocytosis was inhibited by 
dynasore or after siRNA knockdown of Nedd4-2, the inhibitory effect of phenformin on 
ENaC was abolished (Fig. IV.2.3C-G). Thus, regulation of ENaC by AMPK is similar in 
Xenopus oocytes and mammalian cells. 
 
 
 
 
 
Fig. IV.2.3 AMPK inhibits ENaC in epithelial cells from mouse collecting duct. A, B) Original 
recordings and summary of the effects of phenformin on amiloride-sensitive short circuit currents in M1 
collecting duct cells permeabilized basolaterally with nystatin (75 g/mL). C, D) Original recordings and 
summary of the effects of phenformin on amiloride-sensitive short circuit currents in basolaterally 
permeabilized M1 cells treated with the dynamin inhibitor dynasore (40 M). E) siRNA suppression (two 
independent batches of siRNA) of Nedd4-2 expression in mouse M1 cells. F, G) Original recordings and 
summary of the effects of phenformin on amiloride-sensitive short circuit currents in basolaterally 
permeabilized M1 cells treated with siRNA for mNedd4-2. Asterisk indicates significant difference when 
compared to control (paired t test). Number symbol indicates significant difference when compared without 
treatment (unpaired t test). Number of experiments, 8–11 for each series 
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Enhanced amiloride-sensitive Na+ absorption in AMPK1−/− animals 
A mouse KO model for AMPK1 has been generated some time ago172. The animals 
demonstrate normal survival and did not present any obvious phenotype. We further 
examined the physiological role of ENaC regulation by AMPK in mice in vivo and in ex 
vivo tissues. To that end, we performed rectal potential difference measurements by 
introducing a catheter into the rectum of AMPK1+/+ and AMPK1−/− animals. As 
shown in Fig. IV.2.4A and B, in AMPK1−/− animals, the basal rectal PD was 
enhanced, along with an enhanced inhibitory effect of amiloride (10 M) on rectal PD. 
To further quantify the amiloride-sensitive Na+ absorption in the large intestine, distal 
colon was removed after sacrifycing the animals, and transepithelial voltage (Vte) was 
measured under open circuit conditions (Fig. IV.2.4C). In wt animals, amiloride (10 M) 
inhibited the negative Vte, and this effect was either reduced by phenformin (5 mM) or 
was enhanced in the presence of 80 M compound C. Compound C is a potent and 
reversible inhibitor of AMPK by competing for ATP binding at a Ki of 109±16 nM and 
shows little effects on a number of other kinases173. Similar experiments were 
performed in AMPK1−/− animals, and the calculated equivalent short circuit currents 
indicated (1) enhanced amiloride-sensitive Na+ absorption in animals that lack 
expression of AMPK1 and (2) inhibition of AMPK by compound C (80 M) enhanced 
Na+ transport in AMPK1+/+ but not in AMPK1−/− animals (Fig. IV.2.4D). In contrast, 
the AMPK activator phenformin inhibited Na+ absorption in the colon of both wt and KO 
animals (Fig. IV.2.4D), which can be explained by additional inhibition of the 
basolateral Na+/K+-ATPase by phenformin174. In the in vivo rectal PD measurements, 
both amiloride-sensitive and amiloride-insensitive RPD is enhanced in the AMPK1−/− 
mice (Fig. IV.2.4B). It is due to an enhanced baseline cystic fibrosis transmembrane 
receptor (CFTR) activity in the AMPK1−/− animals. CFTR is also regulated by AMPK, 
and we could recently demonstrate that baseline transport and forskolin-activated Cl− 
secretion by CFTR are enhanced in AMPK1−/− animals175. 
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Fig. IV.2.4 AMPK inhibits ENaC in vivo. A) rectal potential difference (RPD) and effect of amiloride 
measured in AMPK1−/− and AMPK1+/+ animals. B) Summary of the RPD and the changes in RPD 
induced by amiloride (ΔRPD) in wt and AMPK1-KO animals. C) Original recordings of the transepithelial 
voltage measured in the colon of wt mice and effects of amiloride (10 M) under control conditions or after 
application of phenformin (1 mM) or compound C (80 M). Compound C (Comp C) was used as an AMPK 
inhibitor. D) Equivalent amiloride-sensitive short circuit currents measured in the colon of wt and AMPK1-
KO animals under control conditions and after exposure to compound C or phenformin. Asterisk indicates 
significant difference when compared to control (paired t test). Number sign indicates significant difference 
when compared without treatment (unpaired t test). Number of experiments, 9–20 for each series. 
Experiments in this figure were performed by Bernhard Hieke (Regensburg) and are reproduced here with 
permission. 
 
The epithelial phenotype in AMPK1−/− mice  
The finding that AMPK inhibits ENaC through Nedd4-2-mediated endocytosis and 
degradation suggests that higher levels of ENaC expression should occur in epithelial 
tissues of AMPK1−/− animals, particularly in the colonic epithelium. In fact, 
immunohistology and western blotting of lysates from isolated colonic crypts indicated 
higher levels of ENaC expression in colonic crypts of AMPK1−/− mice (Fig. IV.2.5A, 
B). Enhanced ENaC levels were also observed by immunohistochemistry of kidneys 
and in western blots from total renal cell lysates from AMPK1−/− animals (Fig. 
IV.2.5C, D). In western blots from renal lysates, additional bands were obtained, which 
may be derived from partial degradation of ENaC by proteases, as described in 
previous studies45. Densitometric analysis revealed clear differences of -ENaC 
expression that were for colon, 2,753 ± 263 (AMPK1+/+) vs. 6,165 ± 1,207 
(AMPK1−/−) (n=2), and for kidney, 3,716 ± 2,229 (AMPK1+/+) vs. 9,026 ± 3,251 
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(AMPK1−/−) (n=3). Similarly, ENaC expression in AMPKα1−/− airways appears to be 
enhanced when compared to wt animals (Fig. IV.2.5E). 
 
 
 
 
Fig. IV.2.5 Enhanced expression of ENaC in AMPK1-KO mice. A) Expression of ENaC in the colon 
of AMPK1−/− and AMPK1+/+ animals at two different magnifications (bar upper panels = 70 m, lower 
panels = 20 m). B) Western blot analysis of ENaC expression in the colon of AMPK1−/− and 
AMPK1+/+ animals. C) Expression of ENaC in kidneys of AMPK1−/− and AMPK1+/+ animals. D) 
Western blot analysis of ENaC expression in the kidney of AMPK1−/− and AMPK1+/+ animals. E) 
Expression of ENaC in airways of AMPK1−/− and AMPK1+/+ animals. Negative control refers to 
staining without primary antibody. Experiments were performed at least in triplicate. Experiments in this 
figure were done by Jiraporn Ousingsawat (Regensburg) and are reproduced here with permission, with 
the exception of panel B.  
 
Although ENaC expression was enhanced in colon, kidney, and airways of AMPK1−/− 
animals, they did not present a clear functional phenotype. Apart from slightly reduced 
body weight, the animals thrived normally (Fig. IV.2.6A). AMPK1−/− animals 
demonstrated increased renal ENaC expression and showed enhanced urinary 
electrolyte excretion (Fig. IV.2.6B), which could be also due to ENaC-independent 
effects of AMPK on renal tubular transport176. Moreover, amiloride (10 M) sensitive 
fractional Na+ excretion was enhanced in AMPK1−/− animals (Fig. IV.2.6C). Serum 
renin was not changed significantly, but serum aldosterone and mean arterial blood 
pressure were reduced (Fig. IV.2.6D-F). The airways presented normal basal 
mucociliary clearance, as assessed by single particle tracking in tracheas ex vivo. The 
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calculated speed for particle transport was slightly reduced in tracheas of AMPK1−/− 
animals. Notably, clearance could not be further activated by pro-secretory stimulation 
with luminal ATP (Fig. IV.2.6G), although activation of Ca2+-dependent Cl−secretion by 
ATP was undisturbed in AMPK1−/− animals106,175. Taken together, abolishing 
AMPK1 does not only affect ENaC function but is likely to change a number of 
additional parameters important for epithelial transport in airways, renal tubules, and 
colonic epithelium, along with other functions unrelated to Na+ transport (data not 
shown). 
 
 
 
 
Fig. IV.2.6 Epithelial phenotype of AMPK1-KO mice. A) Postnatal weight increase in AMPK1−/− and 
AMPK1+/+ animals. B) Urinary salt excretion in AMPK1−/− and AMPK1+/+ animals. C) Amiloride-
sensitive Na+ excretion normalized to urinary creatinin (crea) concentration. Plasma aldosterone (D), 
plasma renin concentration (E) and mean arterial pressure (MAP) (F) measured in AMPK1−/− and 
AMPK1+/+ animals. G) Mucociliary clearance assessed by single particle tracking on mouse tracheas ex 
vivo in a humidified chamber. The calculated speed for particle transport was slightly reduced in tracheas 
of AMPK1−/− animals and could not be activated by pro-secretory stimulation with luminal ATP. Asterisk 
indicates significant difference when compared to control (paired t test). Number sign indicates significant 
difference when compared to wt animals (unpaired t test). Number of experiments, 9–20 for each series. 
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4.2.3 Discussion 
Regulation of ENaC by AMPK in vivo 
The present data show for the first time that epithelial Na+ absorption is regulated by 
AMPK in vivo and that this regulation is of physiological significance. This is 
demonstrated by a larger rectal potential difference and enhanced amiloride-sensitive 
Isc in the trachea of AMPK1−/− animals. Since AMPK is a sensor of the “cellular fuel” 
responding to changes in cellular ATP, AMPK regulation of ENaC may provide a 
mechanism to adapt electrolyte transport to low oxygen supply and/or metabolic stress. 
AMPK has emerged as a potential mediator for transport-metabolism coupling, as this 
kinase has been shown to regulate nutrient transporters and other ion channels, apart 
from ENaC, such as the cystic fibrosis transmembrane conductance regulator 
(CFTR)177. KO of the AMPK1 gene causes increase in ENaC expression in the 
epithelial tissues examined in this study, which is probably the reason for enhanced 
Na+ absorption in these organs. In the experiments with native tissues, the inhibitory 
effect of phenformin on amiloride-sensitive Na+ absorption was in part due to Nedd4-2-
independent effects, probably by inhibiting the basolateral Na+/K+-ATPase174. Therefore 
inhibition of Isc-Amil (open circuit measurements) by phenformin was similar in tissues of 
AMPK1+/+ and AMPK1−/− animals. In contrast, compound C, which inhibits AMPK 
and does not have additional effects on the Na+/K+-ATPase, shows clearly different 
effects in AMPK1+/+ and AMPK1−/− animals. Moreover, ENaC currents measured 
in oocytes and in M1 cells (basolaterally permeabilized monolayers) were not 
compromised by potential effects of phenformin on the Na+/K+-ATPase, since both 
were voltage clamped and the whole-cell current was measured directly. Notably, other 
compounds known to activate AMPK such as AICAR and metformin also inhibited 
ENaC, although they do not inhibit the Na+/K+-ATPase. Moreover, ENaC currents were 
not inhibited by phenformin when C termini were truncated. 
Along the same line, ENaC currents were not inhibited by phenformin when 
endocytosis was blocked by dynasore or by the ubiquitinase Usp2-45. These results 
provide strong evidence that ENaC is inhibited by AMPK through Nedd4-2 and 
activation of endocytosis. This is confirmed by the immunostainings of ENaC and 
detection of ENaC in western blots that again indicate enhanced membrane expression 
in tissues of KO animals. Our data are in perfect agreement with recently published 
data showing that AMPK inhibits the epithelial Na channel through functional regulation 
of the ubiquitin ligase Nedd4-2170. We incubated oocytes and M1 cells for only 2–5 h 
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with the dynamin-inhibitor dynasore, which may not be sufficient to induce 
accumulation of ENaC in the cell membrane and to increase Isc. Similarly, increase of 
Gamil or Isc-Amil by siRNA for Nedd4-2 also required 24–48 h of incubation. However, the 
important finding of the present report is that additional inhibition of Gamil or Isc-Amil by 
activation of AMPK does no longer take place in the presence of dynasore. 
AMPK1-KO mice present additional features that further contribute to the phenotype 
observed in these animals. A mild renal phenotype in AMPK1-KO animals has been 
reported recently, with marked upregulation but reduced phosphorylation of the 
Na+/2Cl−/K+-cotransporter NKCC2 in the thick ascending limb of the loop of Henle176. 
Moreover, we and others found additional defects in the red blood cell system in 
AMPK1-KO animals with the consequence of reduced hematocrit and erythrocyte 
numbers178. Our data confirm previous results demonstrating a splenomegaly in 
AMPK1-KO mice, possibly due to the massive amplification of erythroid-nucleated 
cells178. The complex phenotype indicates multiple defects in AMPK1-KO animals and 
suggests a role of AMPK1 for many still unidentified physiological processes. A 
detailed analysis of the obvious defects in the red blood system occurring in AMPK1-
KO animals will be the subject of a subsequent study.  
 
AMPK induces channel retrieval from the plasma membrane  
Previous studies showed that AMPK neither binds nor phosphorylates any of the ENaC 
subunits. Thus, it has been suggested that ENaC is inhibited through AMPK 
phosphorylation of Nedd4-2 and enhanced Nedd4-2 binding to ENaC169,170. Notably, 
neither ENaC phosphorylation by Erk1/2 nor phosphorylation of Nedd4-2 by the serum-
glucocorticoidregulated kinase or PKA, all demonstrated to affect ENaC activity, 
interferes with AMPK regulation of ENaC170. Our data extend the existing knowledge on 
the molecular mechanism of AMPK inhibition of ENaC and suggest an AMPK-induced 
ubiquitination and channel endocytosis. Consistently, we find that the early 
aldosterone-induced ubiquitinase Usp2-45 that increases expression of ENaC by 
deubiquitylation55 abolished the inhibitory effects of AMPK on ENaC. Thus, ENaC is 
indirectly inhibited by AMPK by phosphorylation of the ubiquitin-ligase Nedd4-2. This is 
different from the inhibition of CFTR by AMPK that occurs through direct binding and 
phosphorylation at the C terminus of the CFTR Cl− channel179. 
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Chapter 3 - High-content microscopy siRNA screens reveal potential 
targets for ENaC inhibition and treatment of cystic fibrosis  
Almaça, J. et al (2010) Manuscript in preparation 
 
Abstract 
One of the major challenges that biomedical research faces today is the identification 
of novel "druggable" targets towards finding therapeutic agents for a number of 
disorders for which the basic cellular defects are known. Alterations in channel 
structure and function of the epithelial sodium (Na+) channel (ENaC) have been shown 
to be important in several human diseases associated with disrupted fluid and 
electrolyte homeostasis and transport, such as hypertension, nephrosis and Cystic 
Fibrosis (CF). Here, we aimed to achieve a deeper understanding of the molecular 
factors involved in ENaC trafficking and function. To this end, we performed high-
content microscopy-based screens of human siRNA libraries to identify gene products 
affecting ENaC. Our screens identified 174 protein factors influencing ENaC function, 
which were partly connected to known pathways involved in the regulation of this 
sodium channel. Compounds that suppress the activity of these targets could be a way 
to inhibit ENaC and to correct the transport defect in CF airways. 
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4.3.1 Introduction 
One of the major challenges that biomedical research faces today is the identification 
of novel "druggable" targets towards finding therapeutic agents for a number of 
disorders for which the basic cellular defects are known. Indeed, as several model 
genomes have been sequenced, post-genomic approaches like transcriptomics and 
proteomics, aimed at identifying gene products differentially expressed in association 
with a given pathology, have held promise of both understanding the pathways that are 
putatively associated with the respective disease and as a fast track to therapy. 
However, extensive use of transcriptomic and proteomic approaches has also 
evidenced that new high-content functional genomics strategies and tools are critically 
needed to distinguish genes and proteins with mere secondary pathological association 
from those that are primarily responsible for the basic cellular defect(s) in disease. 
Ion channels and their regulators are challenging targets in drug discovery processes 
and siRNA screening because of the lack of technologies available to screen large 
number of compounds and genes in functionally relevant assays. Patch-clamp and 
other electrophysiological techniques, although very informative, have very low 
throughput and are not suitable to perform large-content screening. However, in the 
last few years, a number of functional cellular assays in multi-well plate formats have 
become available. These take advantage of various approaches to monitor ion flux or 
membrane potential (Vm) using radioactive, non-radioactive, spectroscopic and 
fluorescence measurements180. 
The epithelial sodium (Na+) channel (ENaC) is a member of the ENaC/degenerin 
(DEG) ion channel family, a group of distantly related, non-voltage gated Na+ channels 
found in animals. ENaC is sensitive to the potassium-sparing diuretic amiloride and its 
canonical form consists of three main subunits, -, - and -ENaC43, although a  
subunit can be found in some tisssues40. ENaC is responsible for transepithelial 
sodium transport and the maintainance of sodium balance in the kidney181,182, 
colon183,184 and in the airways185. In addition to ENaC, other degenerin family members 
are highly relevant to human disorders as the acid-sensing ion channels (ASIC) with a 
recently proposed role in psychological disturbances186 and for which the high-
resolution structure of one member has been solved44,187. Alterations in channel 
structure and function have been shown to be important in several human diseases. 
Indeed, loss- or gain-of-function mutations in ENaC cause hypertension in patients with 
Liddle’s syndrome, renal salt wasting in some variants of pseudohypoaldosteronism 
(PHA) nephrosis, pulmonary edema, chronic obstructive pulmonary disease, acute 
IV Results and Discussion - Chapter 3 
77 
 
respiratory distress syndrome, as well as Cystic Fibrosis (CF)188-190. In fact, excessive 
Na+ absorption is observed in CF and occurs due to reduced density or malfunction of 
the cystic fibrosis transmembrane regulator (CFTR)15 which, apart from being an apical 
membrane-localized chloride channel, also inhibits ENaC185. 
Several mechanisms are known to influence and tightly regulate ENaC-dependent Na+ 
transport and these include changes in protein expression, channel density at the cell 
surface and open probability181. However, many aspects of ENaC trafficking and 
regulation remain unresolved and only a more complete understanding of the 
molecular factors involved can help to elucidate how abnormalities in ENaC behavior 
lead to the above disease conditions. 
Functional genomics, and the discovery and characterization of protein function 
genome-wide, frequently uses small interfering RNAs (siRNAs) to specifically suppress 
the expression of virtually any desired protein-coding gene. This can only be achieved 
using a robust methodology that allows automated and efficient delivery of siRNAs into 
living cells. The methodology used consists on spotting individual siRNA transfection 
mixtures on imaging chambers (chambered slides) and seeding the cells on the top of 
these arrays, allowing them to take up the different siRNAs from the solid phase 
(known as reverse transfection)148,149. We targeted ~8,000 protein-coding genes in the 
human genome using chemically synthesized siRNA libraries designed to uniquely 
target each gene with 2–3 independent sequences. The siRNAs screened were 
grouped in three different libraries according to the biological process and molecular 
function of the targeted gene products. 
The effect of each siRNA on ENaC activity was analysed by live-cell imaging after 
allowing solid-phase reverse transfection to occur for 48 h. As a high-content screening 
assay we chose to monitor and quantify the effect of ENaC specific inhibitor amiloride 
on the fluorescence of a membrane potential sensitive dye, FMP, in a human alveolar 
type II epithelial cell line (A549 cells). This live-cell assay had been used by other 
authors for functional characterization of ATP-sensitive K+ channel (K(ATP)) 
modulators191 and to study ENaC activity on isolated crypts on a colonic cancer mouse 
model192. 
We identified proteins that are present in airway epithelial cells and that are essential to 
maintain ENaC activity. Pharmacological inhibition of these proteins might lead to 
ENaC inhibition and partially correct the Na+ hyperabsorption defect in CF. 
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4.3.2 Results 
Live-cell assay for ENaC activity 
The cells chosen as a model system to perform the screen were epithelial A549 cells 
that endogenously express ENaC subunits, whose transcription and protein synthesis 
is significantly increased upon treatment with the glucocorticoid dexamethasone 
(Dexa)40,60. Thus, the FMP/amiloride assay for ENaC activity (see Methods) was first 
tested in these cells in the presence and in the absence of Dexa. Fig. IV.3.1A shows 
that the FMP dye is fast loaded (1-2 min) into the cells, which are depolarized due to 
high ENaC activity, as seen by the sharp slope of the fluorescence curves both in the 
presence and in the absence of Dexa. Live-cell tracings (Fig. IV.3.1A) and microscopy 
images (Fig. IV.3.1B) also show that cells cultured with Dexa (i.e., with higher ENaC 
activity) evidence a much higher FMP fluorescence peak (Fig. IV.3.1A, blue curve) than 
those grown without Dexa (black curve). Therefore, for the screens, we decided to use 
the assay in A549 cells grown in the presence of Dexa. When the ENaC-specific 
inhibitor amiloride (30 μM) is added in this live-cell assay, cells hyperpolarize due to 
ENaC inhibition and consequently the FMP fluorescence decreases sharply (Fig. 
IV.3.1A,B). Thus, quantification of fluorescence in images of A549 cells loaded with 
FMP dye allows the estimate of ENaC activity in each individual cell through calculation 
of the following ratio: 
Amil-sensitive ratio (%) = (IF-amil - IF+amil) / IF-amil x 100 where IF-amil and IF+amil are the 
mean FMP fluorescence in each cell before and after incubation with amiloride, 
respectively. 
In order to use this assay in siRNA-transfected cells, we first optimized the siRNA 
conditions with a negative and a positive control. As a negative control, we chose a 
“scrambled” siRNA, i.e., not targeting any know human gene193 and as positive 
controls, we tested both the siRNA targeting the subunit of ENaC (si-ENaC) and 
another targeting the beta subunit of the COPI vesicle coat (si-COP). The latter is 
essential for retrograde transport from the Golgi to the endoplasmic reticulum (ER) and 
expected also to affect ENaC traffic. Images evidence that the negative control (in Fig. 
IV.3.1C, upper panels) has virtually no effect on the FMP fluorescence before and after 
amiloride in comparison to non-treated cells under the same culturing conditions 
(Fig.IV.3.1B, lower panels and Fig. IV.3.1D). In contrast, when A549 cells were 
transfected for 48h with ENaC siRNA (Fig. IV.3.1C, middle panels), the initial FMP 
fluorescence (IF-amil) is dramatically less intense than in the non-treated (Fig. IV.3.1B, 
lower panels) or in the scrambled-transfected cells (Fig. IV.3.1C, upper panels). 
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Moreover, the Amil-sensitve ratio is significantly reduced versus those two controls 
(Fig. IV.3.1D). The latter is also observed for COP siRNA (Fig. IV.3.1C, lower panels, 
Fig. IV.3.1D). These results are in good agreement with the fact that interfering with 
ENaC channel composition or with the general trafficking through the secretory 
pathway lead to an inhibition of ENaC and validate the usage of these two siRNAs as 
bona fide positive controls in the screen. 
 
 
 
Fig. IV.3.1 ENaC functional screening assay. A) The assay used to detect novel proteins affecting ENaC 
activity takes advantage of a membrane potential sensitive fluorescent dye (FMP) that enters the cells 
when they are depolarized and whose fluorescence can be quenched upon hyperpolarization of the cell 
membrane, e.g. by inhibiting ENaC with amiloride. B) Images of A549 epithelial cells grown for 48h on 
spots of lipofectamine and transfection mix with no RNAi (“empty”) in the constant presence of 
Dexamethasone (+ Dexa) or after Dexa removal for 6h before the assay (- Dexa). Cells seeded on each 
spot and loaded with FMP were imaged on a Scan^R Olympus microscope, on the Cy3 channel with the 
10x objective, before and after ENaC inhibition with amiloride (at 30 M). C) Images of A549 cells grown 
for 48h on spots of lipofectamine mixed either with scrambled RNAi, ENaC or COP siRNA. D) Summary 
of the median amiloride-sensitive FMP fluorescence ratio (amil-sensitive ratio) for empty (± Dexa), 
scrambled, ENaC and COP siRNA spots. Average of amil-sensitive ratio for 5 siRNA spots is shown in 
black. 
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Overview of the screen 
In the screens, we tested siRNAs for their effect on ENaC function coming from three 
chemically synthesized libraries and targeting altogether ~8,000 protein-coding genes 
in the human genome (see Methods). These were: the druggable library (5,940 genes), 
the kinome (710 genes) and the secretome194 (1,552 genes). The screen protocol 
consisted in first seeding A549 cells for reverse transfection onto pre-spotted 
chambered slides with 384 siRNAs each148. After 48h, the cells were loaded with FMP 
dye and each siRNA spot was imaged before and after incubation with amiloride (Fig. 
IV.3.2A). Each chambered slide included spots serving as positive and negative 
controls, i.e. siRNAs targeting COP and “scrambled”, respectively. Each screen was 
carried out at least in duplicate (kinome plates in triplicate). The “score” for each siRNA 
spot was the median of the above Amil-sensitive ratio for each cell in that spot. To 
normalize the data so as to compare the effects of each siRNA on ENaC activity across 
the whole screen, we used the robust Z-score of each siRNA spot (based on the 
median ratio for all spots in the same chambered slide151, since most siRNAs did not 
have any effect on ENaC activity, see Methods). For each siRNA, the Z-score was 
averaged between the different replicates and their distribution over the entire set of 
screened chambered slides is shown as heatmaps in Fig. IV.3.2B and as absolute 
values in Fig. IV.3.2C. siRNA spots that had an averaged Z-score value lower than -2 
were considered as putative ENaC inhibitors, while Z-scores higher than 2 would 
account for putative ENaC activators. In summary, the screen revealed 817 siRNAs 
inhibiting ENaC function (targeting 794 genes that activate ENaC, 23 genes scored 
with 2 different siRNAs) and 936 siRNAs activating #ENaC (targeting 886 genes that 
inhibit ENaC, 50 genes scored with 2 different siRNAs) (Fig. IV.3.2D). Since the focus 
of this siRNA screen was to identify inhibitors of ENaC, we concentrated mainly on the 
former group. 
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Fig. IV.3.2 Overview of the screen. A) The protocol followed in the screen consisted of seeding A549 
cells grown in the presence of dexamethasone and insulin in chambered slides where 384 different 
siRNAs had been previously spotted. After 48h at 37ºC, the slides were incubated with FMP solution and 
one image per spot was acquired before and after amiloride (30 M). The difference in FMP fluorescence 
intensity before (IF-amil) and after amiloride (IF+amil) reflects the amount of active ENaC in the cells and this 
amiloride-sensitive ratio was used to distinguish the effect of the different siRNAs in the screen. After 
background correction, each spot ratio was normalized to the corresponding plate median ratio and robust 
Z-scores were calculated. B) Heatmaps showing the distribution of the Z-scores averaged between 
replicates for each chambered slide in the screen. Maximum and minimum Z-score values were set to ±10 
for better resolution. C) Absolute Z-score values obtained in the complete screen. siRNAs with Z-scores 
higher or lower than 2 (blue lines) were taken as ENaC activators or inhibitors, respectively. D) Workflow 
showing the different steps in the primary and secondary (validation) screens and the number of hit genes 
obtained in each step. 
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Validation and gene ontology of hits from validated screen 
To minimize the risk of identifying false positive siRNAs as well as to avoid off-target 
effects, we carried out a secondary screen (validation screen) against the best putative 
hit genes from the primary screen. To this end, we chose the hits from the top ~60% 
(456) activatory hits (siRNAs inhibit ENaC) that had Z-score values lower than the -2 
threshold. We used two additional, independent siRNAs for the top-most 150 of these 
genes and one additional siRNA for the remaining 306 (in total 606 additional siRNAs) 
in the same FMP/amiloride assay. In the validation screen we could confirm 33% (151) 
out of 456 potential gene hits and, by combining the results from the primary and 
secondary screens, 174 genes showed a consistent phenotype on ENaC activity with 
two or more siRNAs (Fig. IV.3.2D, Supplementary Table 1). 
Most of the identified gene products are novel proteins for which a role in ENaC 
regulation has never been suggested. Therefore, we classified them by using 
bioinformatic tools such as DAVID database195,196, and grouped them according to the 
Gene Ontology terms “Cellular Component” and “Biological Process” (Fig. IV.3.3A,B). 
This analysis (Fig. IV.3.3A) showed that a large fraction of these validated hits (42%) is 
distributed over the secretory pathway (ER, Golgi, plasma membrane + 
endomembranes and secreted). Nevertheless some also locate to the cytoplasm 
(20%), nucleus (8%), both cytoplasm and nucleus (12%), and mitochondria (5%). 
Bioinformatic classification of the hits according to “Biological process” (Fig. IV.3.3B) 
indicates that 17% belong to metabolic processes, e.g., grouping gene products 
involved in carbohydrate metabolism (CHST9, GLB1L3), metabolism of phospholipids 
(PIK4CA, OC90), ceramide (UGCG) or cholesterol (e.g. MVK) or of different types of 
hormones (DIO1, CYP2R1). 
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Fig. IV.3.3 Validation of screen hits. Gene ontology (GO) terms distribution for the validated hits (174 
genes) using DAVID bioinformatic database according to A) cellular compartment or B) biological process 
annotations. To deal with multiple annotations for each gene, categories were chosen by their relevance to 
ENaC regulation and each gene was assigned to one of the first terms that it had been annotated with. 
 
Pathway classification of validated hits 
Our next goal was to gain further insight on how the hit genes relate to known 
pathways regulating ENaC activity. To this end, we performed the same FMP/Amil 
assay for the 151 validated gene hits whose siRNAs inhibit ENaC under conditions that 
interfere with: 1) ENaC activation by proteolytic cleavage of the extracellular loops of its 
- and -  subunits82,84,88,197; 2) ENaC endocytosis mediated by the E3-ubiquitin-ligase 
Nedd4-2 pathway52,63; 3) CFTR-dependent regulatory pathway15. To interfere with the 
proteolytic activation of ENaC, we performed the FMP/Amil assay after 16h-incubation 
of cells with 20 μg/mL aprotinin. Data in Fig.IV.3.4A show that aprotinin-treated cells 
exhibit a significant decrease (~20%) in the respective amiloride sensitive ratio in 
comparison to vehicle-treated cells (DMSO), in agreement with the removal of 
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inhibitory peptides from regions of ENaC subunits forming the channel pore by serine 
endopeptidases. 
ENaC levels at the plasma membrane are tightly controlled by the ubiquitin ligase 
Nedd4-2, whose binding to proline-tyrosine-rich (PY) motifs in ENaC C-terminus is 
inhibited by serum- and glucocorticoid-induced kinase SGK162,63. In particular, 
dexamethasone-dependent activation of SGK1 leads to phosphorylation of Nedd4-2 
and inhibition by promoting its interaction with members of the 14-3-3 family of 
regulatory proteins51,66. Downregulation of Nedd4-2 by siRNA (72h) and removal of 
dexamethasone from culture medium were used to interfere with the ubiquitination and 
endocytic removal of ENaC from the plasma membrane. Data in Fig. IV.3.4B show that 
removal of dexamethasone for 6h already causes a significant inhibition of ENaC 
activity. These short-term effects of dexamethasone can be partly reverted by 
transfecting the cells with Nedd4-2 since, if A549 cells are treated with siNedd4-2, even 
after 6h without dexamethasone, they exhibit a significant increase (~15%) in the 
respective amil-sensitive ratio in comparison to “scrambled”-transfected cells.  
Despite their high physiological relevance, the molecular mechanisms behind the 
regulation of ENaC by CFTR are still unclear (section 1.4.3.3). Within the TargetScreen 
project we have developed novel cellular systems on the A549 cells background to 
study traffic of CFTR and of other proteins such as ENaC, which exibit CFTR-
dependent regulation. In these model cell lines, expression of fluorescently (mCherry)-
labeled wild type protein (wt-CFTR) or the most common CFTR mutation in CF 
(F508del-CFTR34) is induced by doxycyline (DOX) (and sodium butyrate to increase 
overall cell transcription, see Methods). In these cells, while wt-CFTR is detected at the 
plasma membrane 16h after induction, F508del-CFTR is retained in the ER (Fig. 
IV.3.4C). Interestingly, when we determine ENaC activity in these cells, we observe 
that expression of wt-CFTR by itself is enough to induce a significant inhibition of the 
amil-sensitive ratio, i.e to inhibit ENaC activity by ~50% (Fig. IV.3.4D, black circles). In 
contrast, when the F508del-mutant protein is expressed, the levels of ENaC activity are 
similar to those observed for parental A549 cells under the same conditions of 
induction (Fig. IV.3.4D, grey circles). These cell lines thus constitute useful systems to 
determine the molecular mechanism underlying Na+ hyperabsorption observed in CF 
epithelial tissues as they seem to reproduce well what is observed in vivo. 
In conclusion, the FMP/Amil assay in combination with these tools, i.e. perturbations 
which modulate the activity and/or expression of known regulators of ENaC can be 
used to classify the genes identified in the screen. 
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Fig. IV.3.4 Pathway classification of validated hits. Modulation of the activity and/or expression of 
known regulators of ENaC such as proteases, Nedd4-2/SGK1 and CFTR. The FMP/Amil assay was again 
performed in A549 cells in order to quantify the effect on the amil-sensitive ratio of A) protease inhibitor 
aprotinin (20 g/mL) 16h-treatment in comparison with DMSO (vehicle) treated cells, B) 72h after 
transfection with siNedd4-2 or a scrambled RNAi, in the presence or absence of dexamethasone (Dexa) 
for different time intervals (0, 6 or 48h after removal). C) Expression of a mCherry-FLAG tagged wt or 
F508del-CFTR fusion protein can be induced in a novel cellular system upon incubation with Doxycycline 
(1 g/mL) and Na-butyrate (10 mM), for 16h. Plasma membrane expression of wt-CFTR can be observed 
by staining the wt cells with an anti-FLAG antibody without cell permeabilization but not in F508del cells. 
D) FMP/Amil assay on A549 parental or wt-, F508del-CFTR inducible cells. Mean ± SD are shown, n = 4 
wells. 
 
 
Accordingly, the validated hits were subjected to a first “classification” screen which 
consisted of reproducing the FMP/Amil assay on A549 cells treated as follows: 1) 
depletion of Dexa for 6h, 2) with aprotinin or 3) with siRNA targeting Nedd4-2 or a 
scrambled RNAi. These data were compared with those in similarly siRNA-transfected 
cells, but under control conditions. For cells transfected with siRNAs, dexamethasone 
was removed from culture medium 6h before the live-cell assay. The results of these 
experiments are shown on Fig. IV.3.5 and evidence that each of the applied treatments 
changes the pattern of hit validation. In particular, while in the presence of aprotinin 
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~32% of the validated hits are no longer inhibiting ENaC function (bein thus “aprotinin 
sensitive”). When dexamethasone is removed and the cells are transfected with 
scrambled RNAi ~45%, are no longer inhibitory (“Dexa sensitive”). This fraction is even 
higher (~56%) when Nedd4-2 is downregulated (“Nedd4-2 sensitive” hits). Therefore, 
we grouped the hits in five different classes, according to the sensitivity to the 
treatments (Fig. IV.3.5A and Supplementary Table 2). We included in “Class I” the hits 
that are not sensitive to any of the treatments applied (insensitive to all) and thus 
probably regulate ENaC through an additional pathway (~23%). In “Class II” are 
included the hits that are sensitive to all three treatments (sensitive to all, ~17%). 
Finally, “Classes III, IV and V” contain the hits that are only sensitive to aprotinin (~3%), 
to 6h- dexamethasone deprivation (and/or scrambled RNAi transfection, ~13%), or only 
sensitive to Nedd4-2-downregulation (~21%) respectively. An additional set of hits are 
those which are sensitive to two out of three pathways that were manipulated here 
(~24%). However, for the sake of simplicity, only the genes belonging to Classes I and 
II (insensitive and sensitive to all, respectively) are shown (Fig. IV.3.5B,C, being the 
gene lists in other classes included in Supplementary Table 2).  
It is interesting to speculate that the genes which are sensitive to all three treatments 
(~17%) are probably those that cross-talk between those three ENaC regulatory 
pathways. For instance, a gene product interfering with proteolytic cleavage of ENaC 
but also affecting ENaC ubiquitination, would result under aprotinin and siNedd4-2 
treatments with similar effects on these two classification read-outs (Fig. IV.3.5C). 
Every class described above has potential interest and further experiments are 
required to elucidate the mechanisms underlying the sensitivity of the hit genes to each 
treatment. 
Nevertheless, “Class I” may be of particular relevance and interest since it groups hit 
genes that are not sensitive neither to impairment of proteolytic cleavage, nor to short-
term dexamethasone removal nor to downregulation of Nedd4-2, thus falling into an 
unaddressed, potentially novel, pathway in ENaC regulation. 
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Fig. IV.3.5 Hit classification according to sensitivity to different treatments. A) Venn diagrams 
showing overlap between hit genes that are no longer affecting ENaC if serine proteases are inhibited 
(aprotinin sensitive, blue circle), if Dexa is removed for a 6h-period before FMP/Amil assay (Dexa 
sensitive, green circle) or in case Nedd4-2 is downregulated (Nedd4-2 sensitive, purple circle). There is a 
set of hits, named “Class I”, that are insensitive to any of the treatments (insensitive to all, n = 35 hit genes, 
i.e. 23.2% of validated hits), while another set of hits, named “Class II”, are sensitive to the three 
treatments (sensitive to all, n = 26, i.e 17.2%). B) Heatmap showing Z-score values for the siRNAs 
targeting the 35 genes in Class I, insensitive to all. C) Heatmap showing Z-score values for the siRNAs 
targeting the 26 genes in Class II, sensitive to all. 
 
The validated hits were subjected to a second “classification” screen which consisted of 
reproducing the FMP/Amil siRNA assay on A549 cells expressing mCherry-Flag-CFTR 
constructs (wt- or F508del-) after induction with DOX and also butyrate (But), for 
enhanced expression levels. Indeed, sodium butyrate is an inhibitor of histone 
deacetylase enzymes (HDAC) commonly used to modulate gene expression and 
increase transcription in cultured cells since it enhances transcriptional activity at 
silenced promoters or those downregulated due to histone deacetylase activity. In 
order to control for the effects of both the inducing agent (DOX) and the expression 
enhancer (But) in the CFTR-expressing cells (“induction” conditions), we also analysed 
in parallel the effect of the validated siRNA hits in the parental A549 cells under DOX 
and But on ENaC function (Fig.). We observe that for ~62% of the hit genes the 
corresponding siRNAs no longer reduced ENaC activity under “induction” conditions. 
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These results suggest that, for most of the hit genes, the mRNA levels cannot be 
efficiently downregulated under conditions of enhanced transcription and accelerated 
synthesis. Upon overexpression of wt-CFTR induction, ~79% of the validated hit 
siRNAs are no longer inhibiting ENaC function (wt-CFTR sensitive), while when 
F508del-CFTR protein is present (F508del sensitive) this fraction is slightly lower 
(~66%). We were particularly interested in the hit genes whose siRNAs showed a 
differential effect in the presence of wt- and F508del-CFTR. Therefore, we grouped 
under “Only wt-CFTR sensitive” those hit genes whose siRNAs only inhibit ENaC when 
wt-CFTR is not present (~7%) (Fig. IV.3.6A, B) and under “Only F508del sensitive” 
those whose siRNAs only inhibit ENaC when F508del-CFTR is absent (~5%) (Fig. 
IV.3.6A,C). The list of genes which are differentially affected by the presence of wt- and 
F508del-CFTR (and independent of the “induction conditions”) are shown in Fig. 
IV.3.6B,C. A significant fraction (~41%) of the hit genes no longer affect ENaC function 
under incubation with DOX and But, i.e., are sensitive to the three settings compared 
here. Further experiments are required to understand the differential effect of some 
genes depending on the presence of wt- or mutant CFTR protein. These genes may be 
extremely relevant to elucidate how mutation in a single aminoacid in CFTR can have 
the pleiotropic consequences as those observed in CF. 
 
Fig. IV.3.6. Hit classification according to sensitivity to wt- or F508del-CFTR proteins. The FMP/Amil 
assay was performed on the same conditions as before using this time A549 parental cells or transduced 
with lentiviral constructs encoding mCherry-FLAG-wt- or F508del-CFTR. A) Venn diagrams showing 
overlap between hit genes that are no longer affecting ENaC if A549 parental cells are treated with 
induction reagents (DOX and But, 16h) (induction sensitive, blue circle), if expression of wt-CFTR is 
induced (wtCFTR sensitive, green circle) or that of F508del-CFTR (F508del sensitive, purple circle). There 
is a set of hits are sensitive to the three conditions (sensitive to all, n = 62, i.e 41.1%). B) Heatmap 
showing Z-score values for the siRNAs targeting the 11 genes “Only wtCFTR sensitive”. C) Heatmap 
showing Z-score values for the siRNAs targeting the 7 genes “Only F508del sensitive”. 
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4.3.3 Discussion 
This study presents a valid procedure to evaluate expression of functional ENaC 
channels, in a simple and reproducible way that does not require invasive cell loading 
procedures, such as microinjection. Similar techniques had already been described in 
live-cell assays to accurately evaluate the activity and expression of other ion channels, 
such as CFTR198. Nevertheless, the FMP/Amil assay is an “end-point” assay which is 
only able to detect phenotypes for genes whose protein products are sufficiently 
reduced at the time of the assay and this largely depends on the stability of targeted 
gene product199. It must be born in mind that in high-content siRNA screens, a 
compromise must be made and an intermediate time-point chosen, with the 
consequences of not giving enough time for certain phenotypes to appear. 
The live-cell assay used in this study for siRNA screening had a relatively small 
dynamic range (~10% effect for positive vs. negative control siRNAs). This is probably 
due to significant variability associated with cellular heterogeneity, variable transfection 
efficiencies and the intrinsic nature of the genes being targeted. To circumvent some of 
this variability, we made a “local background” correction  and used a more robust (i.e. 
less sensitive to outliers) statistic method, i.e., based on median and median absolute 
deviation (MAD) in order to achieve a reliable hit selection151.  
Moreover, to avoid siRNA “off-target” effects, we carried out a validation screen against 
the top putative hit genes from the primary screen, with one or two additional 
independent siRNA sequences. We could thus confirm 33% of the potential gene hits. 
By combining the results from the primary and secondary screens, 174 genes showed 
a consistent phenotype on ENaC activity with two or more siRNAs. Although 
complementation experiments, i.e., addition of the respective cDNA (or, ideally the full 
gene) to restore the effects caused by the siRNAs, are still missing, validation of some 
hits by independent assays and techniques that directly measure ENaC activity has 
confirmed specificity of siRNA effects (data not shown).  
Most of the gene products identified in the screens are novel proteins for which a role 
in ENaC regulation has never been described. Bioinformatic tools allow the 
classification and grouping of screen hits and conclusions can be drawn for genes 
falling in the same group. We found a set of gene products that localize to the 
mitochondria (e.g. COX8A, FXC1, TOMM20, AK3, PANK2, ACADS) and we 
hypothesize that these affect ENaC activity indirectly by controlling the cellular energy 
status which is known to be critical for the activation of the AMP-dependent protein 
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kinase (AMPK), a known inhibitor of ENaC activity and expression 169,170,200 (and this 
thesis, Chapter 4.2). However, it is also possible that some of these genes affect ENaC 
function by controlling instead the localization of SGK1, a major player in ENaC 
regulation, whose subcellular localization is still controversial but has recently been 
proposed to be in mitochondria201. 
Classification of the hits into pathways known to be involved in ENaC regulation allows 
us to propose mechanisms underlying the effect of these hits on ENaC function. 
However, further experiments and more integrative bioinformatic analyses are essential 
to further support these hypotheses and fully understand the behavior of these genes 
whose effects on ENaC function depend either on the levels of active proteases, 
Nedd4-2 or on the constant presence of glucocorticoids. 
Neverthess, the genes which we grouped into “Class I”, i.e., the hits which are 
insensitive either to proteolysis inhibition, short-term Dexa removal or downregulation 
of Nedd4-2, are likely to regulate ENaC through a still unaddressed pathway. One of 
these genes is the matricellular protein CCN1 (also known as CYR61; cysteine-rich 
protein 61), which is dynamically expressed at sites of wound repair, and can induce 
fibroblast senescence by binding to integrin and heparan sulphate proteoglycans, 
inducing expression of antifibrotic genes202. A role for this protein on regulating ENaC 
activity or Na+ transport has never been proposed before. Thereffore, it will be 
interesting to further study its effect on ENaC function.  
There is a fraction of hit siRNAs whose effects on ENaC are simultaneously sensitive 
to the three treatments applied, probably reflecting the existence of an interplay 
between the chosen ENaC regulatory pathways. Interference, for instance, with 
proteolytic cleavage of ENaC affects ENaC ubiquitination, thus resulting in similar 
effects on the assay read-out under aprotinin and siNedd4-2. These genes were 
grouped in “Class II” and an example of a gene in this category is HSP90B1. Although 
a role for the molecular chaperone Hsp90 on stabilizing and making the 
mineralocorticoid receptor ligand binding-competent has been shown203, how the ER 
localized Hsp90 isoform, HSP90B1 (or endoplasmin), affects ENaC activity has never 
been addressed. 
There are only four genes in “Class III” whose effect on ENaC is sensitive to aprotinin 
(FRAP1, OR3A2, C20orf186, PLSCR3). Analysis of the molecular function of these 
genes does not indicate that they have proteolysis activity, suggesting that this effect 
may result from an upstream event, yet unclear, in the same pathway.  
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We grouped in “Class IV” the genes whose siRNAs no longer inhibit ENaC if Dexa is 
removed for a 6h-period before the FMP/Amil assay. These genes are likely to affect 
ENaC in a glucocorticoid-sensitive way, either because their expression responds 
directly or indirectly to glucocorticoids. One of these genes is the chitinase-like protein 
YKL-40, encoded by the CHI3L1 gene, a biomarker and functional effector of chronic 
inflammatory and allergic diseases, being associated with asthma severity and reduced 
lung function. Mechanical stress, similar to that experienced during broncho-
constriction, triggers epithelial cell signaling through epidermal growth factor receptor 
(EGFR), fibrotic mediator release, and goblet cell hyperplasia, consistent with airway 
remodeling in asthma, and CHI3L1 expression and secretion of YKL-40 in a EGFR204. 
Interestingly, glucocorticoids are used to treat diseases caused by an overactive 
immune system, such as asthma. Regulation of ENaC by EGFR has also been 
described before and activation of this receptor leads to inhibition of ENaC in tyrosine 
kinase-dependent way205. 
In “Class V” we placed the hits whose effect are sensitive to downregulation of Nedd4-
2. One of these encodes the -subunit of CK2 (CSNK2B), a kinase that has been 
shown to phosphorylate - and -ENaC impairing in this way the binding of Nedd4-2 
and ENaC endocytosis206 (and this thesis, Chapter 4.1). The fact that an siRNA 
targeting CSNK2B does not inhibit ENaC in the absence of Nedd4-2 confirms the 
involvement of this E3 ubiquitin ligase in the regulation of ENaC by CK2, as it had 
already been proposed206. 
The validated hits were also classified according to the dependency of their effect on 
the presence of wt- or F508del-CFTR. In the transduced A549 cells used here, 
expression of wt-CFTR is enough to induce a significant inhibition of ENaC activity, in 
contrast to F508del-CFTR overexpression, thus recapitulating what has been 
described in vivo15,18. Accordingly, these cell lines constitute very useful and probably 
the simplest systems to determine the molecular mechanism underlying Na+ 
hyperabsorption observed in CF epithelial tissues. However, we observed that under 
conditions used to induce expression of the CFTR constructs, the effects of a 
significant proportion of siRNAs (~62%) are no longer observed. This suggests that, for 
most of the hit genes, their respective mRNA cannot be efficiently downregulated under 
conditions of enhanced transcription and accelerated synthesis. 
Still, there is a number of hits that affect ENaC function differentially in the presence of 
wt-CFTR or the F508del mutant and these constitute very interesting targets. Although 
they are only 11 genes sensitive to wt-CFTR and 7 sensitive to F508del, they indicate 
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that expression of functional CFTR or instead of an ER-retained mutant alters cellular 
machinery that regulate Na+ transport through ENaC. Interestingly, a closer look at the 
hits that no longer affect ENaC function when F508del-CFTR is present (F508del 
sensitive) reveals that 3 out of 7 are also classified as belonging to “Class I”, i.e., 
insensitive either to aprotinin, Dexa removal or siNedd4-2 (GAS6, GNB2 and PSMB3). 
GAS6 gene encodes a Ca2+- and receptor-binding protein that is present in the 
extracellular region, while GNB2 encodes in turn a G-protein coupled receptor present 
in the perinuclear region that works as a Ca2+-channel regulator with GTPase activity. 
PSMB3 encodes a subunit of the proteasome. It is still unclear why these proteins are 
no longer activating ENaC when F508del-CFTR is present, but clearly a role for Ca2+ 
signalling might be anticipated under such conditions, i.e., in the absence of wt-CFTR. 
Intracellular Ca2+ may affect ENaC conductance through changes in membrane 
potential or through regulation of the activity of Ca2+-dependent chaperones that are no 
longer available to interact with ENaC when F508del is present. 
Data presented here, resulting from a high-throughput/ high-content microscopy 
platform (omic approach), allow the parallel study of a complete body of genes in one 
single run of experiments. Analysis and integration of such data is quite complex is now 
required in the context of what is known about ENaC regulation. This handling of omic 
data represents one of the most challenging frontiers for all the disciplines related to 
Systems Biology in the post-Genomic Era, and remains a critical step, given the large 
number of hypotheses examined at one time. 
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4.3.4 Supplement material 
Table 1 Gene Symbol, Ensembl ID and Name of validated screen hits with at least two siRNAs 
Gene Symbol Ensembl ID Gene Name 
ABCD3 ENSG00000117528 ATP-binding cassette sub-family D member 3 
ACADS ENSG00000122971 
Short-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
ACCN2 ENSG00000110881 Amiloride-sensitive cation channel 2, neuronal 
ACY3 ENSG00000132744 Aspartoacylase-2 
ADAMTS9 ENSG00000163638 
A disintegrin and metalloproteinase with thrombospondin 
motifs 9 
ADAR ENSG00000160710 Double-stranded RNA-specific adenosine deaminase 
AGTRAP ENSG00000177674 Type-1 angiotensin II receptor-associated protein 
AHSA2  ENSG00000173209 Activator of 90 kDa heat shock protein ATPase homolog 2 
AK3 ENSG00000147853 GTP:AMP phosphotransferase, mitochondrial 
AKAP14  ENSG00000186471 A-kinase anchor protein 14 
ANKK1 ENSG00000170209 
Ankyrin repeat and protein kinase domain-containing 
protein 1 
ANO10  ENSG00000160746 Anoctamin-10 
APC ENSG00000134982 Adenomatous polyposis coli protein 
APLF ENSG00000169621 Aprataxin and PNK-like factor 
ARF4 ENSG00000168374 ADP-ribosylation factor 4 
ARHGEF11  ENSG00000132694 Rho guanine nucleotide exchange factor 11 
AXL ENSG00000167601 Tyrosine-protein kinase receptor UFO 
B4GALT6  ENSG00000118276 Beta-1,4-galactosyltransferase 6 
BCL11B ENSG00000127152 B-cell lymphoma/leukemia 11B 
BRAF ENSG00000157764 Serine/threonine-protein kinase B-raf 
BRD4  ENSG00000141867 Bromodomain-containing protein 4 
BTN2A1 ENSG00000112763 Butyrophilin subfamily 2 member A1 
BUB1 ENSG00000169679 Mitotic checkpoint serine/threonine-protein kinase BUB1 
C20orf186 ENSG00000186191 
Long palate, lung and nasal epithelium carcinoma-
associated protein 4 
C5orf13  ENSG00000134986 chromosome 5 open reading frame 13    
CAPN10  ENSG00000142330 Calpain-10 
CCNI  ENSG00000118816 Cyclin-I 
CDK10 ENSG00000185324 Cell division protein kinase 10 
CFTR ENSG00000001626 Cystic fibrosis transmembrane conductance regulator 
CHAT ENSG00000070748 Choline O-acetyltransferase 
CHCHD6 ENSG00000159685 coiled-coil-helix-coiled-coil-helix domain containing 6 
CHI3L1 ENSG00000133048 Chitinase-3-like protein 1 
CHID1 ENSG00000177830 Chitinase domain-containing protein 1 
CHST9 ENSG00000154080 Carbohydrate sulfotransferase 9 
CHUK ENSG00000213341 Inhibitor of nuclear factor kappa-B kinase subunit alpha 
CKM ENSG00000104879 Creatine kinase M-type 
CLCN6 ENSG00000011021 Chloride transport protein 6 
CNTFR ENSG00000122756 Ciliary neurotrophic factor receptor subunit alpha 
COPB1 ENSG00000129083 Coatomer subunit beta 
COPB2 ENSG00000184432 Coatomer subunit beta 39 
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COPG ENSG00000181789 Coatomer subunit gamma 
COX7C ENSG00000127184 Cytochrome c oxidase subunit 7C, mitochondrial 
COX8A ENSG00000176340 Cytochrome c oxidase subunit 8A, mitochondrial 
CSK ENSG00000103653 Tyrosine-protein kinase CSK 
CSNK2B  ENSG00000204435 Casein kinase II subunit beta 
CXCL13 ENSG00000156234 C-X-C motif chemokine 13 
CYP2R1 ENSG00000186104 Vitamin D 25-hydroxylase 
DERA ENSG00000023697 Putative deoxyribose-phosphate aldolase 
DGKI  ENSG00000157680 Diacylglycerol kinase iota 
DIO1 ENSG00000211452 Type I iodothyronine deiodinase 
DPP9  ENSG00000142002 Dipeptidyl peptidase 9 
DRG1 ENSG00000185721 Developmentally-regulated GTP-binding protein 1 
DYRK4 ENSG00000010219 Dual specificity tyrosine-phosphorylation-regulated kinase 4 
EGLN1 ENSG00000135766 Egl nine homolog 1 
ENPP3 ENSG00000154269 
Ectonucleotide pyrophosphatase/phosphodiesterase family 
member 3 
EPHA6 ENSG00000080224 Ephrin type-A receptor 6 
ERBB2 ENSG00000141736 Receptor tyrosine-protein kinase erbB-2 
FAM179B ENSG00000198718 Protein FAM179B 
FRAP1 ENSG00000198793 Serine/threonine-protein kinase mTOR 
FRK ENSG00000111816 Tyrosine-protein kinase FRK 
FXC1  ENSG00000132286 
Mitochondrial import inner membrane translocase subunit 
Tim9 B 
GALR3  ENSG00000128310 Galanin receptor type 3 
GAS6  ENSG00000183087 Growth arrest-specific protein 6 
GCKR ENSG00000084734 Glucokinase regulatory protein 
GLB1L3 ENSG00000166105 Beta-galactosidase-1-like protein 3 
GNB2 ENSG00000172354 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit 
beta-2 
GPX2 ENSG00000176153 Glutathione peroxidase 2 
GRIA1 ENSG00000155511 Glutamate receptor 1 
GRINA ENSG00000178719 Glutamate [NMDA] receptor-associated protein 1 
GRK5 ENSG00000198873 G protein-coupled receptor kinase 5 
GSTO1 ENSG00000148834 Glutathione S-transferase omega-1 
GYS2 ENSG00000111713 Glycogen [starch] synthase, liver 
HCN1  ENSG00000164588 
Potassium/sodium hyperpolarization-activated cyclic 
nucleotide-gated channel 1 
HIPK3 ENSG00000110422 Homeodomain-interacting protein kinase 3 
HIST1H2AC ENSG00000180573 Histone H2A type 1-C 
HMBOX1 ENSG00000147421 Homeobox-containing protein 1 
HOXD11 ENSG00000128713 Homeobox protein Hox-D11 
HSP90B1 ENSG00000166598 Endoplasmin 
HTR2A ENSG00000102468 5-hydroxytryptamine receptor 2A 
HTR3C ENSG00000178084 5-hydroxytryptamine receptor 3C 
IFIH1 ENSG00000115267 Interferon-induced helicase C domain-containing protein 1 
IFNGR1 ENSG00000027697 Interferon gamma receptor 1 
IPO8 ENSG00000133704 Importin-8 
IQCF1 ENSG00000173389 IQ motif containing F1 
ITPK1 ENSG00000100605 Inositol-tetrakisphosphate 1-kinase 
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KCNAB2 ENSG00000069424 Voltage-gated potassium channel subunit beta-2 
KCNG3 ENSG00000171126 Potassium voltage-gated channel subfamily G member 3 
KCNN1 ENSG00000105642 
Small conductance calcium-activated potassium channel 
protein 1 
KCNQ2 ENSG00000075043 Potassium voltage-gated channel subfamily KQT member 2 
KCNQ3 ENSG00000184156 Potassium voltage-gated channel subfamily KQT member 3 
KCTD10 ENSG00000110906 
BTB/POZ domain-containing adapter for CUL3-mediated 
RhoA degradation protein 3 
KIFAP3  ENSG00000075945 Kinesin-associated protein 3 
KLRC3  ENSG00000205810 NKG2-E type II integral membrane protein 
LEPREL1 ENSG00000090530 Prolyl 3-hydroxylase 2 
LYN ENSG00000249529 Tyrosine-protein kinase Lyn 
MAP3K3 ENSG00000198909 Mitogen-activated protein kinase kinase kinase 3 
MAPK15 ENSG00000181085 Mitogen-activated protein kinase 15 
MAPK8 ENSG00000107643 Mitogen-activated protein kinase 8 
MAPK9 ENSG00000050748 Mitogen-activated protein kinase 9 
MARK3 ENSG00000075413 MAP/microtubule affinity-regulating kinase 3 
MAST3  ENSG00000099308 Microtubule-associated serine/threonine-protein kinase 3 
MBD1 ENSG00000141644 Methyl-CpG-binding domain protein 1 
MC4R  ENSG00000166603 Melanocortin receptor 4 
MEST  ENSG00000106484 Mesoderm-specific transcript homolog protein 
MVK ENSG00000110921 Mevalonate kinase 
NAGK ENSG00000124357 N-acetyl-D-glucosamine kinase 
NME3 ENSG00000103024 Nucleoside diphosphate kinase 3 
NPR2 ENSG00000159899 Atrial natriuretic peptide receptor 2 
OC90  ENSG00000132297 Otoconin-90 
OCRL ENSG00000122126 Inositol polyphosphate 5-phosphatase OCRL-1 
OR3A2 ENSG00000221882 Olfactory receptor 3A2 
PANK2 ENSG00000125779 Pantothenate kinase 2, mitochondrial 
PCTK1 ENSG00000102225 Cell division protein kinase 16 
PIK4CA ENSG00000241973 Phosphatidylinositol 4-kinase alpha 
PIP4K2A ENSG00000150867 Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha 
PLAUR  ENSG00000011422 Urokinase plasminogen activator surface receptor 
PLSCR3  ENSG00000187838 Phospholipid scramblase 3 
PNMAL1 ENSG00000182013 PNMA-like 1    
POLR2D ENSG00000144231 DNA-directed RNA polymerase II subunit RPB4 
PPME1  ENSG00000214517 Protein phosphatase methylesterase 1 
PPP1R1B ENSG00000131771 Protein phosphatase 1 regulatory subunit 1B 
PRKCD ENSG00000163932 Protein kinase C delta type 
PRKD2 ENSG00000105287 Serine/threonine-protein kinase D2 
PROKR2 ENSG00000101292 Prokineticin receptor 2 
PSIP1 ENSG00000164985 PC4 and SFRS1-interacting protein 
PSKH1  ENSG00000159792 Serine/threonine-protein kinase H1 
PSMB3  ENSG00000108294 Proteasome subunit beta type-3 
PTPRD  ENSG00000153707 Receptor-type tyrosine-protein phosphatase delta 
RAB1A ENSG00000138069 Ras-related protein Rab-1A 
RALGPS2  ENSG00000116191 Ras-specific guanine nucleotide-releasing factor RalGPS2 
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RAP2C  ENSG00000123728 Ras-related protein Rap-2c 
RASD2  ENSG00000100302 GTP-binding protein Rhes 
RBM5 ENSG00000003756 RNA-binding protein 5 
RGS10 ENSG00000148908 Regulator of G-protein signaling 10 
RIPK2  ENSG00000104312 Receptor-interacting serine/threonine-protein kinase 2 
ROBO1  ENSG00000169855 Roundabout homolog 1 
ROS1 ENSG00000047936 Proto-oncogene tyrosine-protein kinase ROS 
RYK ENSG00000163785 Tyrosine-protein kinase RYK 
S100A10 ENSG00000197747 Protein S100-A10 
SCARB2  ENSG00000138760 Lysosome membrane protein 2 
SCGB3A1 ENSG00000161055 Secretoglobin family 3A member 1 
SCNN1A ENSG00000111319 Amiloride-sensitive sodium channel subunit alpha 
SDHD ENSG00000204370 
Succinate dehydrogenase cytochrome b small subunit, 
mitochondrial 
SERPINB3  ENSG00000057149 Serpin B3 
SGK269 ENSG00000173517 Tyrosine-protein kinase SgK269 
SLC2A1 ENSG00000117394 
Solute carrier family 2, facilitated glucose transporter 
member 1 
SLC2A3 ENSG00000059804 
Solute carrier family 2, facilitated glucose transporter 
member 3 
SNRK  ENSG00000163788 SNF-related serine/threonine-protein kinase 
SPINT1 ENSG00000166145 Kunitz-type protease inhibitor 1 
SPRYD4 ENSG00000176422 SPRY domain-containing protein 4 
ST5 ENSG00000166444 Suppression of tumorigenicity 5 protein 
STK3 ENSG00000104375 Serine/threonine-protein kinase 3 
STK33 ENSG00000130413 Serine/threonine-protein kinase 33 
STK35 ENSG00000125834 Serine/threonine-protein kinase 35 
STK36 ENSG00000163482 Serine/threonine-protein kinase 36 
TADA2L ENSG00000108264 Transcriptional adapter 2-alpha 
TAS2R1 ENSG00000169777 Taste receptor type 2 member 1 
TAS2R43 ENSG00000226761 Taste receptor type 2 member 43 
TLR2 ENSG00000137462 Toll-like receptor 2 
TMEM16A ENSG00000131620 Anoctamin-1 
TNFRSF17 ENSG00000048462 Tumor necrosis factor receptor superfamily member 17 
TNFRSF1B ENSG00000028137 Tumor necrosis factor receptor superfamily member 1B 
TNR ENSG00000116147 Tenascin-R 
TOMM20 ENSG00000173726 Mitochondrial import receptor subunit TOM20 homolog 
TRIM28 ENSG00000130726 Transcription intermediary factor 1-beta 
TRIML2 ENSG00000179046 Probable E3 ubiquitin-protein ligase TRIML2 
TRMT61A ENSG00000166166 
tRNA (adenine-N(1)-)-methyltransferase catalytic subunit 
TRMT61A 
TRPC4AP  ENSG00000100991 
Short transient receptor potential channel 4-associated 
protein 
TSKS ENSG00000126467 Testis-specific serine kinase substrate 
UBE2Z  ENSG00000159202 Ubiquitin-conjugating enzyme E2 Z 
UGCG ENSG00000148154 Ceramide glucosyltransferase 
UGT1A6 ENSG00000167165 UDP-glucuronosyltransferase 1-6 
WNK3 ENSG00000196632 Serine/threonine-protein kinase WNK3 
XYLB ENSG00000093217 Xylulose kinase 
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Table 2 Gene symbols of hits falling in each of the 5 classes according to sensitivity to the different 
treatments 
Class I Class II Class III Class IV Class V 
Insensitive to all Sensitive to all Aprotinin sensitive Dexa sensitive siNedd4-2 sensitive 
ACY3 HSP90B1 FRAP1 LYN GSTO1 
AXL HMBOX1 OR3A2 GCKR DYRK4 
BRAF KCNN1 C20orf186 TRPC4AP MAPK15 
BUB1 FRK PLSCR3 SNRK RALGPS2 
CCNI GPX2   CHI3L1 COPB2 
CFTR OCRL   TADA2L BRD4 
CNTFR CLCN6   RYK GLB1L3 
COPG SLC2A3   CAPN10 PANK2 
COX8A GRK5   RASD2 ITPK1 
DGKI TAS2R43   ARHGEF11 TSKS 
ENPP3 KCTD10   HTR3C AHSA2 
EPHA6 ARF4   RAP2C TOMM20 
FAM179B CSK   SDHD ST5 
GAS6 HIPK3   GALR3 COPB1 
GNB2 TRMT61A   HCN1 PRDX3 
HTR2A ADAMTS9   PSKH1 CSNK2B 
IQCF1 PIK4CA   STK35 COX7C 
KCNG3 PRKD2   PPME1 RAB1A 
MEST BCL11B   DRG1 PCTK1 
MVK AK3     AGTRAP 
NAGK CHID1     MAPK9 
OC90 PNMAL1     SLC2A1 
PRKCD CXCL13     RIPK2 
PSMB3 PSIP1     MAPK8 
RBM5 DIO1     ROS1 
ROBO1     KLRC3 
SCARB2       SGK269 
SCNN1A       MAP3K3 
SERPINB3       LEPREL1 
SPRYD4       AKAP14 
STK33       PLAUR 
TRIM28       APC 
UBE2Z       
UGCG       
UGT1A6       
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Chapter 4 - ER-localized bestrophin 1 activates Ca2+-dependent ion 
channels TMEM16A and SK4 possibly by acting as a counterion channel 
Barro-Soria, R. et al (2010) Pflugers Arch 459 (3): 485-497 
 
Abstract 
Bestrophins form Ca2+-activated Cl− channels and regulate intracellular Ca2+ signaling. 
We demonstrate that bestrophin 1 is localized in the endoplasmic reticulum (ER), 
where it interacts with stromal interacting molecule 1, the ER-Ca2+ sensor. Intracellular 
Ca2+ transients elicited by stimulation of purinergic P2Y2 receptors in HEK293 cells 
were augmented by hBest1. The p21-activated protein kinase Pak2 was found to 
phosphorylate hBest1, thereby enhancing Ca2+ signaling and activation of Ca2+-
dependent Cl− (TMEM16A) and K+ (SK4) channels. Lack of bestrophin 1 expression in 
respiratory epithelial cells of mBest1 knockout mice caused expansion of ER cisterns 
and induced Ca2+ deposits. hBest1 is, therefore, important for Ca2+ handling of the ER 
store and may resemble the long-suspected counterion channel to balance transient 
membrane potentials occurring through inositol triphosphate (IP3)-induced Ca2+ release 
and store refill. Thus, bestrophin 1 regulates compartmentalized Ca2+ signaling that 
plays an essential role in Best macular dystrophy, inflammatory diseases such as 
cystic fibrosis, as well as proliferation. 
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4.4.1 Introduction 
Mutations in human bestrophin 1 (hBest1) are responsible for early onset of macular 
degeneration called Best vitelliform macular dystrophy112. Bestrophins are also 
upregulated during inflammation and tissue repair and promote proliferation and 
development of cancer124,125. Compelling evidence has been provided that bestrophins 
are Ca2+-activated and DIDS-sensitive Cl− channels (CaCC)113,117, but much 
controversy exists about the question whether these proteins indeed form apical Cl− 
channels in epithelial cells105. Although it has been shown that hBest1 enhances Ca2+-
dependent Cl− secretion in epithelial cells and that Ca2+-dependent Cl− secretion is 
reduced in airways of Best1−/− knockout animals118,119, the precise role of bestrophin 1 
for epithelial CaCC is not clear. Moreover, although overexpressed bestrophin 1 can be 
detected in cell membranes112,120, a large fraction of exogenous and particularly 
endogenous bestrophin 1 is found in intracellular compartments105,115,124. hBest1 has 
also been suggested to control intracellular Ca2+ signaling, e.g., by controlling voltage-
gated Ca2+ channels122. Because it is not clear how bestrophin 1 controls Ca2+-
activated Cl− conductance in epithelial cells, we searched for possible links between 
cytosolic [Ca2+], bestrophin 1, and Ca2+-activated Cl− currents. Here, we present 
evidence that, in both native and overexpressing cells, bestrophin 1 is located primarily 
in the endoplasmic reticulum (ER), where it controls receptor-mediated Ca2+ signals, 
thereby activating Ca2+-dependent ion channels. Our data suggest that bestrophin 1 
acts as a counterion channel for Ca2+ movement over the ER membrane. 
 
4.4.2 Results 
Bestrophin 1 is localized in the ER  
The aim of the present study was to identify the mechanisms by which bestrophin 1 
induces Ca2+-dependent Cl− conductance. Although bestrophin 1 is a Ca2+-activated 
Cl− channel that was found to be expressed in the plasma membrane112,122, other 
studies suggested that a significant portion of bestrophin 1, when overexpressed in 
HEK293 cells, is localized in the ER115. We examined hBest1 expressed endogenously 
in airway epithelial cells and found predominant expression in an intracellular 
compartment where it colocalizes with ER markers such as calreticulin, calnexin, or 
Stim1, the ER Ca2+ sensor207,208 (Fig. IV.4.1a). Each immunohistochemical staining was 
performed in triplicates. The dashed line indicates cell borders and makes clear that 
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endogenous hBest1 in airway epithelial cells is essentially located intracellularly. This 
corresponds well with earlier findings, demonstrating intracellular expression of hBest1 
in mouse collecting duct cells124. Since hBest1 was found in the ER, we examined 
whether it is colocalized more intimately with typical ER proteins such as the Ca2+-
ATPase SERCA, IP3 receptors (IP3-R), or Stim1. To that end, we performed additional 
experiments which indicated that hBest 1 could be coimmunoprecipitated with Stim1 
(Fig. IV.4.1b) but not with IP3-R, SERCA, or components of the store-operated Ca2+ 
influx pathway, such as TRPC1 (data not shown). Because hBest1 is localized in the 
ER, it may have a role in receptor-mediated intracellular Ca2+ signaling. In subsequent 
experiments, we, therefore, examined the effects of hBest1 on receptor mediated Ca2+ 
signaling in HEK293 cells, which apparently do not express hBest1109. However, we 
also found that HEK293 cells express small amounts of endogenous hBest1, as 
detected by RT-PCR and Western blotting. In addition, expression of endogenous 
hBest1 in HEK293 cells could be suppressed by hBest1-siRNA (Fig. IV.4.1c). 
 
Bestrophin 1 is phosphorylated by Pak2 
ER-localized hBest1 may affect Ca2+ release and reuptake and, therefore, control Ca2+ 
signaling. To understand the potential role of bestrophin 1 for intracellular Ca2+ 
signaling, we searched for additional binding partners. To that end, hBest1 was 
overexpressed in HEK293 cells, and coimmunoprecipitated proteins were separated by 
2D-PAGE and subjected to MALDI-TOF analysis. We identified the p21-activated 
serine/threonine kinase Pak2 as a novel binding partner of hBest1. hBest1 carries a 
strong consensus sequence for Pak2 in the C terminus, and we, therefore, were able to 
in vitro phosphorylate hBest1 by hPak2 (Fig. IV.4.1d). In contrast, Pak2 
phosphorylation was eliminated by mutating the responsible serine 358 to an alanine in 
the consensus sequence of hBest1 (hBest-S358A; Fig. IV.4.1d). Phosphorylation by 
Pak2 may change the activity of bestrophin 1 and may thereby affect intracellular Ca2+ 
signaling. An effect of Pak2 on intracellular Ca2+ signaling during T cell activation has 
been described recently209. 
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Fig. IV.4.1 Bestrophin 1 is localized in the ER. a) Colocalization of hBest1 and the ER proteins 
calreticulin, calnexin (endogenous bestrophin 1, calreticulin, and calnexin, respectively, in human airway 
epithelial cells), and Stim1 (overexpression of bestrophin 1 and Stim1 in HEK293 cells). Dashed line 
indicates cell borders (bar=12 m). b) Coimmunoprecipitation of hBest1 and hStim1 in lysates from 
HEK293 cells overexpressing both proteins. Equal amounts of protein (20 g) were loaded, and 
experiments were performed at least in triplicates. c) RT-PCR (upper panel) and Western blot analysis 
(lower panel) indicated the expression of endogenous hBest1 in HEK293 cells, which was suppressed by 
hBest1-RNAi. d) In vitro phosphorylation of hBest1-C terminus by Pak2 and lack of Pak2 phosphorylation 
of hBest1-R218C. Experiments in this figure were done by Fadi Aldehni (Regensburg) and are reproduced 
here with permission. 
 
Intracellular Ca2+ signaling is Cl− dependent and is augmented by bestrophin 1 
We measured intracellular Ca2+ concentrations ([Ca2+]i) in hBest1-transfected HEK293 
cells, using Fura2 as a Ca2+-sensitive dye. If bestrophin 1 affects intracellular Ca2+ 
signals, it is likely that it does so by operating as a Cl− channel, and thus, the Cl− 
concentration should determine the Ca2+ signal. We, therefore, examined ATP-induced 
Ca2+ signals in the absence and presence of extracellular Cl−. Replacement of bath Cl− 
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by gluconate only slightly reduced [Ca2+]i but inhibited the Ca2+ peak and eliminated the 
Ca2+ plateau (Fig. IV.4.2a–c). This clearly points to a role of Cl− in Ca2+ signaling. We, 
therefore, examined the influence of bestrophin 1 on ATP-induced Ca2+ signals. We 
found that the expression of hBest1 amplifies intracellular Ca2+ signals elicited by 
stimulation with ATP (10 M; Fig. IV.4.2d). Ca2+ peaks resembling ER store release 
were significantly augmented. 
Since previous work suggested that bestrophin 1 controls Ca2+ influx pathways, which 
may indirectly affect Ca2+ peaks122, we examined [Ca2+]i increase upon inhibition of 
SERCA using CPA in the absence of extracellular Ca2+. We found that, under these 
conditions, CPA-induced [Ca2+]i increase was faster and more transient in cells 
overexpressing hBest1 (Fig. IV.4.2e). Thus, the effects of bestrophin 1 on Ca2+ signals 
are similar in the presence or absence of extracellular Ca2+, and therefore, it is unlikely 
that Ca2+ influx pathways contribute to the effects of bestrophin 1 on Ca2+ signaling 
observed here. The results rather suggest that bestrophin 1 facilitates the release of 
Ca2+ from intracellular Ca2+ stores. 
We tried to measure cytosolic Ca2+ by a second independent method and in close 
proximity to the ER store and bestrophin 1. We, therefore, fused the Ca2+-sensitive 
protein G-CaMP2210 to hBest1 and to mutant hBest1-R218C, respectively. R218C 
eliminates ion channel function but is otherwise normally expressed, thereby causing 
an autosomal inherited form of macular dystrophy of the retina122. Thus, overexpressed 
hBest1-R218C has a dominant negative effect on hBest1 expressed endogenously in 
HEK293 cells114. Expressing the hBest1-G-CaMP2 construct, we found that ATP is 
actually causing an oscillative [Ca2+]i increase in HEK293 cells, rather than a typical 
peak and plateau response (Fig. IV.4.2f). Notably, the amplitudes for the Ca2+ 
oscillations (minimum–maximum) were large and shortlasting (number of oscillations = 
4.1±0.4; n=8) for hBest1-G-CaMP2, but were small (1.3±0.3; n=12) and long-lasting 
(8.1±0.5; n=12) for hBest1-R218C-G-CaMP2-expressing cells (P<0.05; Fig. IV.4.2f, g). 
These results suggest that bestrophin 1 supports Ca2+ signaling by facilitating Ca2+ 
release from the ER store. 
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Fig. IV.4.2 Intracellular Ca2+ signaling is Cl− dependent and is enhanced by bestrophin 1. a) 
Summary curve (mean ± SEM; n=10) for Ca2+ transients induced by ATP (10 M) in HEK293 cells in the 
absence or presence of extracellular Cl−. b) Summary of the baseline Ca2+ concentrations indicates slightly 
enhanced baseline [Ca2+]i in the presence of extracellular Cl−. c) Summary of peak and plateau Ca2+ 
increase indicates enhanced Ca2+ signaling in the presence of extracellular Cl−. d) Summary (mean ± 
SEM; n=10) of Ca2+ transients induced by ATP (10 M) in hBest1-expressing (red trace) or mock 
transfected (black trace) HEK293 cells. e) Emptying of ER-Ca2+ stores by the SERCA-inhibitor CPA (10 
M) in the absence of extracellular Ca2+ in hBest1-expressing or mock-transfected HEK293 cells (mean ± 
SEM; n=16–27). f) ATP (100 M)-induced oscillations of [Ca2+]i detected by the Ca2+ probe G-CaMP2 
fused to hBest1 (left trace) or hBest1-R218C (right trace), respectively. g) Summary of upper (max) and 
lower (min) amplitudes of Ca2+ oscillations in cells expressing hBest1 or hBest1-R218C, respectively 
(n=16–27). Mean ± SEM. The number sign indicates significant difference when compared to hBest1 or 
control (unpaired t test). Experiments in this figure were done by René Barro-Soria (Regensburg) and are 
reproduced here with permission.  
 
To be sure that we measure a true effect of bestrophin 1 on [Ca2+]i, we used a third 
method to measure [Ca2+]i with the help of a membrane-bound Ca2+ dye (FFP-18) and 
assessed Ca2+ signals in intracellular membranous compartments. Using FFP-18, we 
found that ATP induced the typical peak/plateau response in control cells (Fig. IV.4.3a). 
In hBest1-overexpressing cells, the Ca2+ response was enhanced (1.3±0.3; n=17) and 
more transient and showed Ca2+ oscillations (Fig. IV.4.3a). In contrast, the dominant 
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negative mutant hBest1-R218C reduced the Ca2+ peak (0.5±0.2; n=24, p<0.05) and did 
not induce Ca2+ oscillations (Fig. IV.4.3a). Moreover, the rate of recovery from Ca2+ 
increase (Fig. IV.4.3, red lines) was 0.82±0.1 (relative units per second; n=12) for 
control cells, was enhanced after expression of hBest1 (1.12±0.2; n=13), but was 
significantly reduced by overexpression of hBest1-R218C (0.41±0.08; n=12). Except for 
Ca2+ oscillations, which were not observed in the absence of extracellular Ca2+, similar 
effects of bestrophin 1 and mutant hBest1-R218C were observed when Ca2+ was 
removed from the bath solution (Fig. IV.4.3b). Thus, bestrophin 1 enhances the Ca2+ 
peak and is causing a more transient Ca2+ response, which suggests a role for Ca2+ 
release from the store and reuptake back into the ER. Since bestrophin 1 has the 
function of a Ca2+-activated Cl− channel, it could act as a counterion channel to balance 
transient negative potentials generated by Ca2+ release and reuptake. It may thereby 
augment Ca2+-dependent ion currents as described earlier119,124,211.  
 
 
 
Fig. IV.4.3 Bestrophin 1 accelerates recovery from Ca2+ increase. ATP (100 M)-induced Ca2+ 
transients detected with the membrane-bound Ca2+ probe FFP-18 in the a) absence (0 mM) or b) presence 
(1.5 mM) of extracellular Ca2+. Ca2+ transients were measured in (1) mocktransfected control cells, (2) 
hBest1-expressing cells, and (3) hBest1-R218C-expressing cells. hBest1 accelerates recovery from ATP-
induced Ca2+ increase in both presence or absence of extracellular Ca2+, while hBest1-R218C delays 
recovery from Ca2+ increase. Experiments in this figure were done by René Barro-Soria (Regensburg) and 
are reproduced here with permission. 
 
 
Activation of TMEM16A Cl− channels by bestrophin 1/Pak2 
The data suggest that bestrophin 1 controls intracellular Ca2+ signaling and may, 
therefore, affect Ca2+-dependent Cl− channels in epithelial cells115,118,119. As in previous 
reports113,115 and also in the present study we found that stimulation of hBest1-
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expressing HEK293 cells activated a whole-cell Cl− current (Fig. IV.4.4a, b). Activation 
of Cl− conductance is indicated by inhibition of the Cl− current at low bath Cl− 
concentration (30 mM; gray bars). This additional Cl− conductance may be due to the 
fact that a fraction of overexpressed hBest1 reaches the cell membrane where it 
generates a Ca2+-activated Cl− current113,115,117. However, bestrophin 1 may also 
activate Ca2+-dependent TMEM16A Cl− channels, which we found to be expressed at 
low levels in HEK293 cells212. The kinase Pak2 phosphorylates bestrophin 1, and we 
found that coexpression of Pak2 together with bestrophin 1 largely augmented ATP-
activated Cl− currents. The effects of Pak2 and hBest1 on Ca2+-dependent Cl− channels 
in HEK293 cells were almost completely suppressed by hBest1-siRNA or by 
coexpression of the dominant negative mutant hBest1-R218C (Fig. IV.4.4a, b). 
Downregulation of hBest1 by siRNA was confirmed by Western blotting (Fig. IV.4.1c). 
These results indicate that the activation of Ca2+-dependent Cl− currents in HEK293 
cells was controlled by bestrophin 1/Pak2. The recently identified TMEM16A is likely to 
resemble the molecular counterpart of ubiquitously expressed Ca2+-activated Cl− 
channels129-131. Overexpression of TMEM16A in our study produced large ATP-
activated whole-cell Cl− currents that were further augmented upon coexpression of 
hBest1 (Fig. IV.4.4c, d). In contrast, TMEM16A currents were reduced by coexpression 
of dominant negative hBest1-R218C. Since there is no indication for a direct interaction 
of bestrophin 1with TMEM16A channels (data not shown), the most simple 
interpretation of these data is that bestrophin controls intracellular Ca2+ signals and 
thereby controls the activity of membrane-localized TMEM16A (Fig. IV.4.4d). 
 
Endogenous Pak2 is important for the activation of Ca2+-dependent Cl− currents 
Human airway epithelial cell lines such as 16HBE14o− express both hBest1 and 
hTMEM16A endogenously118,130,212. Here, we demonstrate again the importance of 
endogenous Pak2 for receptor-mediated and bestrophin 1-dependent activation of 
TMEM16A Cl− channels in 16HBE cells, by siRNA knockdown of Pak2. Three 
independent batches of hPak2-siRNA significantly inhibited ATP activation of whole-
cell Cl− currents (Fig. IV.4.4e). Downregulation of Pak2 was confirmed by quantitative 
real-time RT-PCR (data not shown). Thus, bestrophin 1 and Pak2 are important 
regulators of Ca2+- dependent ion channels in mammalian cells. 
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Fig. IV.4.4 Bestrophin 1/Pak2 activates TMEM16A Cl− channels in mammalian cells a) ATP (100 M)-
activated whole-cell currents in hBest1-expressing HEK293 cells and in cells coexpressing Pak2/hBest1, 
Pak2/siRNA-hBest1, or Pak2/hBest2-R218C. Gray bars indicate partial removal of Cl− (30 Cl) from the 
extracellular bath solution. b) Whole-cell conductances under control conditions (white bars), after 
stimulation of ATP (black bars), and after partial removal of extracellular Cl− (30 Cl−; gray bars; n=9–15). 
The dollar sign indicates significant inhibition of whole-cell conductance by 30 Cl (paired t test). c) 
Activation of whole-cell currents by ATP in control HEK293 cells (left trace) and after the expression of 
hTMEM16A (right trace). d) Summary of the whole-cell conductances in control cells (mock) and after 
expression of hTMEM16A, hTMEM16A/hBest1, or hTMEM16A/hBest1-R218C (n=10–22). The dollar sign 
indicates significant difference to TMEM16A (unpaired t test). e) Endogenous whole-cell conductances in 
human bronchial epithelial cells before and after stimulation with ATP (100 M). Three different batches of 
siRNA-Pak2 inhibited ATPactivated conductances (n=11–38). The asterisk indicates significant effect of 
ATP (paired t test). The number sign indicates significant difference when compared to hBest1 or control 
(unpaired t test). Experiments in this figure were done by René Barro-Soria (Regensburg) and are 
reproduced here with permission. 
  
 
Pak2 activates Ca2+-dependent TMEM16A Cl− channels in Xenopus oocytes 
We examined the effects of Pak2 in Xenopus oocytes, which express large Ca2+-
activated Cl− currents, endogenous xBest1213, and xTMEM16A Cl− channels131. Ca2+-
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dependent Cl− channels were activated by ATP in P2Y2-expressing Xenopus oocytes. 
Injection with active Pak2 enzyme largely enhanced the ATP-induced, i.e., Ca2+-
activated, whole-cell currents (Fig. IV.4.5a, b). ATP-activated whole-cell Cl− currents 
were suppressed by replacement of extracellular Cl− by impermeable gluconate (5 Cl−; 
Fig. IV.4.5b). Notably, injection of Pak2 also augmented a delayed inward current 
activated by ATP. This current was inhibited by the removal of bath Na+ and Ca2+ (Fig. 
IV.4.5a, c). Thus, Pak2 injection amplifies endogenous TMEM16A currents as well as a 
Ca2+ influx pathway, probably by enhancing Ca2+ release from ER-Ca2+ stores and 
activation of store-operated Ca2+ influx. Notably, whole-cell currents activated through 
direct increase in intracellular Ca2+ by ionomycin were not further activated by Pak2, 
indicating that Pak2 controls receptor-mediated activation of CaCC (data not shown). In 
contrast to Pak2, injection of Pak1 did not augment Ca2+-activated Cl− currents or 
nonselective cation currents (data not shown). 
To further examine whether Pak2 acts through phosphorylation of xBest1 to activate 
Ca2+-dependent Cl− channels, we overexpressed the phosphorylation mutant hBest-
S358A together with P2Y2 receptors in Xenopus oocytes. While ATP activated a whole-
cell conductance of 55.3±6.3 S (n=12) in oocytes expressing P2Y2 receptors only, 
ATP activated only 31.2±3.3 S (n=8; p≤0.05) in oocytes coexpressing both P2Y2 
receptors and hBest-S358A. Moreover, after the injection of Pak2, ATP induced 
conductance was 160±16.3 S in P2Y2-expressing oocytes but only 82±11.2 S (n=7; 
p≤0.05) in cells coexpressing hBest-S358A. In additional experiments, we injected 
siRNA to knockdown endogenous Xenopus bestrophin (xBest2a, b). In both presence 
and absence of Pak2, ATP-induced but not ionomycin-induced whole-cell conductance 
was reduced in xBest2a, b siRNA-injected cells (data not shown). These experiments 
clearly suggest that Pak2 phosphorylates endogenous xBest2a, b and thereby 
amplifies ATP, i.e., Ca2+-activated Cl− currents. 
A previous report indicated that bestrophin 1 interacts physically and functionally with 
protein phosphatase 2A (PP2A)214. We speculated that Pak2-phosphorylated Best1 is 
rapidly dephosphorylated and deactivated by PP2A215. In fact, in the presence of the 
PP2A-inhibitor okadaic acid (10 nM), ATP-activated whole-cell conductance (GATP) was 
augmented to a similar magnitude as by injecting the Pak2 enzyme (Fig. IV.4.5d). In 
contrast, expression of dominant negative hBest-R218C reduced ATP-activated 
TMEM16A currents in Xenopus oocytes and completely abrogated the stimulating 
effect of Pak2, similar to that shown in Fig. IV.4.4a, b for mammalian cells (Fig. 
IV.4.5d). Noteworthy is that the activation of TMEM16A Cl− currents in Xenopus 
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oocytes through the depletion of ER Ca2+ stores (inhibition of SERCA by CPA) was 
also augmented after injection of Pak2 (Fig. IV.4.5e, f). Therefore, similar effects of 
bestrophin 1 and Pak2 on Ca2+-dependent Cl− currents are observed in both 
mammalian cells and Xenopus oocytes. This phenomenon is not specific for purinergic 
stimulation but was also observed for activation of whole-cell currents by endogenous 
receptors for lysophosphatidic acid (data not shown). 
 
 
 
 
Fig. IV.4.5 Bestrophin 1/Pak2 activates Ca2+-dependent Cl− channels in Xenopus oocytes: a) Whole-
cell currents in Xenopus oocytes expressing P2Y2 receptors (voltage clamped from −60 to +40 mV). ATP 
(100 M) activated endogenous Ca2+-dependent Cl− currents. Injection of Pak2 (2 g/L) increased ATP-
induced outward and inward currents. b) Concentration-dependent activation of outward currents in the 
absence (open bars) or presence (black bars) of Pak2. Removal of extracellular Cl− (5 mM) inhibited ATP-
activated whole-cell currents. c) Concentration-dependent activation of inward currents. Removal of 
extracellular Na+ and Ca2+ (0/0 mM) inhibited inward currents (n=8–21). d) ATP-activated Cl− 
conductances were augmented by injection of Pak2 (2 g/L) and exposure to okadaic acid (10 nM) but 
were inhibited by expression of hBest1-R218C (n=16–38). e) Activation of Cl− currents by inhibition of the 
SERCA pump with CPA (10 M) in the absence and presence of Pak2. f) Pak2 augmented CPA-activated 
Cl− conductance (n=9). The asterisk indicates significant effect of ATP or ionomycin (paired t-test). The 
number sign indicates significant difference when compared to absence of Pak2 (unpaired t test). The 
section sign indicates significant difference when compared to presence of Cl− or Na+/Ca2+ (unpaired t 
test). 
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Pak2 activates Ca2+-dependent SK4 K+ channels in Xenopus oocytes  
If bestrophin 1 and Pak2 activate plasma membrane-localized Cl− channels by 
facilitating intracellular Ca2+ release, they should also be able to activate other Ca2+-
dependent ion channels such as the Ca2+-activated K+ channel SK4216. To test this 
hypothesis, we expressed P2Y2 receptors together with hSK4 in Xenopus oocytes. The 
membrane voltage of these oocytes was strongly hyperpolarized and was further 
hyperpolarized upon stimulation with ATP and activation of hSK4 (Fig. IV.4.6a). 
Activation of CaCC by ATP was negligible in hSK4-expressing oocytes, since the 
removal of extracellular Cl− (5 Cl−) did not compromise the ATP response, while 5 mM 
Ba2+ suppressed the activation of a whole-cell conductance by ATP (Fig. IV.4.6b). 
Moreover, the CaCC-inhibitor DIDS did not inhibit ATP-activated conductance 
(−DIDS=18.3±2.1 S vs +DIDS=17.3±1.9 S; n=17), while the SK4-inhibitor TRAM-34 
inhibited the effect of ATP significantly (−TRAM-34=18.3±2.1 S vs +TRAM-
34=6.43±1.5 S; n=12). We activated hSK4 K+ currents in the absence or presence of 
Pak2, either through stimulation of purinergic receptors by ATP or directly by increasing 
[Ca2+]i with ionomycin (Fig. IV.4.6c). Notably, receptor activation of hSK4 currents was 
augmented by Pak2, while activation through direct increase in [Ca2+]i by ionomycin 
was not affected by Pak2 (Fig. IV.4.6c, d). Thus, not only Ca2+-dependent TMEM16A 
channels are controlled by bestrophin 1/Pak2 but also Ca2+-activated K+ channels. 
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Fig. IV.4.6 Pak2 activates Ca2+-dependent SK4 K+ channels in Xenopus oocytes. a) I/V curves (mean 
± SEM) from SK4-expressing oocytes. Stimulation with ATP (10 M) shifted the reversal potential to −90 
mV (n=12). b) Summary of ATP-activated whole-cell conductances in SK4-expressing Xenopus oocytes in 
the presence of high (100 mM) and low (5 mM) extracellular Cl− concentration and in the absence or 
presence of Ba2+ (5 mM; n=8 for all). c) Effect of Pak2 on K+ currents activated by ATP (10 M) or 
ionomycin (1 M) in oocytes coexpressing P2Y2 receptors and hSK4. d) Pak2 augmented hSK4 whole-cell 
conductances, when activated by ATP but not by ionomycin (n=19–22). The asterisk indicates significant 
effect of ATP, ionomycin, or Ba2+ (paired t test). The number sign indicates significant difference when 
compared to the absence of Pak2 (unpaired t test). 
 
Bestrophin 1 is important for Ca2+ handling of the ER 
The present data suggest that bestrophin 1 is important for Ca2+ handling of the ER, 
probably by acting as a channel for the counterion Cl− (Fig. IV.4.8). As shown earlier, 
airway epithelial cells from mBest1−/− mice display attenuated Ca2+-activated Cl− 
currents119. Since the lack of expression of Best1 Cl− channels in the ER may cause 
structural changes, we decided to employ high-resolution electron microscopy to 
examine tracheal epithelial cells of mBest1−/− mice. To our surprise, we detected 
bloated ER structures in cells of four different Best1−/− mice (Fig. IV.4.7a, right panels, 
yellow arrows). These changes were not observed in airway cells of three control 
littermates (Fig. IV.4.7a, left panels). Moreover, using an oxalate-substituted fixative 
solution, we detected electron-dense Ca2+ precipitations in the ER of Best1−/− mice 
(Fig. IV.4.7b, right panels). Similar structures were occasionally found in cells from 
Best1+/+ animals which, however, did not contain electron-dense Ca2+ precipitations 
(Fig. IV.4.7b, left panels). These findings are in striking similarity to the changes 
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observed in mice that lack another counterion channel in the sarcoplasmic reticulum 
(SR) of cardiomyocytes217. Taken together, we suggest that bestrophin 1 may operate 
as a counterion channel in the ER of epithelial cells to control Ca2+ filling and release. 
By doing so, it controls the activation of plasma membrane-localized Ca2+-dependent 
Cl− (TMEM16A) and K+ (SK4) channels. 
 
 
 
 
 
Fig. IV.4.7 Expanded ER in airway epithelial cells of mBest1 null mice. a) Electron microscopy images 
of airway epithelial cells from Best1+/+ and Best1−/− mice, at low (upper panels; red bar 600 nm) and high 
(lower panels; red bar 100 nm) magnification. EM images revealed swollen ER structures in epithelial cells 
of Best1−/− mice (right panels; yellow arrows) that are not observed in cells from Best1+/+ animals (left 
panels). b) Fixation with oxalate-containing solutions unmasked electron-dense Ca2+-oxalate deposits in 
the bloated ER of airway epithelial cells of Best1−/− animals (right upper panel, yellow arrows). 
Occasionally, small precipitations were found in cells from Best1+/+ animals, which, however, were not 
identified as Ca2+ precipitations (left upper panel). To demonstrate precipitated Ca2+ salts, a special setting 
of the electron beam was used (L2.3 edge at ΔE=346 eV; lower panels). Bright color indicates 
precipitations with high Ca2+ concentration in the ER (in cells from Best1−/− mice; yellow arrow, right lower 
panel). Precipitations in cells from Best1+/+ animals were not electron dense (yellow arrow; left lower 
panel). Experiments in this figure were done by René Barro-Soria (Regensburg) and are reproduced here 
with permission. 
 
4.4.3 Discussion 
Bestrophin 1 in the ER 
Bestrophin 1 is expressed in the basolateral membrane of the retinal pigment 
epithelium218. When overexpressed, bestrophins can be detected in the cell 
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membrane112,120; however, membrane expression is different for the four human and 
mouse paralogs. We found that mouse bestrophin 1 and human bestrophin 2 and 4 
express well in membranes of HEK293 cells, while human bestrophin 1 and bestrophin 
3 show little membrane localization105,115. The present results confirm earlier findings 
that bestrophin 1 expressed endogenously in epithelial cells is localized in the ER105,124. 
As demonstrated for mouse-collecting duct cells, expression of bestrophin 1 depends 
on cell density and proliferation which is likely to shape intracellular Ca2+ transients 
important for cell proliferation124. 
 
Bestrophin 1 controls intracellular Ca2+ signals 
The present data demonstrate that, in all experiments, the expression of bestrophin 1 
significantly augmented the (peak) increase of intracellular Ca2+, while inhibition of 
bestrophin 1 expression or overexpression of hBest1-R218C significantly reduced the 
peak response and delayed the time for recovery from Ca2+ increase. Bestrophin 1 is 
probably not the only ER-localized channel, and Cl− is probably not the only ion that 
counterbalances charges during Ca2+ release and reuptake into the store, since cells 
lacking the expression of endogenous bestrophin 1 are able to generate peak/plateau 
Ca2+ signals. Notably, mice lacking bestrophin 1 expression survive well, although 
Ca2+-activated Cl− currents are reduced in airway epithelial cells of these animals119. 
These results suggest that bestrophin 1 is not essential for cell survival and function, 
but it modulates cellular properties such as proliferation and probably motility as well as 
Cl− conductance124. 
 
Bestrophin 1 is controlled by Pak2 
Bestrophin 1 was found to bind Pak2 and to be phosphorylated by Pak2. Pak2 is 
activated by autophosphorylation through binding of small G proteins such as Cdc42 
and Rac1. It is transiently activated under cell stress and by phosphatidylinositol-3 
kinase or tyrosine kinase or becomes permanently activated through cleavage by 
caspase-3219,220. Pak2 phosphorylation and translocation to the ER can induce either 
proliferation or cytostasis/autophagy219,220. Here, we report that Pak2 largely 
augmented receptor-mediated activation of Ca2+-dependent Cl− and K+ channels in 
Xenopus oocytes. Notably, Pak2 is also known to be activated by TGF1, and 
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exposure to TGF1 has been shown recently to augment Ca2+-dependent Cl− currents 
in collecting duct cells129. 
Bestrophin 1 - a counterion channel 
It is well known that ion conductances affect intracellular Ca2+ signaling. For example, 
activation of voltage-dependent Ca2+ influx depends on membrane depolarization, 
which is controlled by the activity of K+ and Cl− channels (discussed in221). In contrast, 
Ca2+ influx through store-operated Ca2+ channels is reduced with depolarization of the 
membrane voltage222. In addition, we found that not only Ca2+ influx but also Ca2+ 
release from the ER depends on the activity of plasma membrane ion channels and the 
membrane voltage (discussed in126). 
The present data demonstrate that a Cl− channel located in the ER controls intracellular 
Ca2+ signaling. The concept of a counterion channel in the ER to balance negative 
charges occurring through Ca2+ release and reuptake into the ER store has long been 
proposed223. In the sarcoplasmic reticulum (SR), Cl− channels play an essential role in 
excitation-contraction coupling, by balancing charge movement during calcium release 
and reuptake224,225. This has also been well described in airway smooth muscle cells. 
SR-localized Cl− channels in the SR membrane allow for neutralization of electrostatic 
charges that would otherwise build up during Ca2+ movement226,227. Thus, SR-localized 
Cl- channels support Ca2+ signaling and muscle contraction, and blocking these Cl- 
channels might be an effective way in inhibiting airway smooth muscle hyper-
responsiveness in asthma227,228. Our present results suggest that bestrophins 1 is a 
counterion channel in the ER and thereby facilitates intracellular Ca2+ signaling in 
epithelial cells. 
Also, cation channels have been proposed for counterion transport, such as the cation-
selective channel TRIC217. TRIC knockout mice suffer from embryonic cardiac failure, 
and mutant cardiac myocytes show severe dysfunction in intracellular Ca2+ handling. 
The SR of these cells shows reduced K+ permeability, and it was, therefore, concluded 
that TRIC channels act as counterion channels that function in synchronization with 
Ca2+ release from intracellular stores217. Electron microscopy revealed extensively 
swollen SR/ER structures in cardiomyocytes of TRIC knockout mice and showed 
frequent electron-dense Ca2+-oxalate deposits in the bloated SR/ER. These changes 
are in striking similarity with our findings in airway epithelial cells of Best1−/− mice. 
Notably, in the ER of pancreatic epithelial cells, the existence of an ATP-activated, 
DIDS-sensitive 64-kDa Cl− channel has been described earlier229. These previous 
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findings correspond well to the present data since 64 kDa is precisely the molecular 
weight of bestrophin 1105. 
 
Bestrophin 1 and its role in disease 
The present data suggest that bestrophin 1 may operate as a counterion channel to 
control the activation of Ca2+-dependent Cl- (and K+) channels (Fig. IV.4.8). As 
bestrophin 1 is upregulated during inflammation and tissue repair124,230, it may be in 
charge of the enhanced Ca2+-dependent Cl- conductance observed during inflammation 
and proliferation124,125. Since Ca2+ oscillations are fundamental to cell proliferation231, it 
will be interesting to learn whether overexpression of bestrophins 1 in cancer cells 
induces malignancy by affecting intracellular Ca2+ oscillations125. Moreover, enhanced 
Ca2+- dependent Cl- secretion as observed in cystic fibrosis has been shown to be 
caused by an expansion of apical ER Ca2+ stores232. Our own preliminary results show 
enhanced expression of bestrophin 1 in airway epithelial cells under proinflammatory 
conditions such as cystic fibrosis and asthma (147 and unpublished findings from the 
author’s laboratory). Thus, bestrophin 1 may play an unexpected role in a variety of 
diseases, apart from its central role in Best vitelliform macular dystrophy233. 
 
 
Fig. 8 Model for the role of bestrophin 1 as a counterion channel in the ER. ATP stimulation of 
purinergic receptors or other receptors coupling to phospholipase C (PLC) leads to increase of inositol 
triphosphate and release of Ca2+ from the endoplasmic reticulum (ER). ER-located bestrophin 1 acts as a 
counterion channel for Ca2+ release and reuptake (by the endoplasmic reticulum Ca2+ ATPase, SERCA) 
into the store by shuttling Cl- ion over the ER membrane, thereby counteracting diffusion potentials arising 
from Ca2+ movement. Best1 binds to the Ca2+ sensor Stim1 (which binds to components of store-operated 
Ca2+ influx channels such as Orai1/Trp3/Trpc1), is phosphorylated by p21-activated protein kinase (Pak2), 
and is dephosphorylated by protein phosphatase 2A (PP2A). Thus, bestrophin 1 facilitates the activation of 
Ca2+-dependent TMEM16A Cl- and SK4 K+ channels. 
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Chapter 5 - TMEM16 proteins produce volume regulated chloride currents 
that are reduced in mice lacking TMEM16A 
Almaça, J. et al. (2009). J Biol Chem 284 (42): 28571-8. 
 
Abstract 
All vertebrate cells regulate their cell volume by activating chloride channels of 
unknown molecular identity, thereby activating regulatory volume decrease. We show 
that the Ca2+-activated Cl- channel TMEM16A together with other TMEM16 proteins are 
activated by cell swelling through an autocrine mechanism that involves ATP release 
and binding to purinergic P2Y2 receptors. TMEM16A channels are activated by ATP 
through an increase in intracellular Ca2+ and a Ca2+-independent mechanism engaging 
extracellular-regulated protein kinases (ERK1/2). The ability of epithelial cells to 
activate a Cl- conductance upon cell swelling (ICl,swell), and to decrease their cell volume 
(regulatory volume decrease) was dependent on TMEM16 proteins. Activation of ICl,swell 
was reduced in the colonic epithelium and in salivary acinar cells from mice lacking 
expression of TMEM16A. Thus TMEM16 proteins appear to be a crucial component of 
epithelial volume-regulated Cl- channels and may also have a function during 
proliferation and apoptotic cell death. 
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4.5.1 Introduction 
Regulation of cell volume is fundamental to all cells, particularly during cell growth and 
division. External hypotonicity leads to cell swelling and subsequent activation of 
volume-regulated chloride and potassium channels, to release intracellular ions and to 
re-shrink the cells, a process termed regulatory volume decrease (RVD)234. Volume-
regulated chloride currents (ICl,swell) have dual functions during cell proliferation as well 
as apoptotic volume decrease (AVD), preceding apoptotic cell death235. Although ICl,swell 
is activated in swollen cells to induce RVD, AVD takes place under normotonic 
conditions to shrink cells236,237. Early work suggested intracellular Ca2+ as an important 
mediator for activation of ICl,swell and volume-regulated K+ channels238, whereas 
subsequent studies only found a permissive role of Ca2+ for activation of ICl,swell 239, 
reviewed in Ref.234. In addition, a plethora of factors and signaling pathways have been 
implicated in activation of ICl,swell, making cell volume regulation an extremely complex 
process (reviewed in Refs.234,236,240). These factors include intracellular ATP, the 
cytoskeleton, phospholipase A2-dependent pathways, and protein kinases such as 
extracellular-regulated kinase ERK1/2 (reviewed in 234,240). Previous approaches in 
identifying swelling-activated Cl- channels have been unsuccessful or have produced 
controversial data. Thus none of the previous candidates such as pICln, the multidrug 
resistance protein, or ClC-3 are generally accepted to operate as volume-regulated Cl- 
channels (reviewed in 101,241). Notably, the cystic fibrosis transmembrane conductance 
regulator (CFTR) had been shown in earlier studies to influence ICl,swell and volume 
regulation242-244. The variable properties of ICl,swell suggest that several gene products 
may affect ICl,swell in different cell types. 
The TMEM16 transmembrane protein family consists of 10 different proteins with 
numerous splice variants that contain 8-9 transmembrane domains and have predicted 
intracellular N- and C-terminal tails129-131,245. TMEM16A (also called ANO1) is required 
for normal development of the murine trachea137 and is associated with different types 
of tumors, dysplasia, and nonsyndromic hearing impairment140,245. TMEM16A has been 
identified as a subunit of Ca2+- activated Cl- channels that are expressed in epithelial 
and nonepithelial tissues129-131. Interestingly, members of the TMEM16 family have 
been suggested to play a role in osmotolerance in Saccharomyces cerevisiae246. Here 
we show that TMEM16 proteins also contribute to ICl,swell and regulatory volume 
decrease. 
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4.5.2 Results and discussion 
Suppression of ICl,swell by siRNA-TMEM16A in three different cell lines 
Because TMEM16A has been shown to be a major component of the Ca2+-activated Cl- 
channel, we examined the contribution of TMEM16A to swelling-activated whole cell 
currents (ICl,swell) in a human pancreatic cell line (CFPAC) that lacks expression of the 
CFTR Cl- channel247. CFPAC cells express TMEM16A, -F, and -H and show 
pronounced activation of whole cell Cl- currents when exposed to hypotonic bath 
solution247 (Fig. IV.5.1, A and B). Activation of whole cell currents was suppressed by 
siRNA for TMEM16A, but not by siRNA knockdown of CLC3, ClCA1, and CLCA4, 
which are also expressed in CFPAC cells (Fig. IV.5.1C).  
 
 
Fig. IV.5.1 Activation of ICl,swell in CFPAC cells requires TMEM16A channels. A) RT-PCR analysis 
indicates expression of TMEM16A, TMEM16F, and TMEM16H in CFPAC cells. M, marker; A–K, 
TMEM16A–K. Gs, Gl, short and long splice variants. B) Original recordings of whole cell currents in CFPAC 
cells activated by hypotonic bath solution (33%). Cells were voltage clamped in intervals from -50 to +50 
mV. Treatment with siRNA for TMEM16A (si16A) reduced the swelling-activated whole cell current, when 
compared with cells treated with scrambled (scrbld) RNA. C) Summary of swelling-activated whole cell 
conductance (GHypo) measured in CFPAC cells treated with scrambled RNA or after RNA interference 
knockdown of TMEM16A, CLC-3, and CLCA proteins.Mean±S.E., (n) = number of cells measured. #, 
significant inhibition of ICl,swell by RNA interference knockdown of TMEM16A when compared with 
treatment with scrambled RNA (unpaired t test). 
 
 
This result was confirmed in the human colonic epithelial cell line HT29, which also 
expresses TMEM16A, -F, -H, and -J (Fig. IV.5.2A). ICl,swell was activated upon exposure 
to increasing extracellular hypotonicity (17, 25, and 33%, Fig. 2B, arrows). Partial 
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removal of Cl- from the extracellular bath solution (Fig. IV.5.2, white bars, 30 mM Cl-) 
reduced ICl,swell and depolarized Vm by 9.1±0.8 mV (n=7), indicating activation of Cl- 
conductance by hypotonic bath solution. Importantly, activation of ICl,swell was reduced 
by siRNA-TMEM16A (Fig. IV.5.2, B and C). 
 
 
 
Fig. IV.5.2 Activation of ICl,swell in HT29 cells requires TMEM16A channels. A) RT-PCR analysis 
indicates expression of TMEM16A, TMEM16F, TMEM16H, and TMEM16J in HT29 cells.M, marker; A–K, 
TMEM16A-K; Gs, Gl, short and long splice variants. B) Original recordings of whole cell currents in HT29 
cells, activated by a gradual increase of extracellular hypotonicity (17, 25, and 33%, arrows). Cells were 
voltage clamped in intervals from -50 to +50 mV. Partial replacement of extracellular Cl- by gluconate 
(open bar, 30mM Cl-) inhibited whole cell outward currents. Treatment with siRNA for TMEM16A (si16A) 
reduced the swelling-activated whole cell current, when compared with cells treated with scrambled 
(scrbld) RNA. C) Summary of whole cell conductance measured in HT29 cells under control conditions 
(open bars; normotonic bath solution) and after exposure to 33% hypotonicity (black bars). Mean ± S.E., 
(n) = number of cells measured. *, significant increase in whole cell conductance (paired t test). #, 
significant inhibition of ICl,swell by RNA interference knockdown of TMEM16A, when compared with 
treatment with scrambled RNA (unpaired t test). 
 
 
Finally, the role of TMEM16A for ICl,swell was examined in HEK293 cells, which also 
express endogenous TMEM16 proteins (Fig. IV.5.3A). Equal to HT29 and CFPAC 
cells, ICl,swell was activated upon exposure to hypotonic bath solution (Fig. IV.5.3B). 
Partial removal of Cl- from the extracellular bath solution reduced ICl,swell and 
depolarized Vm by 8.2±0.9 mV (n=7). Most important, ICl,swell was inhibited by siRNA-
TMEM16A (Fig. IV.5.3, B and C). 
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Fig. IV.5.3 Activation of ICl,swell in HEK293 cells requires TMEM16A channels. A) RT-PCR analysis 
indicates expression of TMEM16A, TMEM16F, and TMEM16H in HEK293 cells. PCR product of 
TMEM16A becomes only visible when cDNA input was doubled. M, marker; A–K, TMEM16A–K; Gs, Gl, 
short and long splice variants. B) Original recordings of whole cell currents in HEK293 cells, activated by a 
gradual increase of extracellular hypotonicity (17, 25, and 33%, arrows). Cells were voltage clamped in 
intervals from -50 to +50 mV. Partial replacement of extracellular Cl- by gluconate (open bar, 30 mM Cl-) 
inhibited whole cell outward currents. Treatment with siRNA for TMEM16A (si16A) reduced the swelling-
activated whole cell current, when compared with cells treated with scrambled (scrbld) RNA. C) Summary 
of whole cell conductance measured in HEK293 cells under control conditions (open bars, normotonic bath 
solution) and after exposure to 33% hypotonicity (black bars). Mean ± S.E., (n) = number of cells 
measured. *, significant increase in whole cell conductance (paired t test). #, significant inhibition of ICl,swell 
by RNA interference knockdown of TMEM16A, when compared with treatment with scrambled RNA 
(unpaired t test). Experiments in this figure were done by Yuemin Tian (Regensburg), with the exception of 
panel A and are reproduced here with permission. 
 
 
 
Members of the TMEM16 family participate in ICl,swell 
HEK293 cells that express low but detectable amounts of TMEM16A (Figs. 3A and 4A) 
were incubated with two different batches of siRNA and knockdown of TMEM16A was 
verified by real time RT-PCR (Fig. IV.5.4B). Activation of whole cell conductance by 
hypotonic bath solution (GHypo) was potently inhibited by the inhibitor of TMEM16A 
currents, DIDS (100 M)129, the specific inhibitor of Ca2+-activated Cl- currents 
CACCinh-A01248 and tamoxifen (100 M) (Fig. IV.5.4C). We further confirmed the role 
of TMEM16 proteins for swelling-activated Cl- currents by overexpression of exogenous 
TMEM16A or TMEM16B, another Ca2+-activated Cl- channel and member of the 
TMEM16 family249. Overexpression of both TMEM16 proteins augmented swelling-
activated Cl- currents in HEK293 cells (Fig. IV.5.4D). This suggests that several 
TMEM16 proteins may contribute to swelling-activated Cl- currents. We therefore 
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knocked down endogenous TMEM16F, -H, and -J individually or simultaneously, each 
by two different batches of siRNA, which in each case significantly reduced ICl,swell (Fig. 
IV.5.4E). Because knockdown of each TMEM16 protein caused a non-additive 
reduction in ICl,swell, this may suggest that TMEM16 proteins hetero-oligomerize to form 
swelling-activated Cl- channels. In preliminary studies we found that endogenous 
volume-activated Cl- channels in HEK293 cells were potently suppressed by 
expression of K610K-TMEM16A, a TMEM16A mutant that produced very little Cl- 
conductance (unpublished data). 
 
 
 
 
 
Fig. IV.5.4 Activation of ICl,swell in HEK293 cells depends on the presence of TMEM16 channels. A) 
Western blot analysis indicates expression of endogenous TMEM16A in HEK293 cells. B) Real time PCR 
analysis of expression of TMEM16A in HEK293 cells treated with scrambled siRNA (scrbld) and 
TMEM16A-siRNA (si16A). C) Inhibition of swelling-activated whole cell conductance (GHypo) in HEK293 
cells by DIDS (100 M), CaCCinh-A01 (10 M), and tamoxifen (100 M). D) Summary of GHypo in HEK293 
cells expressing empty plasmid (mock), TMEM16A, or TMEM16B. E) Summary of swelling-induced whole 
cell conductance in cells treated with siRNA for various TMEM16 proteins. Mean ± S.E., (n) = number of 
cells measured. #, significant difference when compared with control cells (mock, scrbld, or absence of 
inhibitors) (unpaired t test). Experiments in this figure were done by Yuemin Tian (Regensburg) 
 
Role of purinergic signaling for activation of TMEM16A by cell swelling 
Coexpression of G-protein-coupled receptors has been shown to increase Ca2+-
activated Cl- currents produced by TMEM16A129. Although P2Y2 receptors are 
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expressed endogenously in HEK293 cells, additional expression of exogenous 
purinergic P2Y2 receptors further increased swelling-activated whole cell currents in 
HEK293 cells (Fig. IV.5.5A). Intracellular ATP and swelling-induced ATP release from 
cells has been identified as an important factor for RVD250. Moreover, it has been 
shown that ATP binds to purinergic P2Y2 receptors and activates TMEM16A129. We 
found that blockage of P2Y2 receptors with 100 M suramin largely reduced swelling-
activated whole cell currents (Fig. IV.5.5, B and C), confirming the role of P2Y2 
signalling for ICl,swell. Because ATP release is obviously a critical factor for activation of 
ICl,swell, we exposed the cells to hypotonic bath solution in the presence of the ATP-
hydrolyzing enzyme apyrase, or removed ATP from the pipette filling solution, which 
both significantly reduced ICl,swell (Fig. IV.5.5C). Moreover, TMEM16A has been shown 
to be inhibited by the sulfhydryl reagent MTSET, which reacts with three cysteine 
residues in the putative pore forming loop of TMEM16A129. MTSET also blocked 
swelling-activated whole cell currents in HEK293 cells. Remarkably, the ERK1/2 
inhibitor U0126 completely inhibited ICl,swell thus clearly implying a role of this kinase for 
activation of TMEM16 channels (Fig. IV.5.5C). Notably, also ATP, i.e. Ca2+-activated 
whole cell currents, were reduced by U0126 (data not shown). We further examined 
the contribution of Ca2+ and ERK1/2 for activation of ICl,swell and Ca2+-dependent 
activation of TMEM16A by ATP, using a Ca2+-free solution (in patch pipette and bath) 
and by mutating two potential C-terminal ERK1/2 consensus sides (Ser967 and 
Ser970) in TMEM16A. We found that eliminating Ca2+ abolished activation of 
TMEM16A by ATP and inhibited ICl,swell (Fig. IV.5.5D). Mutating Ser967 to alanine 
inhibited ATP-activated currents, whereas mutating Ser970 to alanine inhibited both 
ATP-activated Cl- currents (TMEM16A) and ICl,swell (Fig. IV.5.5D). Thus both swelling 
activation and ATP-dependent activation of TMEM16A use Ca2+ and ERK1/2 as 
intracellular messengers. Although ICl,swell requires ERK1/2 for activation, Ca2+ has only 
a permissive function251,252. ATP release by swollen cells may activate ERK1/2 at very 
low local extracellular ATP concentrations, and may thereby induce swelling-activated 
Cl- conductance, as reported earlier251. To further demonstrate that ATP and cell 
swelling target the same Cl- channel, we applied ATP before and after exposure to 
hypotonic bath solution (paired experiments). We observed that after activation of 
ICl,swell, ATP-induced (Ca2+ dependent) whole cell currents were largely reduced (Fig. 
IV.5.5, E and F). Similar non-additive effects of ATP and cell swelling on whole cell Cl- 
conductance were observed in HT29 cells (data not shown). 
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Fig. IV.5.5 Role of purinergic signaling for activation of TMEM16A in HEK293 cells by cell swelling. 
A) Activation of whole cell conductance by increased extracellular hypotonicity in cells expressing empty 
plasmid (mock), TMEM16A or TMEM16A together with P2Y2 receptors. B) Swelling activation of whole cell 
currents in a HEK293 cell and inhibition of the current by suramin (100 M; gray bar). C) Inhibition of the 
swelling-activated whole cell conductance by suramin (100 M), apyrase (3 units/mL), ATP-free pipette 
solution, cysteine reagent MTSET (2.5 mM), and the inhibitor of extracellular-regulated kinase (ERK1/2) 
U0126 (25 M). D) Summary of swelling-activated (Hypo) and ATP-induced whole cell conductance in 
TMEM16A expressing HEK293 cells, under control conditions and after removal of Ca2+ from both pipette 
and bath solution. Both ATP and swelling-induced whole cell conductance were reduced under Ca2+-free 
conditions and when two ERK1/2 consensus sites in TMEM16A were mutated. E) Activation of whole cell 
currents by ATP (open bar, 10 M), before and after swelling activation of whole cell currents (Hypo). F) 
Summary of whole cell conductance in the absence and presence of ATP hypotonic bath solution. Mean ± 
S.E., (n) = number of cells measured. *, significant ATP effect (paired t test). #, significant difference when 
compared with control (unpaired t test). §, significant difference when compared with the absence 
ofhypotonic bath solution (unpaired t test). Experiments in this figure were done by Yuemin Tian 
(Regensburg) and are reproduced here with permission. 
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TMEM16 proteins are essential for RVD in HEK293 cells 
To further confirm the role of TMEM16 channels for ICl,swell and RVD we loaded HEK293 
cells with the fluorescence dye calcein253. Hypotonic bath solution induced cell swelling 
and decreased calcein fluorescence, which was followed by a 98% recovery after 20 
min, indicating RVD (Fig. IV.5.6A). Recovery from swelling was reduced in cells treated 
with siRNA-TMEM16A (42% after 20 min). Similarly, inhibition of P2Y2 receptors by 
suramin, or application of the Cl- channel blockers tamoxifen and DIDS or apyrase, all 
significantly reduced RVD (Fig. IV.5.6, A and B). These results obtained in single cell 
measurements were confirmed by FACS analysis of a larger number of cells. HEK293 
cells treated with scrambled siRNA increased their cell volume, which returned to 
control values within 5 min of exposure to hypotonic bath solution (Fig. IV.5.6C). In 
contrast, cells treated with siRNA for TMEM16A did not return to their initial volume, 
demonstrating reduced RVD. Notably, overexpression of P2Y2 receptors together with 
TMEM16A reduced the cell volume of HEK293 cells under control conditions. 
Overexpression of P2Y2 receptors probably sensitizes HEK293 cells toward 
extracellular ATP, thus P2Y2/TMEM16A expressing cells activate Cl- channels more 
rapidly and therefore tend to reduce their cell volume. Moreover, their large RVD 
capacity counteracts any tendency to swell and therefore the cells show only a small 
increase in cell volume when exposed to hypotonic bath solution (Fig. IV.5.6C). We 
determined the rate of recovery from cell swelling and found that not only TMEM16A 
but also the other TMEM16 proteins expressed in HEK293 cells contribute to RVD, as 
demonstrated by siRNA knockdown of the individual TMEM16 proteins (Fig. IV.5.6D). It 
has been reported earlier that cell shrinkage due to opening of ion channels not only 
occurs during hypotonic swelling, but also in normotonic solution, when cells go into 
apoptotic cell death235,254. AVD is an initial step during apoptosis, which can be induced 
by compounds such as staurosporin254. When we exposed HEK293 cells to 
staurosporin we observed a decrease in cell volume, indicating AVD (Fig. IV.5.6E). In 
contrast, knockdown of TMEM16A with two independent siRNAs significantly reduced 
AVD, suggesting that TMEM16A is important for both cell volume regulation (RVD) and 
AVD. 
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Fig. IV.5.6 TMEM16 proteins are essential for RVD in HEK293 cells. A) Swelling (Hypo)-induced 
changes in calcein fluorescence in control HEK293 cells and cells treated with siRNA for TMEM16A or 
suramin (100 M) or DIDS (100 M); mean curve ± S.E. (n=10). B) Summary of the rate of fluorescence 
recovery per second, indicating recovery of the cell volume from hypotonic swelling. Treatment with siRNA 
for TMEM16A or exposure to various inhibitors of ICl,swell inhibited recovery of the cell volume, i.e. RVD. C) 
Hypotonic cell swelling and recovery from cell swelling of cells treated with (i) scrambled RNA, (ii) 
TMEM16A-RNAi, or (iii) coexpressing P2Y2 receptors/TMEM16A, as determined by FACS analysis of 
30,000 cells per experiment. Experiments were performed in triplicate. D) Summary of volume, i.e. 
fluorescence recovery after hypotonic cell swelling of HEK293 cells treated with siRNA for different 
TMEM16 proteins, as determined by FACS analysis of 30,000 cells per experiment. E) Apoptotic cell 
shrinkage induced by staurosporin (2 M) under normotonic conditions in cells treated with two different 
batches of siRNA for TMEM16A (si16A-a and si16A-b), or when treated with scrambled RNA (FACS 
analysis of 30,000 cells). Mean ± S.E., (n) = number of cells measured. *, significant recovery from cell 
swelling of cells treated with scrambled siRNA (paired t test). #, significant differencewhencompared with 
control (unpaired t test). 
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Impaired ICl,swell in epithelial tissues of mice lacking TMEM16 
TMEM16A is expressed at high levels in the submandibular gland and to a lower 
degree in hepatocytes131,137 (Unigene data base). We examined activation of ICl,swell in 
freshly isolated acinar cells from submandibular glands and in hepatocytes of 1-4-day-
old WT (+/+) mouse pups and compared the results with those obtained in cells from 
mice lacking expression of TMEM16A (-/-). Exposure to hypotonic solution of 
submandibular acinar cells from +/+ animals activated a whole cell current that was 
essentially absent in cells from -/- animals (Fig. IV.5.7, A and C). Thus the volume-
activated whole cell conductance was almost abolished in submandibular gland cells 
from -/- mice (Fig. IV.5.7C). In hepatocytes ICl,swell was of similar magnitude in both cells 
from +/+ and -/- animals, however, currents activated in -/- cells showed a different time 
dependence, suggesting some contribution of TMEM16A to ICl,swell also in 
hepatocytes255. Volume-activated Cl- currents have also been identified previously in 
the basolateral membrane of colonic epithelial cells256. Opening of basolateral Cl- 
channels due to exposure to hypotonic bath solution reduced the lumen negative 
transepithelial voltage (Vte) in the distal colonic epithelium (Fig. IV.5.7F). In contrast the 
distal colon from TMEM16A-/- animals showed little changes when exposed to 
hypotonic solution, and thus swelling-induced short circuit currents were significantly 
reduced in the TMEM16A-/- colon (Fig. IV.5.7, F and G). Taken together the data 
clearly indicate that TMEM16A channels contribute to volume-regulated Cl- currents in 
native mouse epithelial cells. The present results suggest that volume-regulated Cl- 
channels may be composed of different members of the TMEM16 family, probably in a 
tissue-specific manner, thus giving rise to variable properties of ICl,swell in different cell 
types and tissues241. As these channels also control apoptotic cell shrinkage, they may 
affect cell survival, which could explain the role of these proteins in tumor 
development245. 
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Fig. IV.5.7 Impaired ICl,swell in epithelial tissues of mice lacking TMEM16A. A and B) Whole cell 
currents and corresponding I/V curves obtained in submandibular acinar cells of TMEM16A knock-out 
mice (-/-) and wild type littermates (+/+) before and after exposure to hypotonic (33%) bath solution. C) 
Summary of the whole cell conductance induced by hypotonic bath solution in WT and knock-out animals. 
Dand E) Whole cell currents and corresponding whole cell conductance obtained in hepatocytes of 
TMEM16A knock-out mice (-/-) and wild type littermates (+/+), before and after exposure to hypotonic bath 
solution. F) Recording of the change in transepithelial voltage (Vte) induced by hypotonic bath solution 
(25%) in WT (+/+) and knock-out (-/-) animals. G) Summary of ion transport, i.e. the short circuit currents 
induced by hypotonic bath solution in WT (+/+) animals and knock-out (-/-) littermates. Mean ± S.E., (n) = 
number of cells measured. *, significant increase in whole cell conductance (paired t test). #, significant 
difference when compared with WT (+/+) (unpaired t test). Experiments in this figure were done by 
Jiraporn Ousingsawat (Regensburg) and are reproduced here with permission. 
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V General Discussion and Perspectives 
 
The complex regulatory network that assures proper electrolyte secretion and 
absorption in epithelia is far from being unraveled. Several mechanisms influence and 
regulate the function of ion channels that mediate cellular responses to various 
extracellular stimuli that constantly challenge epithelial cells. Cellular responses use 
different intracellular signaling pathways but involvement of Ca2+, phospholipids and 
derived second messengers, protein kinases and phosphatases and the dependence 
on the energy status of the cell are usually shared features. 
In the present doctoral thesis, particular aspects on the regulation of ENaC and on the 
role of CaCCs in biological processes, such as intracellular Ca2+ signaling, epithelial ion 
(Cl- and K+) secretion and cell volume regulation, were characterized in detail. Due to 
the complexity of the processes in question, we assessed them separately, so that 
manipulation of each individual variant would give conclusive results. Nevertheless, the 
integration of the results from these independent studies is now required since these 
ion channels are major players of the same network and they function together towards 
the goal of maintaining proper electrolyte secretion and absorption in response to 
different cellular stimuli. We thus aim at providing a more complete understanding of 
the molecular factors involved in the regulation of both epithelial Na+ and Cl- transport 
to elucidate how behavior of the ion channels mediating these conductances are 
affected in the disease state, namely in CF. 
The multitude of symptoms observed in CF, which are hard to conceive with only one 
biological entity having so many distinct roles, can be better understood if we consider 
the variety of interactions of CFTR and other proteins, which are mediated by PDZ 
domains. Indeed, the carboxyl terminus of CFTR contains a PDZ domain binding motif 
that plays several potential roles in CFTR trafficking and interaction with other proteins. 
PDZ proteins are able to form macromolecular complexes, cluster and colocalize 
transport proteins, channels and signaling molecules in specific subcellular domains, 
and modulate protein trafficking257. An example of a protein that binds to the C-
terminus of CFTR is the AMP-dependent protein kinase AMPK179. AMPK inhibits 
channel activity by affecting PKA-dependent stimulation and hence CFTR open 
probability in epithelial cells, mainly through phosphorylation of a Ser residue in the R 
domain considered to be an inhibitory PKA site258. The terminal PDZ domain of CFTR 
also mediates its interaction with the Na+-H+ exchanger regulatory factor (NHERF), 
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which is important for protein kinase C (PKC)--dependent regulation of cAMP-
activated Cl- conductance. PKC- does not directly bind to the channel but does bind to 
receptor for activated C kinase (RACK1) which in turn binds to NHERF1, serving as a 
scaffold protein to anchor the enzyme in close proximity to the channel259. CFTR also 
binds the pleiotropic kinase CK2, although direct phosphorylation by this kinase has not 
yet been confirmed. 
The effect of these two kinase activities, CK2 and AMPK on ENaC activity and 
expression was analysed here in detail (Chapters 1 and 2 of section IV, respectively) 
as they appear as interesting candidates for the coordinated regulation of CFTR and 
ENaC. Indeed, although ENaC is tightly regulated mainly through mechanisms that 
control protein expression, channel density at the cell surface and open probability181, 
the involvement of kinases in ENaC regulation is unquestionable. Such kinases 
(together with phosphatases) are likely to cluster in protein complexes in close 
proximity to plasma membrane ENaC thus facilitating the interaction between ENaC 
(e.g. through PY motifs) and its other regulators, such as Nedd4-2, signalling receptors 
and CFTR (through its PDZ domain). The importance of phosphorylation as an 
intracellular signaling mechanism that activates ENaC is supported by the fact that 
protein phosphatase inhibitors, such as okadaic acid, enhance channel activity, being 
this effect dependent on the presence of cytosolic Mg2+ 163. 
 
ENaC, CFTR and CK2 
CK2 is an essential, constitutively active multifunctional protein kinase that interacts 
with many signaling complexes (p53, ion channels, actin capping at membranes, lipid 
flippases, etc). CK2 controls trafficking and sorting of trans-Golgi proteins, allowing 
proper localization and activity of several membrane ion channels and pumps. CK2 
function affects localization and activity of polycystin-2 (PC2), a divalent cation-
selective channel, whose Ca2+ sensitivity158 and proper ciliary localization are 
maintained by CK2 phosphorylation159. In addition, it regulates the current amplitude of 
voltage-dependent Ca2+ channels161, as well as the Ca2+-dependent gating of small 
conductance Ca2+-activated K+ (SK) channels and SK channels are organized in 
multiprotein complexes together with CK2 and protein phosphatase 2A (PP2A)162. CK2 
phosphorylation is essential for co-localization of nephrocystin with the sorting protein 
PACS-1 at the base of cilia160. 
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CK2 regulates CFTR and its inhibition induces a prompt closure of this Cl- channel (in 
less than 80 s). CK2 becomes plasma membrane-associated when wild type (wt) 
CFTR is present but not when F508del-CFTR is expressed in human airway 
biopsies157. Aditionaly, F508del-CFTR derived peptides have been shown to behave as 
allosteric inhibitors of CK2 by binding to distinct sites in the holoenzyme and interfering 
with CK2 / inter-subunit interaction, altering the proper conformation of the ATP-
binding domain260. It was proposed that impairment of CK2 activity could be the reason 
why loss of one residue (F508) has such a dramatic impact and induces a multi-organ 
disease such as CF260, although these data are still controversial. 
In what concerns ENaC, data presented here (Chapter I of Section IV) show that its 
phosphorylation by CK2 stimulates channel activity as well as membrane expression 
by reducing Nedd4-2 binding to ENaC. A similar scenario had already been proposed 
for activation of ENaC by G protein-coupled receptor kinase 2 (Grk2), in which Grk2-
dependent phosphorylation of Ser-633 on the C terminus of -ENaC reduces the 
affinity of Nedd4-2 binding to ENaC, enhancing ENaC currents69. Analysis of the sites 
phosphorylated by CK2 in its substrates highlights the relevance of negatively charged 
side chains located mostly downstream from the targeted aminoacid (Ser or Thr). 
Because CK2 classically engages in hierarchical phosphorylation with other kinases, 
phosphorylation through either Grk2 or CK2 could control ENaC activity and membrane 
expression depending on the cell type and expression levels of other possible kinases 
involved.  
 
ENaC, CFTR and AMPK 
Unlike CK2 that is constitutively active, AMPK is activated if the intracellular levels of 
AMP increase and ATP concentration decreases. Briefly, upon ATP depletion, AMPK 
activation switches off all cellular ATP-consuming pathways (e.g. fatty acid synthesis 
and sterol synthesis) and switches on alternative pathways for ATP generation (e.g. 
fatty acid oxidation). Accordingly, AMPK has emerged as the potential key mediator for 
transport-metabolism coupling, as this kinase has been shown to regulate nutrient 
transporters, as well as several ion channels such as CFTR177.  
In what concerns ENaC, data presented here (Chapter 2 of Section IV) show that 
AMPK activation also leads to inhibition of ENaC, whose activity is coupled to that of 
Na+,K+-ATPase168,169. Indeed, AMPK also inhibits the basolateral Na+,K+-ATPase giving 
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rise to a very sensitive regulatory system since the Michaelis-Menton constant (KM) of 
this pump for ATP is very low and thus only a drastic reduction of ATP levels would 
alter its activity168. Since AMPK is a sensor of ATP, i.e. the “cellular fuel”, responding to 
changes in cellular ATP concentration, AMPK regulation of ENaC may provide a 
mechanism to adapt electrolyte transport to low oxygen supply and/or metabolic stress. 
AMPK does not directly bind and phosphorylate ENaC, but instead it acts through 
Nedd4-2, by enhancing the association of ENaC  subunit to this ubiquitin ligase, thus 
accounting for an enhanced ENaC turnover upon AMPK activation170. Our data are in 
perfect agreement with this mechanism and provide strong evidence that ENaC is 
inhibited by AMPK through Nedd4-2 and consequent activation of ENaC endocytosis. 
Moreover, data presented here also show that ENaC is regulated in vivo by AMPK and 
this regulation is of physiological significance since enhanced amiloride-sensitive Na+ 
transport is detected in tissues from mice where the -catalytic subunit of AMPK is 
knocked out. Knockout of the AMPK1 gene causes constitutive increase in ENaC 
expression in several epithelial tissues, accounting for enhanced Na+ absorption in the 
respective organs.  
Interestingly, AMPK1 knockout (AMPK1-KO) mice present additional features that 
further contribute to the phenotype observed in these animals. Indeed, a mild renal 
phenotype in AMPK1-KO animals has been reported recently, with marked 
upregulation but reduced phosphorylation of the Na+/2Cl−/K+-cotransporter NKCC2 in 
the thick ascending limb of the loop of Henle176. Additional defects in the red blood cell 
system in AMPK1-KO animals can be found, with the consequence of reduced 
hematocrit and erythrocyte numbers178. Our data confirm previous results 
demonstrating a splenomegaly in AMPK1-KO mice, possibly due to the massive 
amplification of erythroid-nucleated cells178. The complex phenotype indicates multiple 
defects in AMPK1-KO animals and suggests a role of AMPK1 for many still 
unidentified physiological processes. 
 
High-content screens to identify novel regulators of ENaC activity 
Although both CK2 and AMPK significantly affect ENaC activity and expression, these 
are ubiquitously expressed kinases with many cellular substrates and thus hardly 
envisaged as potential targets for the treatment of CF. Therefore, we decided to 
perform high-content screens of human siRNA libraries so as to identify still unknown 
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molecular factors affecting ENaC activity and to better understand the complex network 
that protects the cells (and the organism at different levels) from a huge or deficient 
Na+ load.  
To this end, we performed a live-cell microscopy-based assay in A549 cells 
(expressing ENaC endogenously) using a membrane potential sensitive dye in 
combination with ENaC specific inhibitor, amiloride. Data presented here (Chapter 3 of 
Section IV) evidence the identification of 174 hit genes whose siRNAs showed a 
consistent phenotype on inhibiting ENaC activity (with at least two siRNAs) and other 
50 genes whose siRNAs consistently enhanced ENaC activity.  
Most of the gene products identified in these screens are novel proteins for which a 
role in ENaC regulation had never been described. We used bioinformatic tools to 
classify and group the screen hits and conclusions can be drawn for genes falling in the 
same group. We found a set of gene products that localize to the mitochondria (e.g. 
COX8A, FXC1, TOMM20, AK3, PANK2, ACADS) and we hypothesize that these affect 
ENaC activity indirectly by controlling the cellular energy status which is known to be 
critical for the activation of AMPK, which would in turn lead to ENaC inhibition169,170,200. 
However, it is also possible that they affect ENaC function by controlling instead the 
localization of SGK1, a major player in ENaC regulation, whose subcellular localization 
is still controversial but has recently been attributed to the mitochondria201. 
We also used a combination of experimental tools to classify these genes into 
pathways by interfering with mechanisms known to regulate ENaC. These included: 1) 
inhibition of proteolysis as ENaC activation has been shown to result in consequence 
of several proteolytic evens of its subunits; 2) interefering with glucocorticoid-mediated 
pathways by deprivation of dexamethasone from the culture medium; and 3) knocking 
down the E3 ubiquitin-ligase that most affects ENaC degradation Nedd4-2. We 
observed for instance that one of the hit genes whose effect is sentive to 
downregulation of Nedd4-2 encodes the -subunit of CK2 (CSNK2B). As already 
mentioned, CK2 phosphorylation of - and -ENaC impairs Nedd4-2 binding. The fact 
that a siRNA targeting CSNK2B does not inhibit ENaC in the absence of Nedd4-2 
confirms the involvement of this E3 ubiquitin ligase in the regulation of ENaC by CK2, 
which is in good agreement with our results from Chaper 1. 
The validated hits were also classified according to their effect depending on the 
presence of wt- or F508del-CFTR. The hits that affect ENaC function differentially 
according to whether wt-CFTR protein is present or the mutant version constitute very 
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interesting targets. Although they are only few (11 genes sensitive to wtCFTR and 7 
sensitive to F508del), they indicate that expression of functional CFTR or instead of an 
ER-retained mutant alters cellular machinery that regulate Na+ transport through ENaC. 
Interestingly, a closer look at the hits that no longer affect ENaC function when 
F508del-CFTR is present (F508del sensitive) reveals that 3 out of 7 are also classified 
as belonging to “Class I”, i.e., insensitive either to aprotinin, Dexa removal or siNedd4-2 
(GAS6, GNB2 and PSMB3). GAS6 gene encodes a Ca2+- and receptor-binding protein 
that is present in the extracellular region, while GNB2 encodes in turn a G-protein 
coupled receptor present in the perinuclear region that works as a Ca2+-channel 
regulator with GTPase activity. PSMB3 encodes a subunit of the proteasome. It is still 
unclear why these proteins are no longer activating ENaC when F508del-CFTR is 
present but a role for Ca2+ ion might be antecipated. Intracellular Ca2+ may affect ENaC 
conductance through changes in membrane potential or through regulation of the 
activity of Ca2+-dependent chaperones that are no longer available to interact with 
ENaC when F508del is present. 
 
Role of Bestrophin 1 in epithelia secretion 
Here, we also analysed the role of two different Ca2+-activated Cl- channels, Bestrophin 
1 (Best1) and TMEM16A, on basic biological functions such as Ca2+ signaling and 
volume regulation. Best 1 is upregulated during inflammation and tissue repair124,230, as 
it happens in CF, and it may be responsible for the enhanced Ca2+-dependent Cl- 
conductance observed during inflammation and proliferation124,125. Moreover, enhanced 
Ca2+-dependent Cl- secretion as observed in CF has been shown to be caused by an 
expansion of apical ER Ca2+ stores232. 
Best1 is expressed in the basolateral membrane of the retinal pigment epithelium218. 
However, in human epithelial cells, endogenous Best1 is localized in the ER105,124 and 
its expression depends on cell density and proliferation which is likely to shape 
intracellular Ca2+ transients important for cell proliferation124. Data presented here 
(Chapter 4 of Section IV) show that Best1 is phosphorylated by p21 protein 
(Cdc42/Rac)-activated kinase 2 (Pak2), which is either transiently activated under cell 
stress and by phosphatidylinositol-3 kinase or tyrosine kinase or permanently through 
cleavage by caspase-3219,220. Pak2 is translocated to the ER where it largely augments 
receptor-mediated activation of Ca2+-dependent Cl− and K+ channels in Xenopus 
oocytes.  
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Our results shown here thus suggest that Best1 is a counterion channel in the ER and 
thereby facilitates intracellular Ca2+ signaling in epithelial cells, controlling the activation 
of Ca2+-dependent Cl- (and K+) channels. A counterion channel in the ER would 
balance negative charges left behind upon Ca2+ release and reuptake and avoid 
collapsing of the whole process223. Best1 inhibition reduced the increase (peak) in Ca2+ 
release from the ER stores and delayed the time for recovery from the Ca2+ increase. 
Best1 is probably not the only ER-localized channel since cells lacking the expression 
of endogenous Best1 are able to generate Ca2+ signals. 
 
TMEM16 proteins and volume-regulated Cl- currents 
Since members of the TMEM16 family had been suggested to play a role in 
osmotolerance in Saccharomyces cerevisiae246 we analysed here whether they also 
contribute to swelling-activated Cl- conductance and regulatory volume decrease in 
mammalian cells. Regulation of cell volume is fundamental to all cells, particularly 
during cell growth and division. External hypotonicity leads to cell swelling and 
subsequent activation of volume-regulated Cl- and K+ channels, to release intracellular 
ions and to re-shrink the cells, a process termed regulatory volume decrease234.  
Data presented here (Chapter 5 of Section IV) show that TMEM16A is a major 
component of the Ca2+-activated Cl- channel but it is also necessary for regulatory 
volume decrease (RVD) by mediating the activatation of a whole cell Cl- current after 
exposure to hypotonic solution in different mammalian cells. siRNA targeting 
TMEM16A and compounds that inhibit TMEM16A-dependent currents, such as DIDS 
CACCinh-A01 and tamoxifen, inhibit this swelling-activated Cl- conductance. Similar 
effects were observed upon downregulation of other members of TMEM16 protein 
family (F, H, J), suggesting TMEM16 proteins may hetero-oligomerize to form a 
complete and functional Cl- channel.  
Intracellular ATP and swelling-induced ATP release from cells has been identified as 
an important factor for RVD250. Moreover, secreted ATP binds in an autocrine way to 
purinergic P2Y2 receptors and not only activates TMEM16A129 as it inhibits ENaC. We 
observed that blockage of P2Y2 receptors with suramin, or cell exposure to ATP-
hydrolyzing enzyme apyrase also blocked swelling-activated whole cell currents. 
Similarly, ERK1/2 inhibitor U0126 completely inhibited hypotonicity-induced Cl- current, 
thus clearly implying a role of this kinase for activation of TMEM16 channels. In this 
regard, ATP released by swollen cells may activate ERK1/2 at very low local 
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extracellular ATP concentrations, and may thereby induce swelling-activated Cl- 
conductance251. Simultaneous inhibition of ENaC upon ATP binding to purinergic 
receptors and ERK activation will also decrease Na+ absorption and constitute an 
additional way to fight cell swelling and favor volume recovery. This illustrates how 
mechanisms and pathways are shared inside the cells towards the achievement of 
common goals and functions. 
The present results suggest that volume-regulated Cl- channels may be composed of 
different members of the TMEM16 family, probably in a tissue-specific manner, thus 
giving rise to variable properties of swelling-activated Cl- conductance in different cell 
types and tissues241. 
 
Final remarks and future work 
We believe that the studies presented in this dissertation bring a new insight into the 
expression and regulation of two types of channels of very high relevance to the Cystic 
Fibrosis field, ENaC and CaCCs, which may be crucial for the development of “by-pass 
therapies”, i.e. those aiming at overcoming the ionic defects caused in epithelia by the 
loss of CFTR.  
Particular aspects on the regulation of ENaC and on the role of CaCCs in biological 
processes, such as intracellular Ca2+ signaling, epithelial ion (Cl- and K+) secretion and 
cell volume regulation were assessed separately.  
Primary siRNA screens aimed at identifying regulators of its activity, together with 
validation and classification screens reveal different sets of genes that have an effect 
on ENaC function although through distinct pathways. Most of the genes unravelled by 
these screens are novel proteins for which a role in ENaC regulation had never been 
described and this is the value of “systems” approaches vs traditional (i.e., hypothesis-
driven) ones. Therefore, we attempted to classify these hits into pathways previously 
known to be involved in ENaC regulation, so as to draw conclusions from the 
mechanisms underlying their effect, which may be similar for genes falling in the same 
group. Although this goal was partially acieved, given the complexity of the analyses 
involved and the multiplicity of hypotheses generated, further experiments and more 
integrative mathematical and bioinformatic analyses are essential to fully understand 
the behavior of these genes and its correlation with the levels of active proteases, 
Nedd4-2, glucocorticoids or the presence of wt- or F508del-CFTR proteins. 
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Future work should thus focus on: 
1- To choose a set of genes (from the novel ENaC pathways suggested by the present 
study) to be studied in focused experiments, so as to characterize such pathway(s). 
2- To apply global and integrative mathematical and bioinformatic analyses to the 
obtained data in the ENaC screens and “classification” assays in a systems (modeling) 
approach. 
3- To extend such modelling approach to all results included in the present dissertation 
(and others from the literature) for CFTR, ENaC and CaC, since these three channels 
are major players of the same network and they function together towards the goal of 
maintaining proper electrolyte secretion and absorption in response to different cellular 
stimuli. 
By applying the latter approach, a more complete understanding of the molecular 
factors involved in the regulation of both epithelial Na+ and Cl- transport, in health and 
disease state (in CF in particular), can probably be achieved. 
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VI Appendix 
Buffers and solutions 
Tissue buffer (in mM) NaCl 145, KCI 3.8, D-glucose 5, MgCI2 1, HEPES 5 and Ca2+-
gluconate 1.3, pH 7.4 
Ringer solution (in mM) NaCl 145, KH2PO4 0.4, K2HPO4 1.6, D-glucose 5, MgCI2 1, 
HEPES 5, and Ca2+-gluconate 1.3, pH 7.4 
ND96 buffer (in mM) NaCl 96, KCI 2, CaCI2 1.8, MgCI2 1, HEPES 5, sodium pyruvate 
2.5, theophylline 0.5 and gentamycin (5 mg/L), pH 7.55  
NMDG buffer similar to ND96 buffer but the Na+ ions are replaced by N-methyl-D-
glutamine (NMDG) 
TBS (in mM) Tris 50, NaCl 138 and KCl 2.7, pH 8.0 
PBS (in mM) NaCl 137, KH2PO4 1.8 and Na2HPO4 10.3, pH 7.4 
Pippete solution (patch clamp) (in mM) KCl 30, K-gluconate 95, NaH2PO4 1.2, 
Na2HPO4 4.8, EGTA 1, Ca-gluconate 0.758, MgCl2 1.034, D-glucose 5 and ATP 3; pH 
7.2 
Lysis buffer (in mM) Tris-HCl 50, NaCl 150, Tris 50, DTT 100, NP-40 1%, deoxycholate 
sodium 0.5% and protease inhibitor cocktail 1% 
Phosphorylation buffer (in mM) Tris-HCl 25, MgCl2 5, KCl 150, DTT 1, pH 7.5 
 
Primers and siRNAs 
Table 1 siRNA sequences used 
Gene Name Accession Number Sense strand (5’-3’) 
mNedd4-2  CCAUUUGUCCUAUUUCACCUUCAUU 
xNedd4-2  GCGUGCCUAUGAAUGGAUU 
mCK2  UUGUCAAGAAGAUCUAGGGCCUCC 
hBest1  UGUCCCUGUUGGCUGUGGAUGAGAU 
xBest2a  AUCUGAAUACAUCUCAUCCACAGCC 
xBest2b  GGCGGUGUAAGAUGUUUAACUGGAU 
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Table 2 Primers sequences used in RT- or real time PCR 
Gene Name RefSeq Forward 5’-3’ Reverse 5’-3’
hTMEM16A NM_018043.4 CCTCACGGGCTTTGAAGAG CTCCAAGACTCTGGCTTCGT 
hTMEM16B NM_020373.1 TGGATGTGCAACAATTGAAGA GCATTCTGCTGGTCACACAT 
hTMEM16C NM_031418.2 TCAGAGCAGAAGGCTTGATG AAACATGATATCGGGGCTTG 
hTMEM16D NM_178826.2 TGACTGGGATTTGATAGACTGG GCTTCAAACTGGGGTCGTAT 
hTMEM16E NM_213599.1 TGGAAACATTAAAGAAGCCATTTA GAGTTTGTCCGAGCTTTTCG 
hTMEM16F NM_001025356.1 AGGAATGTTTTGCTACAAATGGA GTCCAAGGTTTTCCAACACG 
hTMEM16GL NM_001001891.3 GCTCTGTGGTGATCGTGGT GGCACGGTACAGGATGATAGA 
hTMEM16GS NM_001001666.3 GGCTCTTACGGGAGCACAG CAAACGAGGACGAAGTCGAT 
hTMEM16H NM_020959.1 GGAGGACCAGCCAATCATC TGCTCGTGGACAGGGAAC 
hTMEM16J NM_001012302.2 CAAACCCCAGCTGGAACTC GGATCCGGAGGCTCTCTT 
hTMEM16K NM_018075.3 CAGGGTCTTCAAACGTCCAT TCATCGTTTCAAAAGCCAACT 
-actin NM_001101 CAACGGCTCCGGCATGTG CTTGCTCTGGGCCTCGTC 
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